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Embryonic stem (ES) cells are pluripotent cells with the ability to self-renew indefinitely. 
These unique properties of ES cells are controlled by genetic and epigenetic factors. The 
aim of our study is to identify, characterize and understand the role of transcriptional 
regulators and chromatin-modifying enzymes in regulating gene expression programs in 
ES cells. Using a combination of genetic and biochemical assays, we have detailed the 
regulatory relationships of Oct4, Sox2 and Nanog at their respective genes. This 
enhances our understanding of the transcriptional regulatory network. Novel 
configurations include autoregulatory and multicomponent loops in regulating these 
essential factors for ES cell pluripotency and self-renewal. Using genome-wide strategies, 
we have reconstructed the Oct4 and Nanog transcription regulatory network. Our study 
has identified a large number of target genes bound and regulated by Oct4 and Nanog. 
Oct4 and Nanog also share a substantial portion of their targets, indicative of 
cooperative regulation. The map of ES cell circuitry that we have generated may serve as 
a useful guide in identifying additional components of the regulatory network important 
for self-renewal, pluripotency and differentiation of ES cells. We uncover new regulatory 
nodes in the network by identifying downstream effectors responsible for implementing 
the decision of Oct4 and Nanog. Esrrb, Rif1 and Zic3 are required for the maintenance of 
self-renewal and pluripotency in ES cells. Lastly, we have elucidated the link between 
transcriptional circuitry and epigenetic regulation of ES cell chromatin. We have showed 
that Oct4 controls the expression of genes which encode for Jmjd1a and Jmjd2c histone 
H3 lysine 9 histone demethylases. We further confirm that these demethylases maintain 
the undifferentiated state of ES cells through their regulation of the H3K9me status at the 
vii 
promoters of pluripotency genes such as Tc1l and Nanog. In conclusion, our studies have 
made important contributions toward elucidating the genetic and epigenetic mechanisms 
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3.1 AN OVERVIEW OF EMBRYONIC STEM CELLS 
 
Embryonic stem cells are derived from the pre-implantation embryo, and can be 
expanded in culture while retaining the ability to participate in multi-lineage 
differentiation. Recent isolation of human ES cells (hES) has dramatically elevated the 
interest of using embryonic stem cells as renewable source of differentiated cells that 
could be used to replace diseased or damaged tissue. Accomplishments in the embryonic 
stem cells field are deeply rooted in past research that have started many decades ago. 
This section of the introduction will evaluate the crucial discoveries and findings that led 
to the current status of embryonic stem cells research. 
 
3.1.1 Teratocarcinoma and embryonal carcinoma 
 
Teratomas and malignant teratocarcinomas are spontaneously occurring tumors that are 
found at the gonads and extra-gonadal tissues. The incidence of these tumors is relatively 
rare in mice, except for strains like mouse strain 129 where teratocarcinomas arise 
spontaneously in testicular tissue in 1% of the population (Stevens and Little, 1954). 
 
Teratomas and teratocarcinomas share two important features. Firstly, they are 
tumourigenic, a property which is exemplified by their rapid growth following repeated 
subcutaneous or intraperitoneal transplantation into the mouse. Secondly, they possess 
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properties of pluripotency as reflected by their multi-lineage composition (Fig 1) and 
their ability to give rise to tumors of differentiated adult tissues upon transplantation into 
mouse. 
 
In 1964, Kleinsmith and Pierce showed that single cells from teratocarcinomas retain the 
tumourigenic and pluripotent capacity to form multi-lineage tumor when injected into 
mice. This finding established that unique stem cells residing in the teratocarcinomas 
could confer both the ability to grow indefinitely as a tumor and the capacity to 




In 1970, two groups reported the derivation of teratocarcinomas from adult mice grafted 
with early mouse embryos (Solter et al., 1970; Stevens, 1970). Further experiments led to 
the discovery that teratocarcinomas can only be produced by injecting embryos at stages 
prior to gastrulation. Moreover, only grafts containing the embryonic epiblast give rise to 
tumor formation (Diwan & Stevens 1976). These findings indicated the embryonic origin 
of teratocarcinomas.  
 
Embryonal carcinoma cells (ECC) are derived from teratocarcinoma fragments. These 
Figure 1 Mouse teratomas and teratocarcinomas. (a) Mouse teratomas showing a haphazard 
mixture of mature adult tissues. (b) Mouse teratocarcinoma showing nests of embryonal 
carcinoma cells. (Adapted from Solter, 2006)  
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cells can be expanded continuously in culture (Fig 2) while retaining the ability to 
differentiate both in vitro or via teratocarcinoma formation in a mouse host. Clonally 
isolated and expanded EC cell lines retain the capacity for differentiation and are able to 
produce derivatives of all three primary germ layers namely the ectoderm, mesoderm, 
and endoderm (Kleinsmith and Pierce, 1964; Martin and Evans, 1975c). The most 
stringent demonstration of pluripotency of the EC cell lines came from the seminal work 
by Brinster in 1974. EC cells introduced into early mouse embryos were able to 
participate in embryogenesis and contributed to derivatives of germ layers in both 
chimeric fetuses and live-born mice. The findings suggest that EC cells are receptive to 
cues in the microenvironment of the embryo. 
 
Varying successes were achieved in subsequent experiments to test for germline 
transmission with EC cell lines. One group described the contribution of EC cells in 
germline chimerism. Notably the malignant phenotype of EC cells was completely 
reversed as no tumor was detected in the EC cell-injected mice (Mintz and Illmense, 
1975; Illmensee and Mintz, 1976; Stewart and Mintz, 1981; Stewart and Mintz, 1982). In 
most cases however, EC cell lines have the tendency to produce embryonic tumors, 
contribute poorly to chimeras and give rise to low levels or no germline transmission 
(Papaioannou et al., 1975; Papaioannou et al., 1978; Rossant and McBurney, 1982). The 
aneuploid nature of most EC cells could account in part for its restricted ability to 
Figure 2 F9 embryonal carcinoma 
cell line. (Adapted from Solter, 
2006).  
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proceed through meiosis and produce mature gametes. 
 
The information obtained from research on teratocarcinoma and EC cells established a 
critical foundation for the subsequent isolation of the “true” stem cells from the 
mammalian embryo capable of continuous culture while retaining full developmental 
potency. 
 
3.1.2 Derivation of mouse embryonic stem cells 
 
The inability of EC cell lines to reproducibly contribute to chimeric mice and the problem 
of recurring tumors when introduced in vivo are limitations for its use as a model for 
early embryogenesis. As a result, there are great interests to determine whether cells of 
pluripotent properties can be obtained directly from the embryo itself. 
 
Mitotically inactivated embryonic fibroblasts are traditionally used in the culture of EC 
cells (Martin and Evans, 1975c; Martin et al., 1977). Co-culturing with these feeder cells 
increases the efficiency of establishing EC cells and enhances their differentiation 
capacity. Because feeder cells support the growth of EC cells, the first derivation of 
pluripotent cell lines directly from the mouse blastocysts (embryonic stem cells) was 
performed on division-incompetent mouse fibroblasts (Evans and Kaufman, 1981; Martin, 
1981) (Figure 3 and Figure 4). As in the case of the EC cells, culturing the embryonic 
stem cells (ES) on the mouse fibroblasts was crucial for their growth and maintenance 
(Figure 3). Repeated dissociation and re-plating onto feeder cells eventually gave rise to 
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clonal secondary colonies that were expanded further as continuous ES cell lines 








Figure 4 Derivation of embryonic stem cells. Fertilized egg develops into the blastocyst which 
consists of trophectoderm and the inner cell mass (ICM). ES cells can be derived from the ICM 
cells cultured under appropriate conditions, for example in LIF or on feeder fibroblasts cells. 
When injected into mice, these cells can differentiate and give rise to teratoma formation. These 
cells can also be integrated into the embryo and give rise to all cell lineages in the body, 
including the germ cells (chimeric mouse). (Adapted from Nishikawa et al., 2007). 
Figure 3 D3 mouse embryonic stem cell 
line on fibroblast feeder layer. (Adapted 
from Solter, 2006) 
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ES cells show striking resemblance to the EC cells in terms of morphology (Figure 3), 
propagation in culture and ability to differentiate extensively in vitro. Like EC cells, ES 
cells are capable of forming embryoid bodies that consist of cells from multiple lineages 
(Doetschman et al., 1985). These embryoid bodies are morphologically similar to the 
early post-implantation mouse embryos and are known to recapitulate the process of 
development. For this reason, embryoid bodies are used as a model to study early 
embryonic differentiation and morphogenesis (Martin and Evans 1975a; Martin and 
Evans 1975b; Martin, 1975). Mouse ES and EC cells also express similar markers 
including alkaline phosphatase and SSEA1 (stage-specific embryonic antigen 1). For 
both cell types, SSEA3 and SSEA4 are only expressed during differentiation (Solter and 
Knowles, 1978; Fenderson et al., 1987; Henderson et al., 2002). Their similarities extend 
to the formation of teratocarcinomas in mice (Figure 4). When injected, ES cells give rise 
to tumors that contain mesodermal, ectodermal, and endodermal cell types (Evans and 
Kaufman, 1983).  
 
Despite these similarities, EC and ES cells behave differently in vivo. These differences 
would later become the foundation on which the ES cells prove its superiority as a model 
for cells from the early embryo. ES cells display high consistency in their ability to 
integrate into the embryo, contribute extensively to the germ layers cells and produce 
viable chimeras (Bradley et al., 1984) (Figure 4).  
 
In comparison to transformed tumor cell lines like EC cells, ES cells are able to retain 
normal diploid karyotype even after extensive passages in the laboratory. This has 
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enables ES cells to generate functional gametes that can colonize the germ cell lineage 
(Bradley et al., 1984). The potential for germline chimerism is important as it enables the 
creation of mice with transgenic genotypes (Gossler et al., 1986; Robertson et al., 1986). 
In combination with gene targeting and homologous recombinations, mouse ES cells 
become one of the most essential and useful tools for the study of gene functions in vivo 
(Thomas and Capecchi, 1986; Thomas et al., 1986; Kuehn et al., 1987; Doetschman et al., 
1987; Thomas et al., 1987; Thompson et al., 1989).  
 
3.1.3 Embryonic germ cells  
 
The derivation of the EC cells from teratocarcinomas of the mouse testes led to attempts 
to isolate stem cells from the germline. 
 
The establishment of founder germ cells takes place in embryos after the implantation 
stage of development (Surani et al., 2004). Presumably, BMP signals from the 
extraembryonic ectoderm induce the specification of the precursor germ cell in the 
adjacent proximal epiblast (Matsui and Okamura, 2005) (Figure 5). The primordial germ 
cells (PGCs) which originated from a pluripotent cells of the proximal epiblast are 





Pluripotent stem cells can be derived from early PGCs by addition of basic fibroblast 
growth factor (Fgf2) to the culture medium (Matsui et al., 1992). These cells are known 
as embryonic germ (EG) cells and are highly similar to ES cells. EG cells can be 
maintained indefinitely in culture and contribute efficiently to chimeras (Labosky et al. 
1994, Stewart et al. 1994). EG cells are also capable of germ line transmission, which 
distinguishes it from its PGC precursor (Labosky et al. 1994, Stewart et al. 1994). 
Previous studies show that the developmental potential of the EG cells correlates with the 
stage of PGCs at which the EG cells are derived. Later stage PGCs appear compromised 
in their ability to produce fully pluripotent EG cells (Tada et al. 1998). Recent studies 
however have reported the isolation of pluripotent cell lines similar to ES cells from 
neonatal mouse testis (Kanatsu-Shinohara et al., 2004). Furthermore, these ES-like cells 
formed germline chimeras when injected into blastocysts. Thus, the capacity to form 
multipotent cells persists in the neonatal testis. 
Figure 5 Induction and localization of PGC precursors. (Adapted from Matsui and Okamura, 
2005). 
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3.1.4 Embryonic stem cells derived from other species 
 
In view of the potential uses of pluripotent cells, various attempts have been made to 
isolate ES cells from other mammals. Rat embryonic stem cell lines that show some 
characteristics of the mouse ES cells have been derived and established at high efficiency. 
These cells are however not pluripotent and are unable to form germline chimaeras 
(Vassilieva et al., 2000). Similarly, pluripotent cells with some features of the mouse ES 
cells were isolated from nonhuman primates (Thomson et al. 1995, Thomson and 
Marshall, 1998). 
 
Teratocarcinomas occur in human and several human EC cell lines have also been 
isolated. Mouse teratocarcinomas and EC cells were used previously as a model for 
pluripotent cells. The subsequent isolation of mouse ES cells which have unlimited self-
renewal and ability for multi-lineage differentiation has fueled much interest in 
establishing similar embryo-derived cell lines of human origin. Potentially, embryo-
derived cells from human can recapitulate early embryonic developmental processes of 
the otherwise inaccessible human embryo. The ability to derive multiple lineages from 
ES cells also opens exciting new opportunities for generating cells and tissues for 
transplantation for the treatment of a broad spectrum of diseases like diabetes and 
Parkinson’s disease (Donovan and Gearhart, 2001).   
 
The isolation of human embryo-derived stem cells has lagged significantly behind their 
mouse counterpart. This is partly due to the difficulties involved in obtaining suitable 
human embryonic material as well as the potential legal and ethical dilemmas. It was not 
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until 1998 that the derivation of cell lines directly from the human blastocysts (human ES 
cells) was achieved (Thomson et al., 1998) (Figure 6). In parallel, Gearhart and 





Human ES cells are very similar to mouse ES cells in culture. They grow as colonies of 
tightly packed cells on inactivated mouse embryonic fibroblast feeders or in conditioned 
medium (CM) derived from feeder cells (Xu et al., 2001) (Figure 6). Human ES cells also 
have the potential to form teratomas and to differentiate in vitro into all three germ layers, 
namely the ectoderm, endoderm, and mesoderm (Amit et al., 2000; Itskovitz-Eldor et al., 
2000; Reubinoff et al., 2000; Schuldiner et al., 2000; Odorico et al., 2001; Xu et al., 
2002). Many markers characteristic of undifferentiated mouse ES cells, including Oct4, 
Nanog, Sox2, and Utf1, are also expressed in the human ES cells. 
 
Nevertheless, important differences exist between human and mouse ES cells in their 
growth rates, culture requirements, and marker expression (Table 1). This divergence has 
generally been ascribed to fundamental differences in the pathways that regulate self-
Figure 6 H7 human embyonic 
stem cell line grown on fibroblast 
feeder cells. (Adapted from Solter,
2006)  
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renewal, apoptosis, and proliferation (Richards et al., 2004; Ginis et al., 2004). Some of 
the differences include SSEA1, SSEA3, and SSEA4 expression (Thomson et al., 1998), 
the ability to differentiate into trophoblasts (Xu et al., 2002) and dependency on leukemia 
inhibitory factor (LIF) (Reubinoff et al., 2000, Thomson et al., 1998). Recent studies 
have also indicated that mouse and human ES cells might represent pluripotent cells of 
different development stages (Tesar et al., 2007; Brons et al., 2007). Due to ethical 
reasons, human ES cells were not tested for chimaeras or germ line colonization. 
Therefore, it remains unknown whether human ES cells are truly equivalent to mouse ES 
























Table 1 Pathways known to be 
important in mouse ES cells that 
are not evolutionarily conserved 
in human. (Adapted from Rao, 
2004) 
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3.1.5 Multilineage differentiation of embryonic stem cells 
 
ES cells hold great promise in regenerative medicine as an unlimited source of cells and 
tissues.  Accumulating evidence indicate that there is no intrinsic limitation to the ability 
of ES cells to differentiate and produce every cell type of the organism (Figure 7). The 
limiting factor seems to be the availability of suitable culture conditions that can direct 





Differentiation of ES cells can be triggered by the formation of aggregates known as 
embryoid bodies (EB) in suspension culture (Figure 8). This technique was originally 
developed with the EC cells (Martin and Evans, 1975c; Martin et al., 1977). Each 
embryoid body develops into cells of multiple lineages. Further differentiation can take 
place on subsequent attachment and outgrowth onto culture plates as a monolayer. The 
Figure 7 Differentiation of the ES cells. Highlighted in blue are lineages colonized by ES 
cells in vivo. ES cells can produce hypoblast derivatives in vitro but rarely do so in vivo.
(Adapted from Smith, 2001) 
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basic principle behind the EB method is to mimic the process of embryonic development. 
In EBs, the developmental program appears to be reactivated in the ES cells. Cellular 
differentiation proceeds in a manner similar to that in the embryo but in the absence of 
axial organization or body plan (Doetschman et al., 1985). Many lineages, including 
neuronal and mesoderm cells have been shown to be readily generated using EB 
formations. Gut endoderm marker gene expression in the EBs has also been reported 
(Abe et al., 1996; Levinson-Dushnik and Benvenisty, 1997). Recent studies demonstrate 
that the precursors of germ cells can be induced using EBs (Hübner et al., 2003, Toyooka 
et al., 2003, Geijsen et al., 2004). Because of its convenience, EB culture has become the 
standard method for inducing ES-cell differentiation in both mouse and human ES cells. 
EB induced differentiation invariably results in a heterogeneous mixture of cell types. In 
view of that, other methods have been developed either to direct differentiation into 
specific lineages or to enrich for cells of interest. 
 
One such approach is to co-culture ES cells with feeder stromal cell lines (Figure 8). 
Feeder cells are thought to provide a highly selective microenvironment to induce guided 
differentiation. The OP9 stromal cell line supports the differentiation of ES cells to 
mostly haematopoietic lineages, including T and B lymphocytes (de Pooter et al., 2003), 
as well as other mesoderm lineages such as paraxial mesoderm (Sakurai et al., 2006; 
Nishikawa et al., 1998). On the other hand, PA6 stromal cell line induces selective 
differentiation of ES cells to the neuronal lineage. Recently, immortalized midbrain 
astrocytes have also been used as feeder cells to induce the differentiation of ES cells to 






An alternative approach to obtain specific cell type is to enrich and purify the cell of 
interest from a mixed population of cells resulting from ES differentiation. One strategy 
is to purify specific differentiated phenotypes based on expression of marker genes. 
Using fluorescence-activated cell sorting (FACS), Nishikawa isolated clonogenic 
endothelial and hematopoietic progenitors from mesodermal subsets produced during 
Figure 8 Comparison of the three protocols for ES-cell differentiation. Embryoid body 
formation, feeder cell culture and defined condition. Each method has specific merits 
and drawbacks, several of which are enumerated in the figure. (Adapted from 
Nishikawa et al., 2007) 
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monolayer differentiation on a collagen substratum (Nishikawa et al. 1998). Another way 
is to introduce transgenes that confer drug resistance or cell sorting capacity to isolate a 
particular subset of cells. A selection marker/reporter can be placed under the control of a 
promoter that is expressed only in the cell type of interest. An advantage of the selection 
route in isolation of somatic stem cells/precursors is that the drug can be maintained to 
eliminate differentiating progeny and facilitate continued amplification of the lineage 
precursors (Li et al., 1998). 
 
A major challenge in ES-cell differentiation is to achieve the process of cell specification 
using fully defined media supplemented with specific inductive factors that serve as 
extrinsic stimulation to generate specific type of mature cells with high purity (Figure 8). 
The main obstacle of doing so is the difficulty to control culture conditions fully and the 
need to optimize the best conditions required for each lineage. Despite the intractable 
problems, efforts have been made to induce ES-cell differentiation under chemically 
defined conditions that are serum-free, in the absence of EB formation. Ying and co-
workers have reported that ES cells cultured on gelatin-coated dishes with serum-free 
medium differentiate selectively to Sox1 positive neuronal cells (Ying et al., 2003). Two 
serum-free culturing conditions for definitive endoderm and visceral endoderm 
differentiation were also reported. The culturing conditions are based on the SFO3 
serum-free medium that contains insulin, transferrin and bovine serum albumin (Tada et 
al., 2005; Yasunaga et al., 2005). Hematopoietic cells have also been shown to be readily 
enriched and expanded by culture in semi-solid media in the presence of hematopoietic 
growth factors (Wiles and Keller, 1991). 
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3.2 MOLECULAR MECHANISMS GOVERNING SELF-RENEWAL AND 
PLURIPOTENCY OF ES CELLS 
 
Although mouse ES cells were first isolated more than 20 years ago, little is known about 
the mechanisms that bestow their unique properties. To date, extrinsic growth factors and 
intrinsic transcriptional regulators are found to support the propagation and multi-lineage 
potential of the ES cells 
 
3.2.1 Extrinsic factors critical for ES cells self-renewal 
 
Several exogenous growth factors that are involved in signaling pathways are known to 
modulate mouse ES cell pluripotency and self-renewal. In contrast to primary cultures of 
somatic cells, ES cells can be propagated indefinitely without showing any sign of 
senescence. However the maintenance of the undifferentiated stem cell phenotype is not 
cell autonomous. Co-culture with a feeder layer was found to be essential for the 
continued propagation of the ES cells. Subsequent studies revealed that conditioned 
media can substitute the use of feeders (Smith and Hooper, 1987). This finding suggests 
that the essential factor for ES cells is secreted into the medium by the feeder cells. It was 
later uncovered that a cytokine, Leukemia inhibitory factor (LIF) sustains ES cell self-
renewal in the absence of the feeders (Smith et al., 1988; Williams et al., 1988). Upon 
withdrawal of LIF, proliferation slows down and differentiation is induced in mouse ES 
cells (Niwa et al., 1998). Studies have also confirmed that LIF is produced by the feeder 
cells, and its expression is stimulated by the presence of ES cells (Rathjen et al., 1990). 
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Importantly, feeder cells without the functional Lif gene do not support ES cell 
propagation effectively (Stewart et al., 1992).  
 
LIF exerts its effect by binding to the gp130 heterodimer receptor (also known as LIF 
receptor) on the cell membrane and activating the downstream signaling pathways. 
Binding of LIF results in JAK kinase-mediated recruitment of Stat3 (Figure 9). Stat3 
undergoes phosphorylation and dimerization before translocating to the nucleus, where it 
functions as a transcription factor. Inhibition of Stat3 causes differentiation of mouse ES 
cells (Niwa et al., 1998). By using a conditional active form of Stat3 that is induced by 
tamoxifen (a STAT3–oestrogen-receptor (ER) fusion protein), Matsuda and co-workers 
have provided evidence that activation of this transcription factor alone is sufficient to 
support ES cell self-renewal in medium without LIF (Matsuda et al., 1999). These results 
confirmed that Stat3 is the downstream effector of the LIF signaling pathway.   
 
LIF and LIF receptor are expressed in the early embryo (Nichols et al., 1996). Although 
LIF is required in vitro for the derivation and preservation of pluripotent ES cells, mouse 
embryos lacking the lif gene can develop to a stage subsequent to that at which ES cell 
are derived (Stewart et al., 1992; Ware et al., 1995; Yoshida et al., 1996). Further 
investigation has uncovered the in vivo role of LIF during embryonic diapause. Embryos 
lacking gp130 fail to recover after diapause, owing to an inability to maintain the epiblast 
(Nichols et al., 2001). The results suggest that signaling through gp130 is essential to 
prolong the epiblast lifespan.   
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Interestingly, LIF is only able to sustain ES cells in the presence of serum. This suggests 
that additional factors found in the serum are required for ES cell maintenance. BMP4, a 
signaling factor present in the serum is known to modulate and support mouse ES cell 
self-renewal. Intriguingly, the presence of both LIF and BMP4 is sufficient to maintain 







In the embryo, BMP4 is an anti-neurogenesis factor. Similar to LIF, mouse embryos 
without BMP4 can also develop past the stage at which ES cells can be derived (Fujiwara 
et al., 2001). In the presence of LIF, it is proposed that BMP4 enhances the self-renewal 
and pluripotency of ES cells by the activation of gene encoding the transcription factor 
Smad4 (similar to mothers against decapentaplegic homologue-4). Smad4 in turn, 
Figure 9 Model of signaling pathways maintaining ES cell self-renewal. LIF and BMP act 
together to block differentiation. LIF activates STAT3 and blocks non-neural differentiation. 
BMP blocks neural differentiation by induction of Id proteins. (Adapted from Chambers and 
Smith, 2004) 
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activates members of the Id (inhibitor of differentiation) gene family, which prevent 
neuronal specifications (Ying et al., 2003) (Figure 9). In contrast, in the absence of LIF, 
BMP4 counteracts the LIF cascade, by interacting with Smad1 and Smad5 transcription 
factors that have inhibitory effects on the Id genes. Thus it seems that the balance 
between LIF and BMP4 is jointly responsible for maintaining the undifferentiated state of 
the mouse ES cells (Figure 9).  
 
Interestingly BMP proteins have been suggested as targets of another ligand pathway that 
is activated by the binding of WNT to its receptor (Haegele et al., 2003). WNT proteins 
are secreted glycoproteins that have widespread roles in tissue differentiation and 
organogenesis (Cadigan and Nusse, 1997). In mouse embryos, Wnt5a and Wnt11 are 
expressed during the morula to blastocyst transition stages.  
 
The canonical WNT pathway is activated when the WNT protein binds to the Frizzled 
receptor on the cell membrane. This leads to inhibition of GSK3 (glycogen-synthase 
kinase-3), and the subsequent translocation of β-catenin to the nucleus resulting in the 
expression of downstream target genes. Genetic manipulations of the WNT pathway 
suggest a role in lineage specification and the prevention of differentiation. The 
dominant-active form of the β-catenin results in the inhibition of neural differentiation in 
vitro (Haegele et al., 2003). The same phenotypes are also observed by the activation of 
downstream targets of WNT signaling, such as cyclin-D1 (Shtutman et al., 1999), 
MYC36 and BMP proteins (Haegele et al., 2003).  
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3.2.2 Genetic factors regulating ES cells 
 
The signaling pathways stimulated by the exogenous factors eventually reach the ES cell 
nucleus and result in transcriptional induction or repression of genes responsible for 
implementing the “stemness” state of the ES cells (Figure 10). In addition to these 
extrinsic signals, the intrinsic nuclear transcription factors like Oct4, Nanog and Sox2 are 









Figure 10 Signalling pathways and intrinsic factors involved in maintaining mouse 
ES cells pluripotency. (Adapted from Boiani and Schöler, 2005) 
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3.2.2.1 Transcription factor Oct4  
 
Oct4 is a POU domain-containing transcription factor encoded by the Pou5f1 gene. 
Expression of Oct4 occurs in the unfertilized egg and in the early embryo during the 
cleavage stages prior to the segregation of the ICM from the trophectoderm (TE) (Pesce 
and Scholer, 2001). Subsequently, expression of Oct4 is maintained in the epiblast of pre- 
and post-implantation embryos before becoming restricted to the migratory primordial 
germ cells (Yeom et al., 1996; Palmieri et al., 1994). Oct4 expression is downregulated 
in the TE, primitive endoderm and the extraembryonic and somatic lineages (Palmieri et 
al., 1994). Interestingly, expression of Oct4 persists in the mature gametes, where Oct4 
mRNA can be readily detected in the oocytes (Pesce et al., 1998). Hansis and co-workers 
have examined the expression of Oct4 in the human blastocysts. The results showed that 
the level of Oct4 mRNA in ICM cells is 30 times higher than in the TE cells. These 
studies suggest that the expression pattern of Oct4 is very similar between mouse and 
human embryos (Hansis et al., 2000; Hansis et al., 2001). 
 
Oct4-deficient embryos develop to the blastocyst stage but do not give rise to the ICM. 
Instead, the Oct4-null embryos contain only trophectoderm cells (Nichols et al., 1998).  
When these embryos are allowed to attach in vitro and outgrow on culture plate, the 
resultant colonies consist entirely of trophectodermal cells (Nichols et al., 1998). In 
human ES cells, depletion of Oct4 expression by RNAi causes the cells to differentiate 
towards the trophectodermal lineage (Zaehres et al., 2005). Therefore, Oct4 plays a 
central role in the prevention of differentiation towards the trophectoderm and somatic-
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cell lineages while maintaining the pluripotent state of the ICM during embryonic 
development (Figure 14). Consistent with its role as the repressor of trophectoderm 
lineage commitment, Oct4 is found to repress the expression of Cdx2, a critical regulator 
of trophoblast cells (Niwa et al., 2005). In addition, manipulation of Oct4 expression 
using inducible Oct4 transgenes indicates that over-expressing Oct4 in mouse ES cells 
results in differentiation that gives rise to endodermal and mesodermal markers (Niwa et 
al., 2000). Thus Oct4 has an essential role in controlling pluripotency, and the relative 






Oct4 is a member of a group of transcription factors that bind the octamer sequence 
(ATGCAAAT). An important feature of the POU family of transcription factors is the 
POU domain. This domain consists of two structurally independent sub-domains 1) a 75 
amino-acid amino-terminal POU specific (POUs) region and 2) a 60 amino-acid 
carboxyl-terminal homeodomain (POUh) (Scholer, 1991) (Figure 11). The POUs and 
POUh sub-domains are connected by a variable linker of 15 to 56 amino-acids. Both 
domains are also known to interact with DNA through the helix-turn-helix structure 
(Klemm et al., 1994). When the POU domain is replaced with DNA binding domain 
Figure 11 Schematic illustration of the Oct4 protein. Both the carboxyl- (C) and amino-
(N) domains confer transactivation activity. The C domain behaves differently from the N 
domain with respect to cell type-specific transactivation. (Adapted from Pan et al., 2002) 
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from other transcriptional factors (e.g. Gal4), the transactivation function of the fusion 
protein is not affected (Brehm et al., 1997). This suggested that the general 
transactivation activity does not reside in the POU domain. It was later reported that the 
Oct4 carboxyl-domain and amino-domain are responsible for its transactivation functions 
(Figure 11). Furthermore, the activity of Oct4 carboxyl-domain is cell-type specific and is 
regulated through phosphorylation (Brehm et al., 1997; Brehm et al., 1998; Brehm et al., 
1999). The cell type specificity is observed only if the domain is linked to the POU 
domains but not when the POU domain is replaced with Gal4 DNA binding domain 
(Brehm et al., 1997). This finding indicates that Oct4 POU-domain may serve as 
interaction sites for cell type-specific regulatory factors. Later studies have revealed that 
the POU-domain is central to the interaction of Oct4 with another pluripotent factor Sox 
via the HMG domain (described in greater detail in later section).  
 
Given its critical role in sustaining the developmental potential of the ES cells and early 
embryo, Oct4 activity is tightly regulated so as to ensure proper differentiation and 
continuity of the germline. Regulation of Oct4 expression is achieved at the transcription 
level by the cis-acting elements located upstream of the Oct4 gene (Ben-Shushan et al., 
1993). Yeom and co-workers identified two elements, the proximal enhancer (PE) and 
the distal enhancer (DE) that are required for the cell-type specific expression of Oct4 
(Yeom et al., 1996). In vivo footprinting experiments have also identified the exact 
binding sites for transcription regulators within the PE and DE enhancers (Figure 12) 
(Yeom et al., 1996). Comparative analysis of the human, bovine, and mouse Oct4 
upstream promoter sequences has revealed four conserved homology regions between 
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these species (CR1 to CR4) (Nordhoff et al., 2001) (Figure 12). Importantly PE overlaps 
with the CR2 and CR3 while the DE overlaps with the CR4 respectively. This suggests 
that evolutionarily conserved elements may regulate the activity of the proximal (PE) and 
the distal enhancer (DE). Additionally, putative Sp1/Sp3 binding site and an overlapping 
hormone responsive element (HRE) identified in the CR1 were found to be among the 








Several transcriptional regulators bind to the conserved regions of the Oct4 promoters 
and regulate its expression. Sall4 (a spalt family member) is a transcriptional activator 
that binds to the highly conserved distal enhancer of the OCT4 gene and regulates its 
expression in vivo and in vitro (Zhang et al., 2006). Hummelke and Cooney reported that 
germ cell nuclear factor (GCNF), an orphan nuclear receptor, is able to repress Oct4 gene 
activity by binding to the sequence within the proximal enhancer (Hummelke and 
Figure 12 The upstream regulatory elements of the Oct4 gene. DE, distal enhancer, and 
PE, proximal enhancer, are important for regulating Oct4 expression. In addition, four
regions that are highly conserved among human, bovine and mouse Oct4
promoter/enhancer elements (green box 1-4). Multiple potential binding sites for 
transcription factors that can either activate (red) or repress Oct4 (black) expression are 
also shown. (Adapted from Pan et al., 2002) 
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Cooney, 2001; Fuhrmann et al., 2001). In Gcnf deficient mice, unrestricted and aberrant 
expression of Oct4 was observed in gastrulation stage embryo (Fuhrmann et al., 2001). 
The results indicate that GCNF is responsible for the repression of Oct4 gene expression 
during embryogenesis and stem cell differentiation. 
 
Epigenetic inactivation of Oct4 by histone H3 lysine 9 methylation of the chromatin 
structure mediated by SET-containing protein G9a has been reported (Feldman et al., 
2006). The histone methylation step is proposed to set the stage for local 
heterochromatinization via the binding of HP1 and is required for subsequent de novo 
methylation at the promoter by the enzymes Dnmt3a/3b (Feldman et al., 2006). Previous 
study by Ben-Shushan and co-workers have reported that the repression of Oct4 activity 
in stem cells-fibroblast hybrid cells was accompanied by rapid DNA methylation of 
regulatory sequences such as PE and DE in the Oct4 regulatory region (Ben-Shushan et 
al., 1993) (Figure 12). Thus epigenetic changes at the Oct4 promoter are important for 










3.2.2.2 Transcription factor Sox2 
 
Sox2 is a member of the HMG-domain DNA-binding-protein family that is implicated in 
the regulation of transcription and chromatin architecture (Pevny and Lovell-Badge, 
1997). Sox2 has an expression pattern similar to that of Oct4. Zygotic expression of Sox2 
is first detected in the blastomeres at the morula stage of the mouse embryo (Avilion et 
al., 2003). Later on, it is specifically expressed in the ICM of the blastocysts and, 
subsequently, in the epiblast (Avilion et al., 2003). However, Sox2 is also expressed in 
extraembryonic ectoderm and neuroectoderm (Avilion et al., 2003) suggesting that its 
function is not restricted to ES cells and early development. Sox2 is also highly expressed 
in both the human and mouse ES cells (Wei et al., 2005). 
 
Sox2-deficient embryos have defective epiblasts and ES cells cannot be derived from 
these embryos (Avilion et al., 2003). In addition, the effect of the inactivated Sox2 could 
be rescued by the injection of wild-type ES cells into the Sox2-deficient blastocysts 
(Avilion et al., 2003). These results implicate Sox2 as a regulator essential for the 
establishment of primitive and extra-embryonic ectoderm.  
 
It was reported that Sox2 is capable of heterodimerizing with Oct4 in the formation of a 
ternary complex on FGF4 gene (Yuan et al., 1995) (Figure 13). Structural information 
reveals that the POU and HMG domains mediate the specific protein- protein and DNA-
protein interactions (Reményi et al., 2003; Williams et al., 2004). Several target genes of 
Oct4 and Sox2 in ES cells have been identified, and these include Fgf4, Utf1, Opn, 
29 
Rex1/Zfp42, Fbx15, and Sox2 (Ben-Shushan et al., 1998; Botquin et al., 1998; Catena et 
al., 2004; Dailey et al., 1994; Nishimoto et al., 1999; Tokuzawa et al., 2003; Tomioka et 
al., 2002; Yuan et al., 1995). The regulatory regions of these genes contain the sox-oct 




Two regulatory regions of Sox2 gene (SRR1 and SRR2) are known to confer ES cell-
specific expression (Tomioka et al., 2002). SRR2 is located 1.2 kb downstream of the 
Sox2 transcription start site, and it contains the composite sox-oct element. Mutations 
introduced into this composite sox-oct element disrupted the in vitro formation of a 
DNA/protein complex and resulted in the loss of SRR2 enhancer activity. In the absence 
of Oct4, the activity of SRR2 is abolished; this supports the positive regulation of SRR2 
Figure 13 Oct4 and Sox2 interact on 
FGF4 and UTF1.  
(a) EMSA assay of Oct4 and Sox2 
with DNA probes of FGF4 and 
UTF1. (Lane 1) No protein added, 
only with DNA probes. (Lane 2) 
Oct4 added with DNA probes. 
(Lanes 3–7) Increasing amounts of 
Sox2 protein mixed with equal 
amounts of Oct4 and DNA probes. 
Note the band for the Oct4/Sox2 
complex. (b) Binding sites for Oct4 
and Sox2 at FGF4 and UTF1.




by Oct4. In addition, Oct4 has recently been shown to bind to the octamer site within the 
SRR1 of Sox2 promoter (Catena et al., 2004). 
 
3.2.2.3 Transcription factor Nanog 
 
Forced expression of Oct4 fails to render LIF independence of mouse ES cells (Niwa et 
al., 2000). This suggests that Oct4 alone is not sufficient for the maintenance of 
pluripotency.  
 
Nanog was first described by Wang and colleagues and was named ENK (early embryo-
specific NK, where NK represents NK-2 which is a synonym of the Drosophila 
melanogaster gene ventral nervous system defective) (Wang et al., 2003) based on its 
homology with members of the NK gene family (Harvey, 1996). However the exact 
function of ENK (Wang et al., 2003) was not known, and subsequently the function of 
Nanog was identified in two separate studies. 
 
Chambers and colleagues (2003) screened expression constructs in LIFR-deficient 
embryonic stem cells. The cDNA inserts were then subcloned into episomal-plasmid 
vectors. The vectors were used to transfect ES cells expressing the polyoma large T 
antigen, and these cells were then selected for growth in the absence of LIF. This led to 
the isolation of LIF-independent cells, which were found to express Nanog (Chambers et 
al., 2003). Mitsui and colleagues (2003) performed digital (in silico) differential display 
of expressed sequence tag (EST) libraries in ES cells comparing to somatic tissues and 
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differentiated cells. They identified Nanog along with several other genes that were 
highly enriched in undifferentiated ES cells (Mitsui et al., 2003). 
 
Nanog expression is first detected in the morula stage embryo. High level of Nanog RNA 
persists in the early blastocyst, but its expression declines prior to implantation 
(Chambers et al., 2003; Mitsui et al., 2003). In post-implantation stage embryos, Nanog 
expression is restricted to a subset of epiblast cells and is subsequently down-regulated 
during primitive streak formation (Chambers et al., 2003; Mitsui et al., 2003). Nanog is 
also expressed in the primordial germ cells (Hart et al., 2004).  
 
Mouse ES cells lacking Nanog differentiate into extra-embryonic endoderm lineages, 
which is consistent with the absence of primitive ectoderm in Nanog-null embryos at 
E5.5 in vivo (Mitsui et al., 2003). Thus, Nanog expression is responsible for the 
maintenance of the primitive ectoderm in the embryo (Figure 14). Nanog +/– ES cells 
results in labile pluripotency whereby rate of spontaneous differentiation is correlated 
with time spent in culture (Hatano et al., 2005). Therefore, the amount of Nanog per cell 
is crucial for the stable maintenance of an undifferentiated state.  
 
Apart from the homeodomain, Nanog consists of an N-terminal domain 96 amino acids in 
length, and a C-terminal domain 150 amino acids long (Figure 15). The transactivation 
function in both N- and C-terminal domains was demonstrated by a Gal4 fusion assay 
(Pan and Pei, 2003). Subsequent assays showed that the C-terminal transactivation 
domain may be separated into two independent transactivation domains (Pan and Pei, 
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retained in the C-terminal domain but not in the N-terminal domain (Oh et al., 2005). 
Nanog can be modified by post-translational modifications such as phosphorylation. 
Treatment of Nanog immunoprecipitates with phosphatases collapses the triplet signal 
normally observed on immunoblots to a single band (Yates and Chambers, 2005). 




Figure 14 Model of the Transcription factors operating in pluripotent ES cells. Both Nanog 
and Oct4 are essential to sustain ES cell self-renewal.  Oct4 function in a specific role in 
blocking differentiation into trophoblast but tends to promote differentiation into primitive 
endoderm and germ layers. Nanog may block this differentiation into the primitive endoderm






The presence of a homeobox domain suggests that Nanog may recognize specific DNA 
sequences. Mitsui and colleagues (2003) have determined the Nanog consensus binding 
sequence using SELEX (systematic evolution of ligands by exponential enrichment). 
They further identified the presence of Nanog consensus sequences in the 
promoter/enhancer regions of Rex1 and Gata6 gene. Interestingly, the phenotype of 
Nanog-null cells is similar to the cell type formed upon ectopic Gata6 expression in ES 
cells (Fujikura et al., 2002). This raised the possibility that Nanog may prevent primitive 
endoderm differentiation through the repression of Gata6. 
 
The tumour suppressor p53 binds to the promoter of Nanog, thereby enabling p53-
dependent suppression of Nanog expression during differentiation (Lin et al., 2005). The 
loss of p53 resulted in a 100-fold increase in susceptibility to testicular teratoma 
formation (Lam and Nadeau, 2003), owing to Nanog derepression. Activation of p53 due 
to DNA damage resulted in reduced Nanog expression, and consequentially the 
differentiation of ES cells (Lin et al., 2005). Thus p53 regulation of Nanog may be a 
mechanism to maintain genetic stability of the ES cells. 
 
Figure 15 Schematic structure of Nanog protein. N and C terminal domains are involved 
in transactivation. (Adapted from Pan and Thomson, 2007)  
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However, ES cells with p53 mutations are still able to down-regulate Nanog and 
differentiate, indicating that other factors are involved (Lin et al., 2005). The major 
transcription initiation site of Nanog has been mapped using the combined techniques of 
RNase protection and primer extension (Wu and Yao, 2005; Chambers, 2005). The 
composite Oct4/Sox motif located 180–166 bp upstream of the major transcription 
initiation site has been noted (Chambers and Smith, 2004).   Indeed, recent studies have 
shown that Oct4 and Sox2 directly regulate the expression of Nanog (Rodda et al., 2005; 
Kuroda et al., 2005). 
 
3.2.3 Transcriptional regulatory network 
 
The biological property of an organism is characterized by its gene expression patterns 
which in turn are determined by the dynamic interplay between transcription factors and 
their target genes. Dissecting the complexities of transcriptional networks is therefore 




At the first level, the transcriptional network comprises of a collection of transcription 
Figure 16 Classifications of transcriptional regulatory networks. (a) Basic unit (b) Motifs 
(c) Modules (d) Transcriptional regulatory network. (Adapted from Babu et al., 2004) 
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factors and their downstream target genes (Figure 16). Recurrent patterns of these basic 
interactions are grouped into motifs. The single input and multiple input motifs (Figure 
16) are direct-acting motifs, in which a single or multiple transcription factors regulate 
their target genes. Target genes belonging to the same motifs also tend to be co-expressed 
(Yu et al., 2003). The feed-forward loop motifs contain a regulator that controls a second 
regulator and have the additional feature that both regulators bind a set of common target 
genes. Other motifs that represent patterns of interconnections have also been identified 
in yeast, for example the autoregulatory and regulatory chain motifs (Lee et al., 2002). 
Motifs are clustered into semi-independent transcriptional units known as modules which 
typically consist of distinct cellular processes (Figure 16). Modules are interconnected 
through local regulatory hubs, which enable for rapid regulatory changes across several 
modules.  
 
Finally, the entire transcriptional regulatory network consists of interconnecting 
interactions among the modules (Figure 16). The transcriptional regulatory network is a 
collection of incoming and outgoing connectivity. The incoming connectivity of the 
network defines the number of transcription factors regulating a target gene. The 
outgoing connectivity is the number of target genes regulated by each transcription factor. 
This is indicative of a network structure consisting of regulatory hubs, in which a few 
transcription factors participate in the regulation of a large number of target genes. These 
hubs can be viewed as global regulators (Shen-Orr et al., 2002; Babu and Teichmann, 
2003). In the yeast transcriptional network, removal of key players of the regulatory hubs 
proved to be lethal (Yu et al., 2004).  
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3.2.4 Transcriptional network in human ES cells 
 
OCT4, SOX2 and NANOG are critical transcriptional factors orchestrating early 
embryonic cell fate and maintaining ES cell phenotype. Deciphering the transcriptional 
circuitry of OCT4, SOX2 and NANOG is the first step to elucidate the mechanisms that 
establish the genomic state necessary for the ES cell self-renewal and pluripotency. 
 
Recent advances in genomic technologies have enabled the construction of transcriptional 
regulatory networks of OCT4, SOX2 and NANOG in human ES cells (Boyer et al., 
2005). The study uses the ChIP-chip methodology (chromatin immunoprecipitation 
coupled with DNA microarrays) to identify DNA bound individually by the three factors.  
Results of the study indicate that a large number of promoter regions are bound by the 
three transcription factors. NANOG binding was uncovered at 9% of the promoter 
regions tested, while SOX2 and OCT4 at 7% and 3% respectively (Boyer et al., 2005). 
The large number of genes bound by these factors indicates their wide regulatory roles in 
cellular processes. The large proportion of target genes which was also observed for 
dominant lineage-specific differentiation factors (Odom et al., 2004), support the roles 
for OCT4, SOX2 and NANOG as the global regulators in the ES cells transcriptional 
regulatory network. 
 
OCT4, NANOG, and SOX2 were also found to co-occupy and share a substantial portion 
of their target genes (Boyer et al., 2005). 353 genes were bound by all three transcription 
factors, and majority of genes bound by OCT4 and SOX2 were also bound by NANOG. 
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These findings suggest that the three pluripotent factors converge and work together on 
regulating common genomic targets.  
 
OCT4, SOX2 and NANOG occupy both transcriptionally active and inactive genes in 
human ES cells (Boyer et al., 2005). Among the active targets are genes coding for 
regulators and pathways that have been implicated in ES cell self-renewal (E.g. OCT4, 
SOX2 and NANOG and components of the TGF-β and Wnt pathways) (Figure 17). 
Interestingly, a large portion of the inactive targets identified in the study include 
transcription factors involved in lineage-specification (Boyer et al., 2005) (Figure 17). 
Thus OCT4, SOX2 and NANOG are thought to maintain pluripotency by promoting the 
expression of other self-renewal genes while simultaneously preventing expression of 
differentiation-promoting genes. 
 
Two regulatory motifs are identified from the OCT4, SOX2 and NANOG circuitry 
(Boyer et al., 2005) (Figure 18). The feed-forward loop described the observation that 
OCT4 and SOX2 converge on NANOG and regulate its expression, which in turn act in 
Figure 17 Core transcriptional 
regulatory network in Human ES Cells. 
OCT4, SOX2, and NANOG are 
represented by blue circles; gene 
promoters are represented by red 
rectangles; gray boxes represent 
putative downstream target genes. 
Positive regulation was assumed if the 
target gene was expressed whereas 
negative regulation was assumed if the 
target gene was not transcribed. 
(Adapted from Boyer et al., 2005) 
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concert with these two factors to control downstream target genes (Boyer et al., 2005). 
The feed-forward loop motif may confer stability of the system and allow for rapid 
response to developmental switching depending on the activities of the individual factors 
(Figure 18A). OCT4, SOX2, and NANOG bind to the promoters of their own genes, thus 
forming the interconnected auto-regulatory loops (Boyer et al., 2005). In the auto-
regulatory loops, the expression and function of these three key stem cell factors are 
linked to one another. Auto-regulation is thought to provide several advantages, including 






The extent to which the genetic regulatory information from the human ES cells study 
can be extrapolated to the mouse cells remains to be determined. Moreover the functional 
relevance of target genes bound by the three factors is not fully understood. Together, 
these studies suggest that OCT4, SOX2 and NANOG function in pathways that might 
converge to regulate certain common genomic targets. It is likely that the interplay 
among these factors is critical for early cell fate decisions.  
Figure 18 Transcriptional Regulatory Motifs in Human ES Cells. (a) Feedforward 
transcriptional regulatory circuitry involving OCT4, SOX2 and NANOG. Regulators are 
represented by blue circles; gene promoters are represented by red rectangles. Binding of a 
regulator to a promoter is indicated by a solid arrow. Genes encoding regulators are linked to 
their respective regulators by dashed arrows. (b) The autoregulatory loop formed by OCT4, 
SOX2, and NANOG. (Adapted from Boyer et al., 2005) 
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3.3 EPIGENETIC MECHANISMS GOVERNING ES CELLS MAINTENANCE 
 
Dynamic programs of gene expression are required for the differentiation of pluripotent 
stem cells into specific tissue lineages. During cell differentiation, specific gene 
expression program becomes restricted to particular types of cells. This restriction 
involves both activation and repression of tissue-specific genes. Studies over the past 20 
years have defined several transcription factors that initiate and control these changing 
transcription programs through the interaction with cis-acting DNA sequences (e.g. Oct4, 
Nanog and Gata6). These transcriptional factors also work with co-activators or co-
repressors that, in turn, reorganize chromatin through the recruitment of enzymes that can 
post-translationally modify histones or mobilize nucleosomes at individual gene 
promoters or on large-scale chromatin domains. Recent studies have indicated that 
specific histone modifications and chromatin modifying enzymes play essential roles in 
chromatin organization during normal embryonic development and ES cells 
differentiation.  
 
3.3.1 Chromatin and histone modifications 
 
In eukaryotic cells, DNA is packaged into nuclear structure known as chromatin.  
Chromatin can be organized into regions of heterochromatin (condensed) and 
euchromatin (open). The fundamental subunit of chromatin is the nucleosome which is 
composed of approximately 146 base pairs of DNA wrapped in two superhelical turns 
around an octamer of core histones (two each of histones H2A, H2B, H3 and H4) 
40 
(Kornberg and Lorch, 1999).  
 
Histones are subject to several post-translational modifications such as acetylation, 
methylation, ubiquitination and phosphorylation (Zhang and Reinberg, 2001) (Figure 19). 
These covalent modifications regulate biological processes that are associated with 
chromatin, such as DNA repair, DNA replication and gene expression.  
 
Lysine and arginine residues of the histones are found to be extensively methylated in 
vivo (Zhang et al., 2003, Zhang et al., 2004 and Margueron et al., 2005) (Figure 19). 
Lysine can be mono-, di-, and trimethylated (Bannister and Kouzarides, 2004), while 
arginine can be monomethylated and symmetrically or asymmetrically dimethylated 
(Bedford and Richard, 2005). A number of lysine residues within histone H3 and H4 are 
subject to methylation by site-specific enzymes (Figure 19). Evidences also suggest that 
methylated lysines within histones direct the recruitment of different methyl-binding 
effector proteins, which mediates the biological effects of lysine methylation (Taverna et 
al., 2006; Bannister et al., 2001; Lachner et al., 2001; Huang et al., 2006; Kim et al., 
2006; Wysocka et al., 2006; Shi et al., 2006). 
41 
 
Methylation of H3K9 and H4K20 are generally associated with the formation of 
heterochromatin structure which is critical for the proper functioning of centromeres and 
certain recombination events (Bannister et al., 2001; Lachner et al., 2001; Schotta et al., 
2004). Methylation of H3K9 facilitates the recruitment of Swi6 or its mammalian 
homologue HP1 (Bannister et al., 2001; Lachner et al., 2001) which functions in 
heterochromatin formation and gene silencing. H3K27 methylation is mediated by 
enzyme complexes composed of members of the Polycomb Group (PcG) (Cao and Zhang, 
2004, Cao et al., 2002; Czermin et al., 2002; Muller et al., 2002; Kuzmichev et al., 2002). 
PcG proteins play a role in a number of silencing functions including homeotic gene 
silencing, X-inactivation and imprinting (Cao and Zhang, 2004). H3K4, H3K36 and 
H3K79 on the other hand have been closely associated with gene activity (Boa et al., 
2003; Ng et al., 2003; Santos-Rosa et al., 2002; Bernstein et al., 2002). The enzymes that 
mediate H3K4 and H3K36 methylation are associated with the transcriptional machinery, 
and these modifications are established during transcription (Ng et al., 2003, Xiao et al., 
2003, Krogan et al., 2003, Li et al., 2003). H3K4 methylation has been shown to function 
Figure 19 Histone modifications. 
Each modification highlighted by its
colour and the position of the 
modified amino acid labeled in 
numerals. (Adapted from Felsenfeld 
and Groudine, 2003) 
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as a binding site for several enzymes that are involved in gene expression, including 
chromatin remodelling enzymes, histone acetyltransferases and lysine methyltransferases 
(Pray-Grant et al., 2005, Santos-Rosa et al., 2003,  Wysocka et al., 2005).  
 
3.3.2 Histone demethylases 
 
Contrary to other modifications, the global turnover of histone lysine methylation is low 
(Byvoet et al., 1972; Duerre et al., 1974), suggesting that the methylation modification is 
stable and is enzymatically irreversible. This has led to the belief that mechanisms such 
as histone replacement or histone tail cleavage are responsible for removing methylated 
histones (Bannister and Kouzarides, 2005; Bannister et al., 2002). Recent studies 
however demonstrate that histone lysine methylation is not static but is dynamically 
regulated by both the histone methyltransferases and the newly discovered histone 
demethylases. 
 
LSD1 is a member of the amine oxidase family and it is the first reported enzyme with 
histone lysine demethylases activity. LSD1 catalyses the removal of one or two methyl 
groups from the H3K4me but shows no enzymatic effect on H3K4me3. The LSD1 
enzymatic reaction requires FAD as a cofactor and produces hydrogen peroxide and 
formaldehyde as the reaction products (Shi et al., 2004) (Figure 20). Interestingly, LSD1 
was also reported to demethylate H3K9me1/2 upon interaction with the androgen 
receptor (Metzger et al., 2005). Hence, a change in substrate specificity can be achieved 





Using a biochemical purification approach, JmjC-domain-containing histone demethylase 
1A (JHDM1A) that can remove histone H3K36me1/2 has been identified (Tsukada et al., 
2006). It is shown that the JmjC domain is the catalytic moiety involved in mediating the 
demethylation reaction (Tsukada et al., 2006). The JHDM1 reaction relies on iron and α-
ketoglutarate as cofactors to catalyse direct hydroxylation of the lysine methylamine 
group and produce succinate and carbon dioxide as reaction products. The 
hydroxymethyl group is lost subsequently as formaldehyde to liberate one methyl group 
from the lysine (Tsukada et al., 2006) (Figure 21).  
 
Figure 20 Chemical mechanisms in LSD1 demethylation reaction. LSD1 removes a 
methyl group from a dimethylated lysine residue. Another round of methyl group 
removal gives rise to the end-product which is an unmethylated lysine. (Adapted from 








Using the same in vitro demethylase assay, JHDM2A (JMJD1A) is identified as a novel 
H3K9-specific demethylase. This enzyme was able to demethylate H3K9me2 resulting in 
unmodified H3K9 (Yamane et al., 2006). Subsequently, various JMJD2 family (JHDM3) 
proteins were found to demethylate H3K9me3 and H3K36me3 both biochemically and in 
vivo, resulting in H3K9me1/2 and H3K36me1/2, respectively (Whetstine et al., 2006; 
Fodor et al., 2006; Klose et al., 2006; Cloos et al., 2006). JMJD2 family of enzymes 
require both the JmjC and JmjN domains to efficiently catalyse demethylation (Klose et 
al., 2006; Fodor et al., 2006) (Figure 21). The C-terminal Tudor domain may function as 
a chromatin-targeting module as it binds to methylated histone H3K4, H3K9 and H3K20 
Figure 21 JmjC-domain containing histone lysine demethylases. (a) The reaction 
mechanism catalysed by the JmjC-domain containing protein. Fe(II) and α-ketoglutarate
are cofactors in the reaction that produces hydroxymethyl-lysine, succinate and CO2 as 
products (1). Subsequent reaction release formaldehyde to liberate a methyl group (2). (b) 
Protein structure of of JHDM3A/JMJD2A. The crystallized fragment (bottom) contains 
the JmjN domain (green), intervening region (grey), JmjC domain (blue) and the C-
terminal region (pink). (Adapted from Klose and Zhang, 2007) 
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(Kim et al., 2006; Wysocka et al., 2006) (Figure 21). In contrast to LSD1 and JHDM1/2, 
the JMJD2 family members can demethylate trimethylated lysine substrates (Cloos et al., 
2006; Fodor et al., 2006; Klose et al., 2006; Whetstine et al., 2006). In addition, two 
members of this family, JMJD2A/JHDM3 and JMJD2C/GASC1, can demethylate both 
H3K9me3 and H3K36me3 (Klose et al., 2006; Whetstine et al., 2006), thus revealing a 
novel link between these two modifications that was previously unsuspected.   
 
Recently, proteins of the JARID1 family are shown to specifically demethylate H3K4 
(Christensen et al 2007; Iwase et al., 2007; Klose et al., 2007; Lee et al., 2007). Like the 
JHDM3/JMJD2 demethylases, JARID1 enzymes target the tri- and dimethyl modification 
states, but fail to initiate demethylation on the mono- methyl group. JARID1 family 
members generally function as transcriptional repressors, as the reduction of JARID1 
protein levels leads to reactivation of target genes and increased levels of H3K4me3 
(Klose et al., 2007).  
 
3.3.3 The unique chromatin structure of the ES cells 
 
Chromatin reorganization is necessary for the establishment of gene expression programs 
during lineage specification (Meshorer and Misteli, 2006). Recent studies have revealed 
distinct properties of the chromatin in pluripotent cells and distinguish them from their 
differentiated counterparts.  
 
A recent study in mouse ES cells analyzing global chromatin dynamics has uncovered 
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rapid exchanges and dynamic association of architectural chromatin proteins (HP1α, 
histones H1, H2B and H3) (Figure 23). Dynamic binding appears to be functionally 
important as the interference of this process affects the differentiation kinetics of ES cells. 
When the dynamic exchange of H1 was restricted by substitution with a mutant that binds 
more tightly to the chromatin, ES cell differentiation was inhibited. In contrast, 
genetically manipulated ES cells lacking the nucleosome assembly factor HirA exhibited 
elevated levels of unbound histones, and differentiation was accelerated in these cells. 
During differentiation however, the binding dynamics of these factors are reduced and 
they tend to be immobilized to the chromatin. These data support a model whereby 
structural proteins are loosely associated with the chromatin in pluripotent cells, and this 
unique association enables the rapid reorganization of the chromatin structure during 
differentiation. 
 
Other lines of evidence also support the existence of an open and loose chromatin 
structure in ES cells. The ES cell chromatin has high accessibility to nucleases such as 
DNaseI. DNaseI hypersensitive sites, which correlate with transcriptionally active 
chromatin, are detected at high frequency for genes in the ES cells (Meshorer et al., 
2006). ES cells have nuclei that are double in volume as compared to those in 
differentiated cells types (Faro-Trindade and Cook, 2006), this is indicative of a loose 
chromatin structure (Figure 22). Furthermore, visualization of the centromeric 
heterochromatin with probes against the major satellite-repeat sequences revealed a 
diffuse heterochromatin structure in undifferentiated ES cells, compared to more compact 
heterochromatin with well-defined foci in neuronal progenitor cells (NPCs) (Meshorer et 
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al., 2006). One possible outcome of the open chromatin of the pluripotent cells is to 
provide high accessibility for transcription factors to their target genes for the control of 
differentiation. In fact, previous studies performed by forced-expression of sole 
transcription factors such as Gata6 or Cdx2 in ES cells (Fujikura et al., 2002; Niwa et al., 






Post-translational modifications of core histones have been associated with chromatin 
states and the transcriptional status of genes (Fischle, 2003; Hsieh, 2000). Methylation of 
histone H3K4 generally correlates with active gene status while methylation of K27 serve 
as repressive chromatin marks (Lachner and Jenuwein, 2002; Turner, 2002; Martin and 
Zhang, 2005; Kouzarides, 2007). H3K4 and H3K27 histone methylation are usually 
mutually exclusive and their distributions distinct and non-overlapping. In ES cells, 
recent studies however have reported the finding of ‘bivalent domains’ (Bernstein et al., 
Figure 22 Nuclei of undifferentiated (left) and differentiated (right) ES cells. Differentiation 
induced by ectopic expression of Gata6 resulted in the nucleus organization characterized 
by the condensed chromatin and reduction in nucleus volume. (Adapted from Niwa, 2007) 
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2006; Azuara et al., 2006; Pan et al., 2007; Zhao et al., 2007; Mikkelsen et al., 2007), 
where H3K4me3 marks flanked by larger regions H3K27me3 modifications are 
associated with a large set of developmentally important genes that are expressed at low 
levels in ES cells (Figure 23). The bivalent marks suggest that lineage-specific genes are 
cued in ES cells for subsequent activation during differentiation. Interestingly, many of 
the PcG target genes in ES cells contain bivalent chromatin domains in their promoter 
regions (Boyer et al., 2006; Lee et al., 2006). These associations are lost during ES cell 
differentiation, which suggest that the PcG proteins are responsible for methylating 
H3K27Me at these bivalent domains.  The observation that Oct4, Sox2 and Nanog co-
occupied large numbers of genes harboring bivalent domains and sites of PcG binding 
also provides a link between repression of differentiation and the maintenance of 
pluripotency in ES cell (Lee et al., 2006).  
 
Finally, chromatin modifications may directly influence gene function by affecting the 
accessibility of regulatory proteins to their target sites and by modulating the binding 
affinity of transcriptional regulators. ES cell chromatin displays characteristics of 
transcriptionally permissive euchromatin, such as an abundance of transcription 
associated histone modifications (e.g. H3K4me and acetylation of H3 and H4) and low 
level of silencing modifications (e.g. H3K9me) (Meshorer and Misteli, 2006; Lee et al., 
2004) (Figure 23). Conversely, lineage specification is typified by a decrease in active 
modifications and concomitant increase in transcriptionally inactive heterochromatin 
regions due in part to the elevation of repressive H3K9me (Arney and Fisher, 2004). 
These observations suggest that ES-cell chromatin is overall more active, or at least 
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marked with activity-associated histone modifications, and that differentiation is 







In summary, these findings suggest that the dynamic repression of developmental 
pathways, as well as the maintenance of open and transcriptional permissive chromatin in 
ES cells by epigenetic processes, could be important for the maintenance of plasticity and 
pluripotency in ES cells. However, the mechanisms and histone-modifying enzymes 
involved in maintaining this unique ES cell epigenetic status are not known. In particular 
the relationship between low levels of H3K9 methylation in ES cells and the role of 
histone H3K9 demethylases (JHDMs) in mediating this effect has not been previously 
explored. 
Figure 23 The epigenetic features of the pluripotent ES cells. Hyperdynamic 
associations of chromatin-associated proteins (green) are key to the open chromatin 
structure. The genome consists of large region of euchromatin characterized by the 
presence of histone marks associated with transcriptional activity (H3K4me). Only 
small regions of perinuclear heterochromatin exist. Bivalent domains are also a feature 
of the pluripotent epigenome, in which active histone modifications (H3K4me) are 
flanked by the transcriptionally repressive histone modifications (H3K27me). (Adapted 
from Niwa, 2007) 
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4. AIMS AND KEY FINDINGS OF EACH PAPER INCLUDED IN THE THESIS 
 
4.1 Paper I 
 
Oct4 (POU domain-containing transcription factor) and Sox2 (SRY-related HMG box) 
are essential for both the formation of the ICM during mouse preimplantation 
development and for the self-renewal of pluripotent ES cells (Nichols et al., 1998; 
Avilion et al., 2003). However, little is known on how the expression Oct4 and Sox2 are 
regulated in the ES cells. It has previously been demonstrated that Oct4 and Sox2 are 
partners in regulating several ES cell-specific genes (Ben-Shushan et al., 1998; Botquin 
et al., 1998; Catena et al., 2004; Dailey et al., 1994; Nishimoto et al., 1999; Tokuzawa et 
al., 2003; Tomioka et al., 2002; Yuan et al., 1995). In this study, we show that both the 
CR4 and SRR2 enhancer regions of Oct4 and Sox2 respectively, contain the sox-oct 
elements. Mutations introduced to the sox-oct elements abolished the activation of Oct4 
and Sox2 in ES cells. Moreover Oct4 and Sox2 bind to the regulatory elements as a 
binary complex in both human and mouse ES cells. EMSA assays also confirmed the 
direct interaction of Oct4 and Sox2 with the DNA probes containing the sequences of the 
CR4 and SRR2 enhancers. Using RNA interference (RNAi), we further examined the 
functional role exerted by the Oct4/Sox2 heterodimer on these regulatory elements and 
their corresponding levels of endogenous gene expression. Our data support a model in 
which the Oct4/Sox2 complex plays a key role in maintaining the expression of essential 
transcription factors in ES cells through autoregulatory and multicomponent loop 
network motifs. What emerges is a genetic regulatory network linking the key 
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transcription factors Oct4 and Sox2 in embryonic stem cells. 
 
4.2 Paper II 
 
Oct4 and Nanog are key transcriptional regulators essential both for the formation of the 
ICM during mouse preimplantation development, and for the self-renewal of pluripotent 
ES cells (Nichols et al., 1998, Mitsui et al., 2003; Chambers et al., 2003). How these two 
transcriptional factors regulate their down-stream target genes and whether this regulation 
is important in governing ES cell fates remained unknown. To address these questions, 
we sought to identify the physiological targets of Oct4 and Nanog in mouse ES cells. We 
utilized the recently developed paired-end ditag (PET) technology to characterize 
chromatin immunoprecipitation (ChIP)-enriched DNA fragments to achieve unbiased, 
genome-wide mapping of transcription factor binding sites (Wei et al., 2006). This 
method extracts a pair of signature tags from the 5’ and 3’ ends of each DNA fragment, 
concatenates these paired-end ditags for efficient sequencing, and subsequently maps 
them to the genome (Ng et al., 2005). Comparative whole genome location analyses also 
revealed that Nanog and Oct4 share a substantial portion of their targets. Here we 
combine ChIP-PET identification of Oct4 and Nanog binding sites with RNA 
interference (RNAi) analyses to demonstrate the regulation of Oct4 and Nanog target 
gene expression. Over-expression of Nanog in ES cells further identified upregulated or 
downregulated genes. This comprehensive analysis uncovers a complex network 
connecting the regulators important in maintaining ES cell pluripotency. We further show 
that common core downstream targets (Esrrb and Rif1) play an important role in 
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preventing ES cell differentiation. Esrrb and Rif1-knockdown cells demonstrated 
flattened and fibroblast-like morphology, with a loss of alkaline phosphatase staining of 
non-differentiated ES cells. Consistent with the differentiation phenotype, assessment of 
molecular markers revealed that the ES cell-specific gene Zfp42 was reduced in Esrrb and 
Rif1 knockdown cells, whereas the trophectoderm marker Hand1 was induced. Thus our 
work extends the ES cell transcriptional network beyond Oct4 and Nanog, and further 
establishes that downstream transcriptional factors play important roles in the 
maintenance of pluripotency. 
 
4.3 Paper III 
 
The transcription factors Oct4, Nanog, and Sox2 are key regulatory players in embryonic 
stem (ES) cell biology (Nichols et al., 1998, Mitsui et al., 2003; Chambers et al., 2003; 
Avilion et al., 2003). In ES cells Oct4, Nanog, and Sox2 co-occupy promoters of 
hundreds of genes that are both expressed and repressed in the pluripotent state (Paper II). 
This suggests complex regulatory circuitry in which Oct4, Nanog, and Sox2 collectively 
and uniquely regulate downstream genes to control ES cell differentiation. However, it 
remains unclear what are the downstream effectors of these transcription factors that 
contribute to maintaining the pluripotent status of ES cells. In this study, we have 
identified Zic3 (Zinc finger protein of the cerebellum 3) as a transcription factor of 
interest. Oct4, Nanog, and Sox2 binding have been mapped to the Zic3 promoter regions 
in both human and mouse ES cells (Paper II; Boyer et al., 2005), implying that these key 
factors may regulate Zic3 expression. The conservation between the two species also 
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highlights the potential importance of Zic3 in ES cells. Genetic depletion of Zic3 using 
RNAi resulted in differentiation of ES cells which demonstrated reduced capacity for 
colony formation in secondary re-plating assays. Reduced levels of Zic3 also resulted in 
the concomitant up-regulation of endoderm gene expression, suggesting that Zic3 is 
important in maintaining ES cell pluripotency by preventing differentiation of cells into 
endodermal lineages. Thus our results serve to extend and validate our current knowledge 
of the ES cell transcriptional circuitry downstream of Oct4, Nanog, and Sox2. 
 
4.4 Paper IV 
 
Embryonic stem cells are pluripotent stem cells with the ability to differentiate into many 
lineages (Keller, 2005). This plasticity of the ES cell genome is conferred by a permissive 
and open chromatin environment favorable for the expression of a wide range of lineage 
specific genes (Meshorer and Misteli, 2006). How ES cell-specific transcription factors 
modulate the chromatin architecture of ES cells is however not clear. ES cell chromatin is 
enriched in active marks (methylation of H3K4 and acetylation of H3 and H4) and 
deficient in silencing modifications (methylation of H3K9) (Meshorer and Misteli, 2006; 
Lee et al., 2004). Differentiation of ES cells is accompanied by global changes in histone 
modifications and a transition to a transcriptionally less-permissive chromatin state 
characterized by a decrease in H3K4me3 and an elevation of H3K9 methylation 
(Meshorer and Misteli, 2006; Lee et al., 2004). Thus the maintenance of transcriptional 
permissive chromatin with low levels of H3K9 methylation in ES cells by epigenetic 
processes may be required for the maintenance of ES cells plasticity and pluripotency. 
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These findings also suggest potential roles for histone H3K9 demethylases (JHDMs) in 
maintaining a transcriptionally-permissive ES epigenome. Jmjd1a, Jmjd2c and several 
other JmjC-domain containing proteins have recently been shown to be histone 
demethylases (JHDMs) (Tsukada et al., 2006; Yamane et al., 2006; Whetstine et al., 
2006; Fodor et al., 2006; Cloos et al., 2006; Klose et al., 2006). Jmjd1a can demethylate 
H3K9 mono- and dimethylation in vitro and functions as a coactivator for androgen 
receptor (AR) to demethylate chromatin of AR target genes (Yamane et al., 2006). 
Jmjd2c has different specificity and is shown to convert H3K9 and H3K36 from the 
trimethylation to dimethylation state (Whetstine et al., 2006). Recent studies indicate that 
Jmjd1a and Jmjd2c are highly expressed in ES cells (Ko et al., 2006; Katoh and Katoh, 
2007), suggesting their roles in modulating the chromatin structure of ES cells. 
Furthermore, our previous chromatin immunoprecipitation-paired end ditag (ChIP-PET) 
binding site mapping study revealed Oct4 binding clusters within Jmjd1a and Jmjd2c 
genes (Paper II). Notably, JMJD1A is also bound by OCT4 in human ES cells (Boyer et 
al., 2005); further underscoring its functional importance in ES cell biology. 
 
In this study, we have identified the histone demethylases Jmjd1a and Jmjd2c as 
regulatory targets of Oct4 in mouse ES cells. We confirmed that Oct4 binds to Jmjd1a 
and Jmjd2c using chromatin-immunoprecipitation assays. Furthermore, depletion of Oct4 
by RNA interference (RNAi) led to decreased Jmjd1a and Jmjd2c expression. Our data 
support a model where Oct4 regulates downstream histone demethylases. Using RNA 
interference (RNAi), we showed that depletion of these JHDMs in ES cells resulted in 
cellular differentiation, providing evidence for their role in ES cells maintenance. 
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Furthermore, we have identified Tcl1 and Nanog to be downstream effectors of Jmjd1a 
and Jmjd2c respectively, in the maintenance of ES cell state. Our data support a model in 
which Oct4 regulates downstream histone demethylases which in turn maintain 
permissive histone modifications (low H3K9me) at the promoters of genes critical for the 




















5. CONTRIBUTIONS IN EACH PAPER INCLUDED IN THE THESIS  
 
5.1 Paper I 
 
In this study, we examined the role of Oct4 and Sox2 binary complex in regulating the 
the expression of Oct4 and Sox2 genes in ES cells. J.L.C., Y.H.L., P.R., B.L. and H.H.N. 
were involved in project planning, data analysis and manuscript preparation; J.L.C. 
performed chromatin immunoprecipitations (ChIP); W.S.Z. performed electrophoretic 
mobility shift assay (EMSA); X.C. was involved in cloning some of the reporter 
constructs; W.L.T., L.S.Y., P.L., and Y.S.A. were involved in mouse and human ES cell 
culture. 
 
I designed the Pou5f1 (Oct4) and Sox2 shRNA constructs (Constructs were used in Fig. 5, 
Fig. 6 and Fig. 7) and showed that they are effective in depleting endogenous Oct4 and 
Sox2 levels (Fig. 6). I further confirmed the importance of Oct4 and Sox2 in mouse ES 
cells as knockdown of either genes resulted in morphological differentiation, reduction in 
alkaline phosphatase staining, and induction of lineage genes (Fig. 6). I next determined 
that the human OCT4 promoter that contains the conserved regions CR1 to CR4 showed 
ES-specific activity and displayed robust expression in ES cells (Fig. 1). I then showed 
that constructs harboring the deletions of the individual CR4-A, CR4-B, and CR4-C sites 
as well as CR4 regions in the OCT4 promoter drastically reduced its promoter activities 
(Fig. 1). Likewise, when single or double mutations were introduced at the oct and sox 
elements of the OCT4 promoter, the activities of the mutant promoters were decreased 
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(Fig. 4). These experiments thus confirm the enhancer activities of the sox-oct elements 
at the CR4 region. I next cloned the Oct4 and Sox2 open reading frames downstream of 
the luciferase (Luc) gene. These fusion constructs were used to demonstrate the 
knockdown efficiency of the Oct4 and Sox2 RNAi (Fig. 5). Furthermore, my results also 
indicate that the RNAi constructs are specific and only target the intended genes (Fig. 5). 
I next demonstrated that the reduction of either Oct4 or Sox2 reduced the activity of the 
OCT4 promoter (Fig. 5). I was also able to show that endogenous expression of Oct4 was 
reduced in both Oct or Sox2 knockdowns in ES cells (Fig. 6). Thus our results establish 
the positive regulatory role of Oct4 and Sox2 at the OCT4 promoter. I next cloned the 
Sox2 enhancer regions that contain the SRR2 element upstream of an SV40 promoter 
driving the Luc gene, and determined that it displays ES cell-specific activity (Fig. 7). 
Having co-transfected the Oct4 or Sox2 RNAi constructs along with this Sox2-SV40-Luc 
reporter into mouse ES cells, I reported that the luciferase activity diminished with 
knockdown of either Sox2 or Oct4 mRNA (Fig. 7). Furthermore, depletion of Oct4 
reduced the expression of endogenous Sox2 as measured by mRNA level (Fig. 7). Thus 
our results support the positive regulatory role of Oct4 and Sox2 at the SRR2 enhancer. 
In this study, we use ES cells as a model for understanding the role of Oct4 and Sox2 in 
the genetic regulatory network of pluripotent cells. Our data uncover a positive and 
potentially self-reinforcing regulatory loop that maintains Oct4 and Sox2 expression via 





5.2 Paper II 
 
This project is divided into three parts namely: (1) genetic mapping of the Oct4 and 
Nanog transcriptional network; (2) functional analysis of the important nodes in the Oct4 
and Nanog circuitry; (3) physical mapping of Oct4 and Nanog binding loci using 
chromatin immuno-precipitation (ChIP). Y.H.L., Q.W., J.L.C., B.L., P.R., C.L.W., Y.J.R., 
and H.H.N. were involved in project planning, data analysis and manuscript preparation; 
J.L.C. and Q.W. performed chromatin immunoprecipitations (ChIP); W.W.Z constructed 
the Nanog OE cell lines and performed microarray analysis; X.C. performed cloning and 
EMSA assay; V.V., G.B., J.G., B.L., K.S., C.L., K.P.C., L.L. and V.K. were involved in 
computational analysis of the location and microarray data. J.L., X.D.Z., C.L.W. and 
Y.J.R. performed the genome-wide sequencing of the ChIP enriched DNA. K.Y.W. and 
L.S. generated the microarray data for the induced differentiation of ES cells.  
 
To determine the functional relevance of the Oct4 and Nanog binding sites, I depleted 
Oct4 or Nanog by RNAi and examined the differential gene expression by microarray 
profiling (Fig. 6 and Suppl Table 5 
http://www.nature.com/ng/journal/v38/n4/extref/ng1760-S17.xls). As a pre-requisite, I 
have confirmed that our Oct4 and Nanog RNAi constructs are effective in down-
regulating endogenous mRNA and proteins levels (Suppl Fig. 8 and Suppl Fig. 9). The 
global expression profiles indicated that 4,711 genes were significantly expressed in the 
Oct4 knockdown experiments, among which 394 genes contained the Oct4 binding sites 
(Fig.6 and Suppl Table 6 http://www.nature.com/ng/journal/v38/n4/extref/ng1760-
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S18.xls). Of the 2,264 differentially expressed genes in the Nanog knockdown 
experiments, 475 were bound by Nanog (Fig.6; Suppl Table 6). Using this strategy, I 
have identified the direct targets regulated by the respective transcription factors (Fig.6, 
Suppl Table 6). The genome-wide expression results were integrated with location 
studies of ChIP-PET clusters relative to genes (Suppl Fig. 10). The global expression 
profiles indicate that Oct4 and Nanog can function either as positive or negative 
regulators of gene expression (Fig. 6, Suppl Table 5 and Suppl Table 6). To confirm the 
role of Oct4 as a repressor of its direct targets, I validated the expression level of Dkk1, 
Cdx2 and Cldn4 in Oct4 knockdown cells (Fig. 6). Likewise I showed that the removal of 
Nanog increased the expression of target genes Dkk1, Nrp2 and Klf6 (Fig. 6). This is the 
key demonstration of the negative regulatory roles of Oct4 and Nanog on direct 
downstream target genes. On the other hand, Nanog and Oct4 activate the transcription of 
many other targets genes (e.g. Oct4, Sox2, Nanog, Esrrb, Rif1, Rest and Jarid2) as 
evaluated by the level of mRNA (Fig. 6). Our previous works (Paper I; Rodda et al., 2005) 
have shown that the Oct4/Sox2 binary complex plays a role in regulating Oct4, Sox2 and 
Nanog gene expression. The data presented in this study further extend this by showing 
the complementary links from Nanog to Oct4, Sox2 and Nanog (Fig. 6 and Fig.7). To 
further substantiate the functional role of Nanog in ES cells, I provided evidence that 
overexpression of Nanog can modulate the transcription of a subset of target genes, and 
sustains the expression of several key genes in the presence of RA treatment (Fig. 6). In 
summary, we have uncovered diverse classes of genes bound and regulated by Oct4 and 
Nanog. These targets include genes encoding for transcriptional regulators, growth 
factors, signaling molecules, DNA damage response sensors and suppressors of lineage-
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specific genes (Fig. 6). Prior to this, there were no reported studies on Nanog-depletion in 
mouse ES cells using RNAi. Thus, I have demonstrated the first instance of 
morphological differentiation and changes in marker genes expression in Nanog-depleted 
mouse ES cells (Suppl Fig. 9). Importantly, I have confirmed that the shRNA are specific 
as the effects of knockdown could be rescued by co-expression of the respective RNAi-
immune ORFs (Suppl Fig. 8 and Suppl Fig. 9).  Our functional analysis identified 77 
genes that were bound and regulated by both Oct4 and Nanog. Many of these genes 
encode known or putative transcriptional regulators; they include key pluripotent genes 
Oct4, Sox2 and Nanog (Fig. 6 and Suppl Table 6). We therefore reasoned that common 
core downstream targets of Oct4 and Nanog could be required for proper ES cell 
maintenance. I thus performed RNAi mediated loss-of-function genetic screens to 
examine the importance of these downstream target genes. A collection of RNAi 
constructs targeting 25 candidate genes were constructed and used to knockdown 
endogenous transcripts in mouse ES cells.  The genetic screen was designed to report ES 
cell pluripotency after the RNAi knockdown, based on the transcriptional activity from 
the promoter/enhancer of ES-specific genes OCT4, Sox2 (Paper I) and Nanog (Rodda et 
al., 2005) (Data not shown). To this end, I have identified two Oct4- and Nanog-
regulated target genes, Esrrb and Rif1, to be important in maintaining the pluripotent 
state of ES cells (Fig. 7). I have further demonstrated that Esrrb and Rif1 knockdown ES 
cells became flattened and fibroblast-like, with a loss of alkaline phosphatase staining of 
non-differentiated ES cells (Fig. 7). Knockdown of another downstream gene REST, 
resulted in neither the change in morphology nor the level of alkaline phosphatase 
staining (Fig 7). Consistent with the differentiation morphology, assessment of molecular 
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markers revealed that ES cell specific gene Zfp42 was reduced in Esrrb and Rif1 
knockdown cells, whereas the trophectoderm marker Hand1 was induced (Fig. 7). I also 
showed that the observed phenotypic and molecular changes could be repeated with 
multiple shRNA constructs targeting different regions of the Esrrb and Rif1 transcripts 
(Fig 7). I further verified the specificity of the shRNA constructs by using scrambled 
siRNA sequences which produce no effect in the ES cells (Suppl Fig. 12). Thus I have 
identified two new nodes in the Oct4 and Nanog circuitries that are important for 
maintaining the non-differentiated state of mouse ES cells (Fig 7). This study serves as a 
useful guide for identifying additional components in the regulatory network important 
for self-renewal, pluripotency and differentiation of ES cells.  
 
5.3 Paper III 
 
In this study, we examined the role of Zic3, a downstream target of Oct4 and Nanog, in 
regulating the pluripotency of mouse ES cells. L.L., Y.H.L., H.H.N. and L.S. were 
involved in project planning, data analysis and manuscript preparation; L.L. performed 
siRNA knockdown in human and/or mouse ES cells, did realtime PCR analysis and 
generated Zic3 knockdown clones for immunofluorescence assay. W.W.Z. cloned the 
Zic3 RNAi-immune constructs and established the Nanog OE cell line; X.C. cloned the 
Zic3 reporter construct; Y.N.W. performed luciferase assay with the Zic3 reporter 




In this work, I have designed the Zic3 shRNA constructs targeting the mouse Zic3 
transcript (Constructs were used in Fig. 3, Fig. 4, Fig. 5, Fig. 7 and Fig. 8). The RNAi 
constructs were shown to be effective in depleting the endogenous Zic3 level (Fig. 3). I 
have also demonstrated that the reduction of Oct4, Sox2 and Nanog by RNAi lead to a 
reduced level of Zic3 expression, thus establishing the regulation of Zic3 by the three 
transcription factors (Fig. 2). Also, the knockdown of Zic3 using shRNA in mouse ES 
cells has little effects on the level of Oct4, Sox2 and Nanog (Fig. 3). Using the Nanog 
over-expression cell line (Paper II), I was able to show sustained Zic3 expression under 
RA treatment (Fig. 2). Furthermore, Nanog depletion by RNAi reduced the activity from 
the Zic3 promoter cloned upstream of a Luc gene (Fig. 2). These experiments further 
indicate the regulatory role of Nanog on Zic3 (Fig. 9). To determine the role of Zic3 in 
mouse ES cells, I used shRNA to deplete Zic3 level. The resultant ES cells were 
morphological differentiated, negatively stained in alkaline phosphatase and have 
reduced capacity to form colonies in secondary re-plating assay (Fig. 3). Thus Zic3 is an 
essential factor in regulating ES cells. Depletion of Zic3 in mouse ES cells, resulted in 
the concomitant up-regulation of endoderm markers expressions (Fig. 4), suggesting that 
Zic3 might be preventing endoderm lineage commitment (Fig. 9). The observations from 
Zic3 knockdown using shRNA are specific as I am able to rescue the induction of 
endoderm markers using RNAi-immune over-expression constructs (Fig. 5, Suppl Fig. 1 
and Suppl Table 1a/b). In this study, we examined the function of Zic3 as a regulatory 
target of Oct4, Nanog, and Sox2 in ES cells. We showed that Zic3 is important in 
maintaining ES cell pluripotency by preventing differentiation of cells into endodermal 
lineages.   
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5.4 Paper IV 
 
In this study, we examined the role of Histone lysine demethylases that are downstream 
target of Oct4 in regulating the open chromatin structures in mouse ES cells. Y.H.L., 
W.W.Z and H.H.N. were involved in project planning, data analysis and manuscript 
preparation; W.W.Z was involved in ChIP and realtime PCR analyses; X.C. performed 
EMSA and reporter assays; J.G. analyzed the microarray data.  
 
In the current study, I have demonstrated that Oct4 binds to the regulatory regions of 
Jmjd1a and Jmjd2c using ChIP assays (Fig. 1). Furthermore, I showed that depletion of 
Oct4 by RNAi led to the decrease of Jmjd1a and Jmjd2c expression, indicating that Oct4 
positively regulates the JHDMs (JmjC domain-containing histone demethylase) (Fig. 1 
and Suppl Fig. S1). I further confirmed that the Oct4 regulation is specific, and is not due 
to secondary effects induced by differentiation, as the knock down of Nanog and Esrrb 
showed little reduction of Jmjd1a and Jmjd2c expression (Fig. 1 and Suppl Fig. S1).  To 
study the function of Jmjd1a and Jmjd2c in ES cells, I depleted their endogenous 
expression using RNAi (Fig. 2). The RNAi constructs are effective as both endogenous 
mRNA and protein levels were reduced (Fig. 2). I further demonstrated that Jmjd1a and 
Jmjd2c are important in ES cells self-renewal as knockdown of both JHDMs resulted in 
morphological differentiation, reduction in alkaline phosphatase staining, and reduced 
capacity to form colonies in secondary re-plating assays (Fig. 2 and Suppl Fig S6). To 
rule out nonspecific effects, I performed control experiments with shRNA constructs 
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carrying mutations of two nucleotide bases. These mutations abolished their silencing 
effects and the ES cells remained undifferentiated (Suppl Fig. S3 and Suppl Fig. S4). I 
showed that each JHDM shRNA set was specific for targeting the intended transcript as 
knockdown of Jmjd1a did not appreciably affect Jmjd2c and vice versa (Suppl Fig S2). I 
also proved that the differentiation phenotype is specific to Jmjd1a and Jmjd2c 
knockdown ES cells, as we did not observe morphology changes or any reduction in Oct4 
expression when we depleted transcripts coding for other JmjC-domain containing 
proteins, Jarid2, Jarid1a and Jhdm1 (Suppl Fig S5). Consistent with the differentiation 
morphology, I have confirmed that the cellular differentiation induced by Jmjd1a or 
Jmjd2c knockdown was accompanied by corresponding reduction in pluripotency 
markers and concurrent induction of genes associated with differentiation (Fig. 2 and 
Suppl Fig. S7). To understand the molecular basis of JHDMs requirements in ES cell 
maintenance, I performed expression analysis of the Jmjd1a and Jmj2c knockdown cells 
using Illumina gene expression microarrays (Fig. 2, Fig. 3, Fig. 5). From the results of the 
microarray, I short-listed 7 genes that might be regulated by Jmjd1a (Suppl Table 2). Our 
ChIP analysis indicates that Jmjd1a regulates Tcl1, Tcfcp2l1 and Zfp57 through the 
modulation of H3K9me2 at the promoter regions (Fig. 3 and Suppl Fig. S8). Using the 
anti-Jmjd1a polyclonal antibodies that I have generated and characterized, I was able to 
show that Jmjd1a is associated with the promoter regions of Tcl1, Tcfcp2l1 and Zfp57 
(Fig. 3 and Suppl Fig. S8). Moreover, I demonstrated that Tcl1 over-expression can 
compensate for the loss of Jmjd1a. Thus we conclude that Tcl1 is an important 
downstream effector of Jmjd1a in ES cells regulation (Fig. 4 and Suppl Fig. S9). 
Similarly, for Jmjd2c, I have identified 10 genes from the microarray results (Suppl Table 
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2). ChIP analysis using the anti-Jmjd2c polyclonal antibodies that I have generated, 
showed that Jmjd2c binds to the Nanog promoter (Fig. 5).  I further confirmed that 
Jmjd2c regulates Nanog expression through the modulation of H3K9me3 (Fig. 5). I have 
also determined that Nanog is a downstream effector of Jmjd2c in regulating ES cells 
(Fig. 6 and Suppl Fig. S11). Taken together, our results demonstrate for the first time an 
ES cell transcription factor regulating a novel pathway that specifies the epigenetic status 


















6. MATERIAL AND METHODS 
 
6.1 CELL CULTURE AND TRANSFECTION 
 
293T cells were cultured in Dulbecco’s modified Eagle’s medium (GIBCO) 
supplemented with 10% heat-inactivated fetal bovine serum (GIBCO) and maintained at 
37°C with 5% CO2. Feeder-free E14 mouse ES cells were cultured at 37°C with 5% CO2. 
All cells were maintained on gelatin-coated dishes in Dulbecco’s modified Eagle medium 
(DMEM; GIBCO), supplemented with 15% heat-inactivated fetal bovine serum (FBS; 
GIBCO), 0.055 mM β-mercaptoethanol (GIBCO), 2 mM L-glutamine, 0.1 mM MEM 
nonessential amino acid, 5,000 units/ml penicillin/streptomycin and 1,000 units/ml of LIF 
(Chemicon).  
 
Transfection of shRNA and overexpression plasmids was performed using Lipofectamine 
2000 (Invitrogen). 2 µg of plasmids were transfected into ES cells on 60mm plates for 
RNA and protein extraction. For RNAi ChIP assay, 18 µg of plasmids were transfected 
into ES cells on 150mm plates. Puromycin (Sigma) selection was introduced 1 day after 
transfection at 1.0 µg/ml, and maintained for 2-6 days prior to harvesting. Detection of 
alkaline phosphatase which is indicative of the non-differentiated state of ES cells was 





6.2 RNA INTERFERENCE ASSAY 
 
19 base-pair gene-specific regions for RNA interference were designed based on the 
work of Reynolds et al. (2004) and Ui-Tei et al. (2004). RNAi oligonucleotides were 
cloned into pSuperpuro (BglII and HindIII sites; Oligoengine), which expresses 19-
nucleotide short hairpin RNAs (shRNAs) with a 9-nucleotide loop, The pSuperpuro 
plasmid carries a puromycin gene driven by a PGK promoter. All sequences were 
analyzed by BLAST search to ensure that they did not have significant sequence 
similarity with other genes. For rescue experiments, RNAi construct was co-transfected 
with a construct expressing targeting gene ORF with mutations that destroy the target site 
of shRNA sequence.  
 
6.3 RNA ISOLATION, REVERSE TRANSCRIPTION AND REAL-TIME PCR 
ANALYSIS 
 
Total RNA was isolated using Trizol reagent (Invitrogen) and purified with the RNeasy 
minikit (Qiagen). cDNA synthesis was performed with 500-1000 ng of total RNA using 
the SuperScript II kit (Invitrogen). Endogenous mRNA levels were measured by real-
time PCR analysis based on SYBR Green detection with the ABI Prism 7900HT machine 
(Applied Biosystems). The real-time PCR mixture contained 2 µl of the reverse 
transcription reaction product in a total volume of 10 µl, consisting of 5µl SYBR Green 
mix reagent (Applied Biosystems), 50 nM forward primer, and 50 nM reverse primer. 
Each sample was analyzed in duplicate. Results were normalized with β- actin. Two pairs 
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of primers were used to quantify the amount of cDNA, and both primer pairs showed 
identical results. For all the primers used, each gave a single product of the right size. 
 
6.4 PROTEIN EXTRACTION AND WESTERN BLOTTING 
 
Total protein extracts were prepared by lysing cells in SDS loading buffer. Total protein 
(40 µg) were separated by SDS–PAGE and transferred to PVDF membrane. Membrane 
was probed with antibodies against protein of interest. Anti-β-tubulin was used as loading 
controls. Histones were extracted using the acid extraction method. Cells were scraped 
from culture dishes in chilled PBS, centrifuged and washed once with ice-cold PBS. Cell 
pellets were then incubated in triton extraction buffer (PBS, 0.5% Triton-X-100, 2mM 
PMSF) for 10 minutes on ice. Pellets were re-suspended in 0.2 N HCl overnight for the 
extraction of histone.  
 
6.5 LUCIFERASE REPORTER CONSTRUCTS AND ASSAYS 
 
For human POU5F1-Luc, a 3-kb fragment of the human POU5F1 promoter was cloned 
into pGL3-Basic plasmid (BglII and NcoI sites) upstream of the firefly luciferase gene 
(Promega). For the Sox2-SV40-Luc construct, a 461-bp fragment of genomic DNA 
containing the SRR2 enhancer was amplified and cloned into a pGL3 promoter plasmid 
(MluI and BglII sites) containing the simian virus 40 (SV40) promoter upstream of a 
firefly luciferase gene (Promega). The Luc-Sox2 open reading frame (ORF) construct was 
generated by cloning the Sox2 open reading frame (NM_011443) into XhoI and NotI 
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sites downstream of the Renilla luciferase gene (psiCHECK-2; Promega). Similarly, the 
Luc-Pou5f1 ORF construct was generated by cloning the Pou5f1 open reading frame 
(NM_013633) into XhoI and NotI sites downstream of the Renilla luciferase gene 
(psiCHECK-2; Promega).  
 
To assay for knockdown in 293T cells, 5 ng of plasmids containing Renilla luciferase 
fused to ORF and 100 ng of shRNA plasmids (pSUPER.puro; Oligoengine) were 
transfected with Lipofectamine 2000 (Invitrogen) into 293FT cells. The cells were seeded 
at a density of 25,000 to 30,000/well in 96-well plates (Costar). To study the effects of 
knockdown on the Pou5f1 promoter, 100 ng of human POU5F1-Luc plasmid, 100 ng of 
shRNA plasmid (pSUPER.puro;Oligoengine), and 5 ng of plasmid containing Renilla 
luciferase (pRL-SV40; Promega) were transfected into E14 ESCs. The pRL-SV40 
plasmid served as an internal control for normalizing the transfection efficiency. For the 
Sox2 enhancer assay, E14 ESCs were transfected with 100 ng of plasmids containing the 
SRR2 enhancer activating firefly luciferase, 100 ng of shRNA plasmid, and 5 ng of 
plasmids containing Renilla luciferase (pRL-SV40). Firefly and Renilla luciferase 
activities were measured 48 to 60 h after transfection with the Dual Luciferase System 
(Promega) using a Centro LB960 96-well luminometer (Berthold Technologies). 
 
6.6 MICROARRAY ANALYSIS OF GENE EXPRESSION 
 
For Jmjd1a shRNA 1, Jmjd2c shRNA 1 and Luc shRNA treated ES cells, Illumina 
microarray platform (Sentrix Mouse-6 Expression BeadChip v 1.0) was used to analyze 
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the reverse transcribed mRNAs. Three biological repeats of the profiles (each for control 
and knockdown of the two genes) were used to generate statistically significant gene lists. 
Rank Invariant normalization was use to normalize the microarrays. Significance analysis 
of microarrays (SAM) was used to select differentially expressed genes. The 
differentially expressed genes were selected based on the following three criteria (Fold 
change (FC)>1.5 for up-regulated, FC<0.6 for down-regulated; q value<2%; and 
detection probability greater than 0.99 in at least all three samples of any one group 
(control or treatment)). To compute the nominal p-value for the overlapping gene lists, 
Monte Carlo simulation was performed. The microarray data files are deposited at GEO 
database (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE8937).  
 
For Pou5f1 or Nanog shRNA and Gfp shRNA treated ES cells, Affymetrix Mouse 
Genome 430 2.0 Array arrays were used to profile the transcriptome. For the Pou5f1 
knockdown experiment, we had four replicates. For the control and Nanog knockdown 
experiments, we had five replicates for each. The probes for hybridization were prepared 
by GeneChip One-Cycle Target Labeling kit (Affymetrix). The microarray data files are 
deposited at GEO database 
(http://www.ncbi.nlm.nih.gov/projects/geo/gds/gds_browse.cgi?gds=1824). RMA 
(Robust Multichip Averaging) method was employed to normalize the array data. After 
the normalization we used Significance Analysis of Microarray (SAM) statistics to select 
differentially expressed genes from the two groups. SAM (http://www-
stat.stanford.edu/~tibs/SAM) uses permutations of the repeated measurements to estimate 
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the percentage of genes identified by chance. The selected genes have a median FDR 
(false discovery rate) of less than 0.001.  
 
6.7 CHROMATIN IMMUNOPRECIPITATION (CHIP) ASSAY 
 
ES cells were cross-linked with 1% (w/v) formaldehyde for 10 min at room temperature 
and formaldehyde was then inactivated by the addition of 125 mM glycine. Chromatin 
extracts containing DNA fragments with an average size of 500 bp were 
immunoprecipitated using antibodies against protein of interest or anti-GFP (sc-9996, 
Santa Cruz) antibodies were used as mock ChIP controls. Quantitative PCR analyses 
were performed in real-time using the ABI PRISM 7900 sequence detection system and 
SYBR green master mix. Threshold cycles (Ct) were determined for both 
immunoprecipitated DNA and known amount of DNA from input sample for different 
primer pairs. Relative occupancy values (also known as fold enrichments) were 
calculated by determining the IP efficiency (ratios of the amount of immunoprecipitated 
DNA to that of the input sample) and normalized to the level observed at a control region, 
which was defined as 1.0. For all the primers used, each gave a single product of the right 









7.1 AIMS AND OBJECTIVES OF THE STUDIES 
 
Embryonic stem (ES) cells are derived from the inner cell mass (ICM) of early 
mammalian embryos (Evans and Kaufman, 1981; Martin, 1981). They can be propagated 
indefinitely in culture while retaining the potential to generate every cell type of the 
organism (Keller, 2005). Understanding the molecular mechanisms that underlie these 
unique properties will be useful in harnessing ES cells for their applications in 
regenerative medicine.  
 
The aim of our study is to identify, characterize and understand the role of genetic and 
epigenetic regulators in controlling the gene expression programs that define the 
undifferentiated state of ES cells. Specifically, we want to understand  1) the 
relationships between Oct4, Sox2 and Nanog, whether they function in distinct pathways 
or operate inter-dependently to coordinate the specification of the ES cell state (Paper I, 
Paper II)   2) the regulation of downstream genomic targets by the key factors, which will 
be instrumental in delineating their specific roles in regulating biological processes or 
pathways in their governance of the ES cell pluripotency   3) the functional relevance of 
the downstream targets and the identification of downstream effectors which may have 
novel roles in propagating the effects of the core network (Paper II; Paper III)   4) the 
mechanisms whereby the core transcription factors can modulate the open chromatin 
architecture of the pluripotent ES cells (Paper IV). 
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7.2 GENETIC DISSECTION OF TRANSCRIPTION REGULATORY NETWORK 
IN ES CELLS USING RNA INTERFERENCE 
 
RNA interference (RNAi) is an evolutionary conserved, sequence-specific silencing of 
gene expression. RNAi can be used to induce the down-regulation of endogenous gene-
expression efficiently and rapidly. Hence RNAi provides an attractive alternative to 






Several studies have highlighted the potential problem of off-target effects when using 
RNAi in gene knockdown experiments (Scacheri et al., 2004; Fedorov et al., 2006; 
Jackson et al., 2003; Jackson et al., 2006; Birmingham et al., 2006). To minimize the 
likelihood of off-target effects, we adopted several experimental approaches to ensure the 
specificity of our RNAi and to confirm the validity of the knockdown results. Firstly, 
Figure 24 Morphological changes in ES cells induced by Oct4, Sox2 and Nanog 
knockdown. Note that fibroblastic and trophoblast giant-like cells were produced after 
knockdown of Oct4 and Sox2. Meanwhile the presence of stellate shaped cells after 
knockdown of Nanog was observed. (Adapted from Wu et al., 2006) 
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only shRNA with full sequence homology to the desired mRNA target were used. These 
shRNA sequences bear little homology to other mRNAs in the EST database as 
determined by BLAST analysis. Secondly, at least two distinct shRNAs that target 
different regions of the mRNA and showed the same phenotypic effects were used. 
Thirdly, shRNA with mutations of 2 or more nucleotides mismatch to the target mRNA 
were used as negative controls. Lastly, forced expression of RNAi-immune form of the 
targeted mRNA was used to rescue the observed RNAi phenotype.  
 
In mouse ES cells, transcription factors Oct4, Sox2 and Nanog are found to play central 
roles in directing self-renewal and maintaining pluripotency (Nichols et al., 1998, Mitsui 
et al., 2003; Chambers et al., 2003; Avilion et al., 2003). To dissect the molecular 
mechanisms behind these properties, we used RNAi to deplete their expression in ES 
cells. Our Oct4, Sox2 and Nanog RNAi constructs are effective in down-regulating both 
the endogenous mRNA and protein of the intended targets (Paper I, Paper II, and Paper 
III). Strikingly, with the depletion of Oct4, Sox2 or Nanog by RNAi, the colony 
morphology of ES cells was lost and the cells became flattened and fibroblast-like 
(Figure 24). The alkaline phosphatase staining typical of undifferentiated ES cells was 
also reduced upon knockdown of these transcripts (Paper I, Paper II).  
 
Oct4-deficient embryos develop to the blastocyst stage but do not give rise to the ICM. 
When these embryos are allowed to attach in vitro, they become trophectodermal cells 
(Nichols et al., 1998). In our studies, Oct4 knockdown in ES cells induced differentiation 
resulting in cells with enlarged nuclei typical of trophoblast giant-like cells (Figure 24).  
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Cellular differentiation induced by Oct4 knockdown was accompanied by a 
corresponding induction of genes associated with differentiation. They included the 
trophectodermal and endodermal lineage markers such as Hand1, Cdx2, Gata6 and Bmp4 
(Paper I; Paper II). Interestingly mesodermal and neuroectodermal markers (Brachyury, 
Fgf5 and Nestin) (Paper I) were not affected.  
 
Sox2 is implicated in the establishment of primitive and extra-embryonic ectoderm. Sox2-
deficient embryos have defective epiblast and ES cells cannot be derived from these 
embryos (Avilion et al., 2003). Sox2 is capable of heterodimerizing with Oct4 (Reményi 
et al., 2003; Williams et al., 2004) to mediate the transcription of several genes in ES 
cells (Ben-Shushan et al., 1998; Botquin et al., 1998; Catena et al., 2004; Dailey et al., 
1994; Nishimoto et al., 1999; Tokuzawa et al., 2003; Tomioka et al., 2002; Yuan et al., 
1995). ES cells with knockdown of Sox2 form fibroblast-like cell types with extensive 
cytoplasmic projection and some trophoblast giant-like cells (Figure 24). Thus Sox2-
depleted ES cells are morphologically similar to the Oct4 knockdown cells. Gene 
expression profiles for both Sox2 and Oct4 knockdown ES cells are quite similar (Paper 
I). However Sox2 depletion also induced the expression of neuroectodermal marker such 
as Fgf5, suggesting that Sox2 could also be acting in pathways that are independent of 
Oct4. 
 
Nanog is required for the maintenance of the primitive ectoderm in the embryo. Mouse 
Cells derived from the ICM lacking Nanog differentiate into extra-embryonic endoderm 
lineages (Mitsui et al., 2003). Our Nanog-depleted mouse ES cells produced stellate-
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shaped cells with different morphologies compared to those of Oct4- or Sox2- depleted 
cells.  This is supported by the different lineage expression profile observed in Nanog 
knockdown cells. For example, the induction of Gata4 (endoderm marker) was not 
detected in Oct4 and Sox2 knockdown ES cells. Prior to our study, there have been no 
reported studies on Oct4, Sox2 and Nanog depletion in mouse ES cells using RNAi. Thus, 
we have demonstrated the first instance of morphological differentiation and changes in 
gene expression in mouse ES cells upon depletion of the three key factors.   
 
Together we have shown that RNAi technology can be applied for functional studies in 
mouse ES cells. Consistent with their in vivo requirement in early embryos, we have 
reported that the depletion of Oct4, Sox2 and Nanog in mouse ES cells resulted in cellular 
differentiation and the loss of self-renewal capacity. A major goal of our work is to 
elucidate the intricate molecular mechanisms that govern the unique ES cell state. Here, 
we have shown that using RNAi experiment, we can achieve our aim of deciphering the 
specific and distinct mechanisms involved in the maintenance of self-renewal by 
transcription factors Oct4, Sox2 and Nanog. The use of RNAi technology in ES cells will 
also facilitate the identification of additional gene products that have important roles in 







7.3 RELATIONSHIPS BETWEEN OCT4, SOX2 AND NANOG 
 
Oct4, Sox2 and Nanog have been shown to be essential for both the formation of the ICM 
during pre-implantation development and for the self-renewal of pluripotent ES cells 
(Nichols et al., 1998, Mitsui et al., 2003; Chambers et al., 2003; Avilion et al., 2003). 
However, the regulatory relationships between these three factors (whether they are 
transcriptional linked and modulate each others expression) are not known prior to our 
study.  
 
It has previously been shown that Pou5f1, the Oct4 gene, contains a distal enhancer 
imparting its specific expression pattern in both ES cells and pre-implantation embryos 
(Yeom et al., 1996). In vivo footprinting experiments have also identified the exact 
binding sites for transcription regulators within the distal enhancer (DE). Comparative 
analysis of the human, bovine, and mouse Oct4 upstream promoter sequences has 
revealed four conserved regions between these species (CR1 to CR4) (Nordhoff et al., 
2001). Interestingly, CR4 overlaps with the distal enhancer, suggesting that 
evolutionarily conserved elements may regulate the activity of the enhancer. Our study 
(Paper I) has shown that the OCT4 promoter containing the conserved regions CR1 to 
CR4 displays ES cell-specific activity. Deletions affecting the CR4 region and mutations 
at the sox-oct element drastically reduced the activity of the promoter in ES cells. These 
experiments confirmed the enhancer activity of the sox-oct element in CR4 region. Using 
RNAi, we further examined the functional role exerted by the Oct4/Sox2 heterodimer on 
these regulatory elements and their endogenous gene expression. Silencing of Oct4 or 
78 
Sox2 led to the down-regulation of OCT4 enhancer activities. Thus our results have 
established the positive regulatory role of Oct4 and Sox2 at the OCT4 enhancer.  
 
Two regulatory regions of the Sox2 gene (SRR1 and SRR2) are known to confer ES cell-
specific expression (Tomioka et al., 2002). SRR2 is located 1.2 kb downstream of the 
Sox2 transcription start site, and it contains the composite sox-oct element. In addition, 
Oct4 has been shown to bind to the octamer site within the SRR1 of Sox2 promoter in 
vitro (Catena et al., 2004). In our study (Paper I), we showed that the Sox2 enhancer 
region that contains the SRR2 element exhibits ES cell-specific activity. Co-transfection 
of the Oct4 or Sox2 RNAi constructs along with this Sox2 enhancer reporter into mouse 
ES cells resulted in diminished enhancer activity. Furthermore, depletion of Oct4 reduced 
the expression of endogenous Sox2. Thus our results support the positive regulatory role 
of Oct4 and Sox2 at the Sox2 SRR2 enhancer.  
 
We and others have previously reported that the Oct4/Sox2 complex regulates Nanog 
expression in ES cells (Rodda et al., 2005; Kuroda et al., 2005). Knockdown of either 
Oct4 or Sox2 reduced the reporter activity from the Nanog promoter (Rodda et al., 2005). 
Importantly, Oct4 or Sox2 RNAi also reduced endogenous expression of Nanog (Paper II 
and unpublished data). Thus we have expanded the list of genes regulated by both Oct4 
and Sox2 to include Nanog. In addition, our work has provided evidence for the 
functional links from Nanog to Oct4, Sox2 and Nanog (Paper II). Nanog depletion 
resulted in drastic reduction of Oct4 and Sox2 expression (Paper II). Interestingly, over-
expression of Nanog in ES cells can sustain the level of Oct4 and Sox2 expression under 
79 
RA-induced differentiation condition (Paper II). These evidences suggest that Nanog 
positively regulates Oct4 and Sox2 expression. 
 
What emerges is a genetic regulatory network linking the key transcription factors Oct4 
Sox2 and Nanog in embryonic stem cells. Our data uncover a positive autoregulatory 
loop that maintains the expression of Oct4, Sox2 and Nanog (Figure 25). Auto-regulation 
is thought to provide several advantages, including reduced response time to 
environmental stimuli and increased stability of gene expression. Thus it appears that 
Oct4, Sox2 and Nanog promote the expression of pluripotency genes such as themselves 
to reinforce the state of self-renewal in ES cells. In the event of differentiation, however, 
when the concentration of the individual factors is reduced, these autoregulatory loops 







Figure 25 Oct4, Sox2 and Nanog auto-regulatory motif in ES cells. Transcription 
factors are represented by ovals, and the genes (printed in italics) are represented by 
rectangles. A black arrow depicts synthesis of gene products from their respective 
genes. Gray dotted arrows denote the positive regulation of the genes by the 
transcription factors via a cis element. (Adapted from Paper I and Paper II) 
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7.4 TRANSCRIPTIONAL REGULATORY NETWORK OF OCT4 AND NANOG  
 
Despite the importance of Oct4 and Nanog in mouse ES cells, surprisingly little was 
known about the importance of down-stream targets of these two transcriptional factors 
in governing ES cell fate.  
 
A previous study by Young and co-workers (Boyer et al., 2005) has employed genome-
wide location analysis (ChIP-chip) to construct the core transcriptional regulatory 
network in the human embryonic stem cells. However, the functional relevance of the 
genes identified as targets of these three factors is not fully described, as protein 
occupancy is not necessarily a predictor of function (Orkin, 2005). To address these 
questions, we have integrated genome-wide expression profiling with location studies of 
sites bound by these regulators, in the construction of the Oct4 and Nanog transcriptional 
circuitry in mouse ES cells (Paper II).    
 
The study (Paper II) utilized the recently developed paired-end ditag (PET) technology to 
characterize chromatin immunoprecipitation enriched DNA fragments to achieve 
unbiased, genome-wide mapping of transcription factor binding sites (Wei et al., 2006). 
As binding does not imply regulation, Oct4 and Nanog were depleted using RNAi and 
the resultant knockdown cells were profiled using gene expression microarrays to 
elucidate the mode of regulations on target genes. The global expression profiles 
indicated that 4,711 genes were significantly affected in Oct4 knockdown experiments, 
among which 394 genes contained the Oct4 binding sites. Of the 2,264 differentially 
regulated genes in Nanog knockdown experiments, 475 were bound by Nanog. Using this 
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strategy, the direct targets regulated by the respective transcription factors were identified. 
The downstream targets represent diverse classes of genes encoding for transcription 
regulators, growth factors, signaling molecules, DNA damage response sensors and 
lineage-specific genes, suggesting that Oct4 and Nanog have wider regulatory roles than 
previously thought.  
 
Besides protein-coding genes, both Oct4 and Nanog also regulate genes that encode for 
microRNAs. Nanog binds four microRNA genes mir296, mir302, mir124a and mir9-2, 
while Oct4 binds the mir296 and mir302 genes. Drosha and Dicer are the enzymes 
responsible for the cleavage of the primary miRNA transcripts (pri-miRNAs) to mature 
miRNAs, which are incorporated into the RNA interference silencing complex (RISC) 
(Carmell and Hannon, 2004). The Loss of Dicer1 results in the failure of the ability to 
generate pluripotent ES cells from the ICM (Bernstein et al., 2003). Notably, Dicer1 can 
be deleted after the ES cells are established. However the Dicer1-/- ES cells are incapable 
of differentiation, indicating the lack of pluripotency (Kanellopoulou et al., 2005). 
Recently, miR-134 was shown to induce differentiation of mouse ES cells to a primitive 
ectodermal phenotype when overexpressed (Tay et al., 2007). Furthermore, it was found 
that miR-134 targets the 3’UTR of Nanog mRNA and regulates its expression. Together 
these data highlighted the critical roles played by the miRNA machinery in maintaining 
the ES cell pluripotency. Our study suggests that miRNA genes are likely to be regulated 
by Oct4 and Nanog in mouse ES cells (Paper II) and that the miRNA are important 
components of the transcriptional regulatory circuitry. 
The global expression profiles indicate that Oct4 and Nanog can function as positive or 
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negative regulators of gene expression. Among the active targets are genes coding for 
regulators and pathways that function in ES cell self-renewal, for example Oct4, Sox2, 
Nanog, Sall4 and Foxd3. Whereas, a large fraction of the repressed targets identified 
include genes encoding for factors that play important roles in development, for example 
Cdx2 and Nrp1. Thus one strategy that Oct4 and Nanog maintain pluripotency is by 
promoting the expression of downstream self-renewal genes while simultaneously 
repressing the activity of differentiation-promoting genes.  
 
Our comparative whole genome location analyses also revealed that Nanog and Oct4 
share a substantial portion of their targets. Our functional analysis further identified 77 
genes that were bound and regulated by both Oct4 and Nanog. This result suggests that 
the two important regulators work together on regulating multiple common genomic 
targets. Many of the commonly bound and regulated genes encode known or putative 
transcriptional regulators, including Oct4, Sox2 and Nanog. We therefore reasoned that a 
common core of downstream targets of Oct4 and Nanog may be required for proper ES 
cell maintenance. 
 
Together, the Oct4 and Nanog regulatory circuit maps provided a foundation for 
understanding how Oct4 and Nanog can work together in orchestrating early cell fate 





7.5 COMPARISON OF THE TRANSCRIPTIONAL NETWORKS BETWEEN 
HUMAN AND MOUSE ES CELLS 
 
Comparison of the Oct4 and Nanog-bound sites between the mouse and human has 
revealed modest similarity (Paper II) (Boyer et al., 2006). There are merely 32 common 
genes that are co-bound by the two transcription factors in both mouse and human ES 
cells (Paper II). The difficulties to reconcile the two data sets have been attributed to the 
differences in the genomic platforms used or the genuine dissimilarities in the 
pluripotency circuitries of the two species. 
 
In the human study, only promoters were surveyed for binding sites using arrays with low 
probe density (average of 1 probe per 280 bp) (Boyer et al., 2006). In contrast, the mouse 
study used an unbiased approach to identify binding sites and obtained high resolution 
data. It is well recognized that mammalian transcription factors can bind to regions 
outside proximal promoters (Cawley et al., 2004; Kim et al., 2005; Impey et al., 2004). 
Hence, the limited overlaps between the mouse and human studies could be the 
manifestation of the differences in scope and breadth of the location analyses performed 
by the two groups. On the other hand numerous studies have identified differences 
between human and mouse ES cells in terms of their morphologies, growth rates, marker 
expression, and culture requirements (Rao, 2004). For example, human ES cells depend 
on bFGF for self-renewal, whereas their mouse counterparts depend on the Lif/Stat3 
pathway (Reubinoff et al., 2000, Thomson et al., 1998). Recent studies have provided 
new perspective towards our understanding of the differences between mouse and human 
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ES cells (Brons et al. 2007; Tesar et al. 2007). Tesar et al. (2007) confirmed that there are 
little overlaps between the Oct4 binding sites in the ES cells of the mouse and human. 
Surprisingly, Oct4 binding sites of human ES cells coincide more closely with the mouse 
EpiSCs (Epiblast stem cells). There is also great resemblance of mouse EpiSCs to human 
ES cells in terms of morphology, growth conditions, transcriptional profile and epigenetic 
regulation (Brons et al. 2007; Tesar et al. 2007). Therefore, it is conceivable that the 
observed differences between the mouse ES cells and human ES cells networks could be 
due to the fact that they are pluripotent cells derived from different developmental stages.  
 
7.6 NOVEL REGULATORS OF SELF-RENEWAL IN ES CELLS 
 
The Oct4 and Nanog transcriptional regulatory networks in mouse ES cells (Paper II) 
provide much insight into how the key factors regulate pluripotency and influence 
subsequent differentiation events. However the functional relevance of the downstream 
targets identified remains largely unknown. Of particular interest, Oct4 and Nanog co-
occupy and collaborate in regulating many common downstream genes (Paper II). We 
reasoned that some of these targets could be important for proper ES cell maintenance. 
Therefore, we sought to identify the downstream effectors responsible for implementing 
the decision of Oct4 and Nanog to maintain the self-renewal state of the ES cells. 
 
Estrogen related receptor beta (Esrrb) is an orphan nuclear receptor closely related to 
estrogen receptor but lacks identified ligands. Esrrb is positively regulated by both Oct4 
and Nanog in mouse ES cells (Paper II). Previous study has reported that null mutants of 
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Esrrb displayed embryonic lethality largely due to abnormal placental development (Luo 
et al., 1997). More recently, Mitsunaga and colleagues have shown that mutant embryos 
gave rise to fewer germ cells (Mitsunaga et al., 2004). In pluripotent ES cells, the 
expression of Esrrb is up-regulated (Wei et al., 2005). Its expression is inhibited during 
differentiation induced by LIF-withdrawal (Palmqvist et al., 2005). Using RNAi, we 
showed that Esrrb knockdown cells became flattened and fibroblast-like in morphology, 
with a loss of alkaline phosphatase staining (Paper II). Consistent with the differentiation 
phenotype, expression analysis of markers revealed that the ES cell-specific gene Zfp42 
was reduced in Esrrb depleted cells, whereas the trophectoderm marker Hand1 was 
induced (Paper II). These results revealed a previously unsuspected requirement for Esrrb 
in maintaining the self-renewal state of ES cells (Paper II). Recently, Lemischka and 
colleagues (Ivanova et al., 2006) have used stable knockdown cell lines of Esrrb and 
confirmed its role as a regulator of ES cell self-renewal. The mechanism by which Esrrb 
maintains the ES cell state is however not well studied. A group (Wang et al., 2006) has 
previously mapped the Nanog interactome by affinity purification coupled to mass-
spectrometry. Esrrb is a member of the Nanog interactome, suggesting that Esrrb may 
function as a partner of Nanog in regulating ES gene expression in ES cells. 
 
Rif1 encodes a mouse ortholog of the yeast RIF1 family of telomere-associated proteins 
(Adams and McLaren, 2004). Rif1 is a downstream target of both Oct4 and Nanog (Paper 
II). Notably, RIF1 is also a target of OCT4 and NANOG in human ES cells (Boyer et al., 
2005). This further underscores its functional importance in ES cell biology. Rif1 has 
been shown to be highly expressed in mouse ES and germ cells and its expression is 
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down-regulated during ES cell differentiation in parallel with down-regulation of Oct4 
expression (Adams and McLaren, 2004). RNAi-mediated knockdown of Rif1 resulted in 
a rapid loss of ES cell morphology, induction of differentiation markers and the depletion 
of pluripotency gene expression (Paper II). Thus Rif1 has a role in the preservation of 
pluripotent ES cells state (Paper II). Interestingly, Rif1 was identified to be an interacting 
partner of Nanog, Dax1, Zfp281 and Nac1 (Wang et al., 2006), all of which have been 
shown to be either important for early embryonic development or ES cells maintenance 
(Chambers et al., 2003; Mitsui et al., 2003; Niakan et al., 2006; Wang et al., 2006). 
Therefore, like Esrrb, Rif1 may play an important role as a partner to these key factors. 
 
Zic3 encodes a zinc finger transcription factor that is a member of a family of the Gli 
transcriptional factor superfamily (Aruga et al., 1996). Zic3 is a target of Oct4 and Nanog 
in both mouse and human ES cells (Boyer et al., 2005; Paper II). Zic3-null mice show 
varieties of different phenotypes including embryonic lethality, laterality defects in axial 
patterning and neural tube closure (Purandare et al., 2002). In collaboration with Linda 
Lim and Larry Stanton, we showed that ES cells depleted of Zic3 were morphological 
differentiated, stained negative for alkaline phosphatase and exhibited reduced capacity 
to form colonies in secondary re-plating assay (Paper III). Thus Zic3 is an essential factor 
in maintaining ES cells (Paper III). Zic3-depleted ES cells displayed a highly significant 
increase in the endodermal marker genes expression (Paper III). Mitsui and colleagues 
(2003) have previously identified the presence of Nanog consensus sequences in the 
promoter region of Gata6 gene (Mitsui et al., 2003). Ectopic expression of Gata6 in ES 
cells can induce endodermal specification which results in a phenotype similar to the 
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Nanog-null cells (Fujikura et al., 2002). This raised the possibility that Nanog may 
prevent primitive endoderm differentiation through the repression of Gata6. Since the 
level of Nanog expression was reduced in our Zic3 depleted ES cells, Zic3 may prevent 
endodermal marker expression through the regulation of Nanog-regulated pathways.  
 
In summary, we showed that downstream targets of Oct4 and Nanog are also important in 









Figure 26 Oct4 and Nanog regulatory 
network controlling pluripotency in ES 
cells. Transcription factors are
represented by ovals, and the genes 
(printed in italics) are represented by 
rectangles. A black arrow indicates a 
transcription factor binding to a gene 
and positively regulating its 
expression. Gray arrows denote the 
synthesis of gene products from their 
respective genes. The genes printed in 
colours (Esrrb and Rif1) are novel 
functional nodes in this network. 
(Adapted from Paper II) 
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7.7 HISTONE DEMETHYLASES REGULATE SELF-RENEWAL IN ES CELLS 
 
During the process of ES cell division, the choice between self-renewal and 
differentiation is decided by the complex interplay between signaling pathways, 
transcription factor networks and epigenetic processes. The exit from the self-renewing 
state is accompanied by changes in epigenetic chromatin modifications such as an 
induction in the silencing-associated histone H3 lysine 9 dimethylation and trimethylation 
(H3K9me2/me3) marks (Lee et al., 2004; Meshorer and Misteli, 2006). This suggests a 
role for histone demethylases in maintaining a transcriptionally permissive chromatin 
environment in ES cells.  Jmjd1a and Jmjd2c are JmjC-domain containing proteins that 
have recently been shown to be histone demethylases (JHDMs) (Tsukada et al., 2006; 
Yamane et al., 2006; Whetstine et al., 2006; Fodor et al., 2006; Cloos et al., 2006; Klose 
et al., 2006). Our ChIP-PET study revealed Oct4 binding clusters within Jmjd1a and 
Jmjd2c genes. We have confirmed that Jmjd1a and Jmjd2s are bona fide targets of Oct4 
by ChIP and EMSA assays (Paper IV). Furthermore, depletion of Oct4 by RNAi led to 
decreased Jmjd1a and Jmjd2c expression (Paper IV). Thus, Oct4 specifically upregulates 
H3K9 di- and tri-demethylases in ES cells.  The levels of these demethylases and 
H3K9me2/me3 also correlate with the pluripotent state of ES cells. 
 
To further characterize the functions of Jmjd1a and Jmjd2c, we use RNAi to genetically 
deplete their expression in mouse ES cells. Depletion of Jmjd1a and Jmjd2c in ES cells 
resulted in the loss of their distinctive ES cell-colony morphology and the ability to form 
colonies in secondary re-plating assays. Thus, we have uncovered novel functions of 
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Jmjd1a and Jmjd2c in regulating self-renewal of ES cells (Paper IV).  
 
Our results revealed that Jmjd1a binds and demethylates H3K9me2 at the promoter 
regions of Tcl1, Tcfcp2l1 and Zfp57 and positively regulates the expression of these 
pluripotency-associated genes. We further showed that Oct4 binding to the Tcl1 promoter 
was reduced in the Jmjd1a knockdown ES cells. It is likely that the increased H3K9me2 
limited the access of Oct4 to the oct element of the Tcl1 promoter region. Tcl1, a gene 
encoding for a cofactor of the Akt1 kinase has been shown to regulate self-renewal of ES 
cells (Ivanova et al., 2006; Matoba et al., 2006). Together we have identified a novel 
mechanism involving Jmjd1a in regulating the expression of pluripotency-associated 
genes by antagonizing H3K9me2 at the promoter regions. 
 
Most interestingly, we demonstrated that Jmjd2c regulates tri-methylation and expression 
of key pluripotency gene, Nanog.  In the absence of Jmjd2c, the chromatin of Nanog 
promoter is H3K9 trimethylated leading to the recruitment of repressor proteins HP1 and 
KAP1.  This result is surprising as Jmjd2 family of histone demethylases have been 
shown to regulate pericentric heterochromatin through overexpression studies (Fodor et 
al., 2006; Cloos et al., 2006; Klose et al., 2006). Our result indicates that Jmjd2c can 
reverse H3K9me3 level of key pluripotency gene.  We have thus uncovered a novel 
function of Jmjd2 demethylase in regulating the euchromatin. 
 
We uncovered a novel link to connect epigenetic regulation of pluripotency genes 
through histone demethylation in embryonic stem cells and we further demonstrate that 
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they are critical to self-renewal in ES cells.  No other histone modifying enzymes 
(histone acetylases, deacetylases, methylases and DNA methylases) are known to play 
such key roles in ES cells (Niwa et al., 2007).  Our finding also connects the ES cell 
transcription circuitry to chromatin modifiers Jmjd1a and Jmjd2c.  This represents a 


















Figure 27 Model for the maintenance of self-renewal of ES cells by Jmjd1a and Jmjd2c.
Schematic showing the interplay of Oct4 with Jmjd1a and Jmjd2c in sustaining ES cell
self-renewal. In ES cells, Oct4 up-regulates the levels of Jmjd1a and Jmjd2c. Jmjd1a 
and Jmjd2c maintain Tcl1 and Nanog by demethylation of the repressive H3K9me2 and 
H3K9me3 marks respectively. Notably, Tcl1 and Nanog are both downstream targets of 
Oct4. With differentiation, the down-regulation of Jmjd1a and Jmjd2c (dashed arrows) 
results in an elevation of the repressive H3K9me2/me3 modifications and reduced 
expression of downstream genes. (Adapted from Paper IV)
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Our study also has a broader implication on the mechanism of reprogramming.  Recently, 
Shinya Yamanaka showed that it is possible to convert highly differentiated somatic cells 
to induced pluripotent stem (iPS) cells (Takahashi and Yamanaka, 2006).  The finding 
implies that epigenetic regulation may not be as important as transcription factors, since 
transcription factors alone can bring about the reprogramming.  We show that Oct4 
directly regulates Jmjd1a and Jmjd2c expression.  Hence, one possible avenue of 
resetting the epigenetic landscapes of somatic cells by ES specific transcription factors is 
through the upregulation of histone demethylases that remove H3K9 di- and tri-
methylation (repressive marks) from the genomic chromatin, as well as pluripotency 
associated genes. 
 
7.8 CONCLUDING REMARKS  
 
In conclusion, our studies have made important contributions toward elucidating the 
complexity of cell fate determination and identifying mechanisms for stable propagation 
of ES cells in the pluripotent state. The elucidation of the molecular mechanisms 
governing the interactions between transcriptional network and epigenetic mechanisms 
has provided critical insight into how pluripotency is established and maintained in 
embryonic stem cells. The knowledge gained from our studies will thus aid in realizing 
the therapeutic objective of the ES cells and contribute towards harnessing their potential 
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Embryonic stem cells (ESCs) are pluripotent cells that can either self-renew or differentiate into many cell
types. Oct4 and Sox2 are transcription factors essential to the pluripotent and self-renewing phenotypes of
ESCs. Both factors are upstream in the hierarchy of the transcription regulatory network and are partners in
regulating several ESC-speciﬁc genes. In ESCs, Sox2 is transcriptionally regulated by an enhancer containing
a composite sox-oct element that Oct4 and Sox2 bind in a combinatorial interaction. It has previously been
shown that Pou5f1, the Oct4 gene, contains a distal enhancer imparting speciﬁc expression in both ESCs and
preimplantation embryos. Here, we identify a composite sox-oct element within this enhancer and show that it
is involved in Pou5f1 transcriptional activity in ESCs. In vitro experiments with ESC nuclear extracts dem-
onstrate that Oct4 and Sox2 interact speciﬁcally with this regulatory element. More importantly, by chromatin
immunoprecipitation assay, we establish that both Oct4 and Sox2 bind directly to the composite sox-oct
elements in both Pou5f1 and Sox2 in living mouse and human ESCs. Speciﬁc knockdown of either Oct4 or Sox2
by RNA interference leads to the reduction of both genes’ enhancer activities and endogenous expression levels
in addition to ESC differentiation. Our data uncover a positive and potentially self-reinforcing regulatory loop
that maintains Pou5f1 and Sox2 expression via the Oct4/Sox2 complex in pluripotent cells.
Embryonic stem cells (ESCs) are derived from the inner cell
mass (ICM) of the mammalian blastocyst. They are able to
undergo self-renewing cell division under speciﬁc cell culture
conditions for extended periods, thereby maintaining their plu-
ripotency (22, 43). This pluripotency is best displayed by their
ability to give rise to all embryonic lineages subsequent to their
reintroduction into the blastocyst. In addition, ESCs can also
differentiate into a variety of different cell types when cultured
in vitro (17, 19, 20, 40, 52). This property of ESCs, particularly
for human ESCs, holds great promise for regenerative thera-
peutic medicine (14, 32).
Several key regulators have been identiﬁed that are essential
both for the formation of the ICM during mouse preimplan-
tation development and for self-renewal of pluripotent ESCs
(3, 10, 24, 26, 41). These regulators include Oct4, Sox2, and
Nanog. Oct4 (also known as Oct3 and encoded by Pou5f1) is a
POU domain-containing transcription factor that binds to an
octamer sequence, ATGCAAAT. During mouse preimplanta-
tion development, zygotic Pou5f1 expression is activated at the
four-cell stage and is later restricted to the pluripotent cells of
the ICM and epiblast. In the mouse postimplantation embryo,
Pou5f1 expression is down-regulated upon epiblast differenti-
ation and its expression is maintained only in the primordial
germ cells (51). In addition, Oct4 is highly expressed in human
and mouse ESCs, and its expression diminishes when these
cells differentiate and lose pluripotency (31). Several target
genes of Oct4 in ESCs have been identiﬁed, and these include
Fgf4, Utf1, Opn, Rex1/Zfp42, Fbx15, and Sox2 (5, 6, 8, 12, 27, 46,
47, 53). The regulatory regions of these genes contain an oc-
tamer element capable of binding Oct4, at least in an in vitro
setting. These sites have been shown to be important for tran-
scriptional activity of their respective genes as indicated by
comparisons of octamer mutant and wild-type constructs in
reporter assays.
The octamer elements within the enhancers of Fgf4, Utf1,
Opn, Fbx15, and Sox2 are found in proximity to Sox2-binding
sox elements. Sox2 (SRY-related HMG box 2) is an HMG
domain-containing transcription factor essential for pluripo-
tent cell development (3). Sox2 has an expression pattern sim-
ilar to that of Pou5f1 through mouse preimplantation devel-
opment, as it is expressed in all blastomeres of the four-cell
embryo and becomes restricted to the ICM and epiblast of the
blastocyst (3). These two factors are also expressed in ESCs. Of
the Sox2-Oct4 target genes, all but Opn have the octamer and
sox heptamer elements separated by either 0 or 3 bp. Such
proximity suggests that these factors may interact with each
other. Indeed, two structures have recently been solved for a
POU/HMG ternary complex bound to composite sox-oct ele-
ments; one of these is on an element separated by 3 bp (36)
and the other is on an element separated by 0 bp (50). Both
reveal that the POU and HMG domains mediate speciﬁc pro-
tein-protein and DNA-protein interactions. In addition, it has
also been demonstrated that Sox2 and Oct4 can interact in the
* Corresponding author. Mailing address: Genome Institute of Sin-
gapore, 60 Biopolis Street, #02-01, Genome Building, Singapore
138672, Singapore. Phone: (65) 6478 8145. Fax: (65) 6478 9004. E-
mail: nghh@gis.a-star.edu.sg.
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absence of DNA and that the HMG and POU domains are
involved in this interaction (2). Hence, Oct4 and Sox2 are
capable of forming heterodimers both on and off the DNA.
Despite the limited number of Oct4 target genes, we can
nevertheless place Oct4 upstream in the hierarchy of the ESC-
speciﬁc gene regulatory network. Therefore, elucidating the
mechanisms behind the transcriptional regulation of Pou5f1 is
of considerable interest (33). Previous studies have deﬁned
regulatory regions that are important for driving Pou5f1 ex-
pression in different cell types of the early mouse embryo
through the analysis of lacZ reporter genes under the control
of different mouse Pou5f1 genomic fragments (51). These re-
gions include the core promoter which is located within the
ﬁrst 250 bp of the transcription initiation site. A proximal
enhancer, located about 1.2 kb upstream (1524 to 30), is
responsible for Pou5f1 expression in the epiblast, and a distal
enhancer region (located about 2 kb upstream) drives expres-
sion in the morula, ICM, and primordial germ cells. This distal
enhancer is also required for ESC-speciﬁc expression. Align-
ment between the upstream sequences of human, bovine, and
mouse Pou5f1 promoters revealed four conserved regions
(CR1 through CR4) (30). Interestingly, CR4 overlaps with the
distal enhancer, suggesting that evolutionarily conserved ele-
ments may be regulating the activity of the distal enhancer. To
date, the factors that bind and regulate these key regulatory
elements have not been identiﬁed.
Two regulatory regions (SRR1 and SRR2) in Sox2 are
known to confer ESC-speciﬁc expression (47). SRR2, located
1.2 kb downstream of the transcription start site, contains the
composite sox-oct element. Mutations within this composite
element disrupted the in vitro formation of a DNA/protein
complex and additionally resulted in the loss of SRR2 en-
hancer activity. More importantly, the reduction of Pou5f1
abolished the SRR2 activity, indicating that Oct4 can positively
regulate SRR2, but whether Oct4 and Sox2 are indeed bound
to SRR2 in ESCs remains to be demonstrated. In addition, the
FIG. 1. (A) Conserved motifs within the distal enhancer of Pou5f1. Alignment of the CR4 region of Pou5f1 from genomic sequence from six
eutherian mammals: Bos taurus (Bt), Sus scrofa (Ss), Homo sapiens (Hs), Canus familiaris (Cf), Rattus norvegicus (Rn), and Mus musculus (Mm).
Invariant positions within this alignment are indicated by a shaded box. The numbering corresponds to the mouse sequence (Mm) and is relative
to the translation start site. CR4-A, -B, and -C are regions discussed in the text. (B) Alignment of the composite sox-oct cis elements from the
respective mouse target genes that are known to bind Sox2 and Oct4, including that described in this paper and present in the CR4-B region in
panel A (complementary strand). (C) The 3-kb human POU5F1 promoter drives luciferase expression speciﬁc to ESC. (D) The effects of deleting
the speciﬁc CR4-A, CR4-B, and CR4-C regions highlighted in panel A and of the deletion of the entire CR4 region, in the context of the 3-kb
human POU5F1 promoter, on luciferase reporter activity in mouse ESCs. Activity is expressed relative to the wild-type construct (POU5F1-Luc).
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necessity of Sox2 binding to the SRR2 region for the transcrip-
tional activity of Sox2 has not been established. Nevertheless,
this still strongly suggests that Sox2 is the downstream target of
Oct4 (and possibly Sox2 itself). Interestingly, Oct4 has recently
been shown by chromatin immunoprecipitation (ChIP) to bind
to an octamer site within SRR1 of Sox2 (8).
In this study, we show that Oct4 and Sox2 bind to impor-
tant regulatory elements of Pou5f1 and Sox2 as a binary
complex in living human and mouse ESCs. Using RNA
interference (RNAi), we further examine the functional role
exerted by this complex on these regulatory elements and
the corresponding expression of their endogenous genes.
Our data support a model in which the Oct4/Sox2 complex
plays a key role in maintaining the expression of essential
transcription factors in ESCs through autoregulatory and
multicomponent loop network motifs. What emerges is a
genetic regulatory network linking the key transcription fac-
tors in ESCs.
FIG. 2. Oct4 and Sox2 bind to the distal enhancer of Pou5f1 in living mouse ESCs. (A) Speciﬁcity of the antibodies used in the ChIP assays
was conﬁrmed by Western blotting of mouse ESC nuclear extracts. (B) The locations of the ampliﬁed products (black boxes) of the primer sets
used to detect the ChIP-enriched DNA fragments, shown within the context of the genomic structure of mouse Pou5f1. The locations of the
conserved regions within the promoter are indicated. The composite sox-oct element is within CR4. Amplicons are numbered in order relative to
their sites along the gene. Open boxes represent exons. (C to E) High-resolution mapping of Oct4 (C), Sox2 (D), and control (glutathione
S-transferase antibody [GST]) (E) binding sites across the Pou5f1 promoter in mouse ESCs by ChIP analysis. Fold enrichment is the relative
abundance of DNA fragments at the indicated regions (see panel B) over a control region as quantiﬁed by real-time PCR. Standard deviations
are shown. (F to I) A similar analysis of Oct4 (G) and Sox2 (H) occupancy on the Pou5f1 promoter in undifferentiated mouse ESCs and in ESCs
induced to differentiate with RA for 3 and 6 days. Oct4 and Sox2 levels are shown to decrease in these differentiating conditions as identiﬁed by
Western blotting (F) with a histone deacetylase 1 antibody (HDAC1) used as a loading control. ChIP analysis was used as a subset (4, 6, and 7)
of the amplicons described in panel B. (I) A control ChIP assay using an anti-MLL antibody.
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Cell culture. 293T cells were cultured in Dulbecco’s modiﬁed Eagle’s medium
(GIBCO) supplemented with 10% heat-inactivated fetal bovine serum (GIBCO)
and maintained at 37°C with 5% CO2. E14 mouse ESCs, cocultured with mouse
primary embryonic ﬁbroblast feeder in 0.1% gelatin-coated ﬂasks, were main-
tained in Dulbecco’s modiﬁed Eagle’s medium (GIBCO), supplemented with
15% heat-inactivated fetal bovine serum, 0.055 mM 2--mercaptoethanol
(GIBCO), 2 mM L-glutamine (GIBCO), 0.1 mM minimal essential medium
with nonessential amino acids (GIBCO), 5,000-U/ml penicillin-streptomycin
(GIBCO), and 1,000 U/ml of leukemia inhibitory factor (LIF) (Chemicon). For
certain experiments, the ESCs were cultured under feeder-free conditions. In
differentiation experiments, the cells were treated with 0.5 M of retinoic acid
(RA). The human ESC line HUES-6 (obtained from Doug Melton, Harvard
University) was passaged according to the method of Cowan et al. (11).
RNAi design and construction of plasmids for shRNA synthesis. Nineteen-
base-pair gene-speciﬁc regions for RNA interference were designed based on the
work of Reynolds et al. and Ui-Tei et al. (37, 48). Oligonucleotides were cloned
into pSUPER.puro (BglII and HindIII sites; Oligoengine), which expresses 19-
nucleotide hairpin-type short hairpin RNAs (shRNAs) with a 9-nucleotide loop,
as described previously (7). All sequences were analyzed by BLAST search to
ensure that they did not have signiﬁcant sequence similarity with other genes.
The oligonucleotides used were as follows: for Gfp RNAi, 5-GATCCCCGAA
CGGCATCAAGGTGAACTTCAAGAGAGTTCACCTTGATGCCGTTCTT
TTTA-3 and 5-AGCTTAAAAAGAACGGCATCAAGGTGAACTCTCTTG
AAGTTCACCTTGATGCCGTTCGGG-3; for Pou5f1 RNAi, 5-GATCCCC
GAAGGATGTGGTTCGAGTATTCAAGAGATACTCGAACCACATCCT
TCTTTTTA-3 and 5-AGCTTAAAAAGAAGGATGTGGTTCGAGTATC
TCTTGAATACTCGAACCACATCCTTCGGG-3; for Sox2 RNAi, 5-GAT
CCCCGAAGGAGCACCCGGATTATTTCAAGAGAATAATCCGGGTGC
TCCTTCTTTTTA-3 and 5-AGCTTAAAAAGAAGGAGCACCCGGATT
ATTCTCTTGAAATAATCCGGGTGCTCCTTCGGG-3. For the Oct4
RNAi target sequence, the Reynolds score and Ui-Tei class value were 6 and
class Ib, respectively. For the Sox2 RNAi target sequence, these were 5 and
class Ia, respectively.
Luciferase reporter constructs. For human POU5F1-Luc, a 3-kb fragment of
the human POU5F1 promoter was cloned into pGL3-Basic plasmid (BglII and
NcoI sites) upstream of the ﬁreﬂy luciferase gene (Promega). The CR4-A
construct contained a 27-bp deletion of AGGCCTGCCCCTCCCCCTCCTCTG
AGA; the CR4-B construct contained a 22-bp deletion of AGAGAGATGCA
TGACAAAGGTG (the oct-sox motif is underlined); the CR4-C construct
contained a 25-bp deletion of CTGGGGAGGGGCCTCCTCCTGTTCC; the
CR4 construct contained a 1,028-bp deletion of XhoI and SalI fragments. All
these deletions were introduced into the human POU5F1-Luc plasmid.
For the Sox2-SV40-Luc construct, a 461-bp fragment of genomic DNA con-
taining the SRR2 enhancer was ampliﬁed and cloned into a pGL3 promoter
plasmid (MluI and BglII sites) containing the simian virus 40 (SV40) promoter
upstream of a ﬁreﬂy luciferase gene (Promega). The Luc-Sox2 open reading
frame (ORF) construct was generated by cloning the Sox2 open reading frame
(NM_011443) into XhoI and NotI sites downstream of the Renilla luciferase
gene (psiCHECK-2; Promega). Similarly, the Luc-Pou5f1 ORF construct was
generated by cloning the Pou5f1 open reading frame (NM_013633) into XhoI
and NotI sites downstream of the Renilla luciferase gene (psiCHECK-2; Pro-
mega).
The cloning primers used are as follows: for Sox2-SV40-Luc, 5-CGCTTTAC
GCGTCTGCCCTTCAGCCGAGTACCG-3 and 5-TTGGCTAGATCTGGA
GTTCCGGGAATATCCTCC-3; for Luc Sox2 ORF, 5-TGAAAACTCGAGA
TGTATAACATGATGGAG-3 and 5-TTTTCAGCGGCCGCCATGTGCGA
CAGGGGCAG-3; for Luc Pou5f1 ORF, 5-TGAAAACTCGAGATGGCTGG
ACACCTGGCTTCAG-3 and 5-TTTTCAGCGGCCGCACCCCAAAGCTCC
AGGTTCTCT-3.
Luciferase reporter assays. To assay for knockdown in 293T cells, 5 ng of
plasmids containing Renilla luciferase fused to ORF and 100 ng of shRNA
plasmids (pSUPER.puro; Oligoengine) were transfected with Lipofectamine
2000 (Invitrogen) into 293FT cells. The cells were seeded at a density of 25,000
to 30,000/well in 96-well plates (Costar).
To study the effects of Oct4 and Sox2 knockdown on the Pou5f1 promoter, 100
ng of human POU5F1-Luc plasmid, 100 ng of shRNA plasmid (pSUPER.puro;
Oligoengine), and 5 ng of plasmid containing Renilla luciferase (pRL-SV40;
Promega) were transfected into E14 ESCs. The pRL-SV40 plasmid served as an
internal control for normalizing the transfection efﬁciency. The E14 ESCs were
cocultured with inactivated mouse primary embryonic ﬁbroblasts.
For the Sox2 enhancer assay, E14 ESCs were transfected with 100 ng of
plasmids containing the SRR2 enhancer activating ﬁreﬂy luciferase (see Fig. 7A),
100 ng of shRNA plasmid, and 5 ng of plasmids containing Renilla luciferase
(pRL-SV40). Fireﬂy and Renilla luciferase activities were measured 48 to 60 h
after transfection with the Dual Luciferase System (Promega) using a Centro
LB960 96-well luminometer (Berthold Technologies).
RNA preparation/reverse transcription/real-time PCR analysis. To examine
the effects of knocking down endogenous Pou5f1 or Sox2, E14 ESCs were
cotransfected with 3.5 g of shRNA plasmids and 0.5 g of Gfp plasmids in
60-mm plates at 50% conﬂuency. Selection by puromycin (Sigma) was performed
1 day after transfection for a period of 2 days at a concentration of 1 g/ml. Total
RNA was isolated using Trizol reagent (Invitrogen) and puriﬁed with the
RNeasy minikit (Qiagen). cDNA synthesis was performed with 500 ng of total
RNA and the SuperScript II kit (Invitrogen) according to the manufacturer’s
instructions. Endogenous mRNA levels were measured by real-time PCR anal-
ysis based on SYBR Green detection with the ABI Prism 7900HT real-time PCR
machine. Brieﬂy, the real-time PCR mixture contained 2 l of the reverse
transcription reaction product in a total volume of 20 l, consisting of 1 SYBR
Green mix reagent (Applied Biosystems), 50 nM forward primer, and 50 nM
reverse primer. Each sample was analyzed in duplicate. The real-time PCR
primers used were as follows: for Gapd, 5-GGTTGTCTCCTGCGACTTCAA
CAGC-3 and 5-CGAGTTGGGATAGGGCCTCTCTTGC-3; for Pou5f1, 5-
TTGGGCTAGAGAAGGATGTGGTT-3 and 5-GGAAAAGGGACTGAGT
AGAGTGTGG-3; for Sox2, 5-GCACATGAACGGCTGGAGCAACG-3 and
5-TGCTGCGAGTAGGACATGCTGTAGG-3; for Brachury, 5-CCAACCTA
TGCGGACAATTCATCTGC-3 and 5-GTGTAATGTGCAGGGGAGCCTC
GAA-3; for Nestin, 5-AGAGGAAGAGCAGCAAGGCCATGAC-3 and 5-T
CCCTGACTCTGCTCCTTCTTCTTCAT-3; for Gata6, 5-TGTGCAATGCA
TGCGGTCTCTACAGCA-3 and 5-TTCATAGCAAGTGGTCGAGGCACC
C-3; for Bmp2, 5-CCAAGATGAACACAGCTGGTCACAGATAAGGC-3
and 5-AGGTGGTCAGCAAGGGGAAAAGGACACTCC-3; for Cdx2, 5-CG
CAGAACTTTGTCAGTCCTCCGCAGTACC-3 and 5-GTATTCGGCGGG
GCTGCTGTAGCCCATAGC-3; for Hand1, 5-CCTGCCCAAACGAAAAG
GCTCAGGACCCAA-3 and 5-CGACCGCCATCCGTCTTTTTGAGTTCAG
CC-3.
ChIP assay. ChIP assays with feeder-free E14 mouse ESCs were carried out as
described previously (9). Brieﬂy, cells were cross-linked with 1% formaldehyde
for 10 min at room temperature and formaldehyde was then inactivated by the
addition of 125 mM glycine. Chromatin extracts containing DNA fragments with
an average size of 500 bp were immunoprecipitated using anti-Oct4 or anti-Sox2
polyclonal antibodies (Santa Cruz Biotechnology). For all ChIP experiments,
quantitative PCR analyses were performed in real time using the ABI PRISM
7900 Sequence Detection System and SYBR Green Master Mix as described
previously (25). Relative occupancy values were calculated by determining the
apparent immunoprecipitation efﬁciency (ratios of the amount of immunopre-
cipitated DNA to that of the input sample) and normalized to the level observed
at a control region, which was deﬁned as 1.0. All ChIP experiments were re-
FIG. 3. OCT4 and SOX2 bind to the distal enhancer/CR4 region of
POU5F1 in living human ESCs. (A) Schematic of the location of the
amplicons (A, B, and C) used to detect ChIP-enriched fragments in
POU5F1 shown relative to the distal enhancer (DE)/CR4 region in
which the composite sox-oct element resides, to the proximal enhancer
(PE), and to the transcription start site (arrow). (B) Real-time PCR
detection of enriched fragments from ChIP assays using OCT4, SOX2,
and a control glutathione S-transferase (GST) antibody.
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peated at least three times. For all the primers used, each gave a single product
of the right size, as conﬁrmed by agarose gel electrophoresis and dissociation
curve analysis. These primers also gave no DNA product in the no-template
control. The primers used for real-time PCR to quantitate the ChIP-enriched
DNA are as follows: Fig. 2, region 1 (mouse Pou5f1), 4003/3798 relative to
translation start site, CAGAACATCTGGATTTGGGAAGAGACGTT and GA
GCAGGGAAATCACTCGTGTTAGCATC; Fig. 2, region 2 (mouse Pou5f1),
3383/3219, CATTATAGGTGTGGCATTCCGCATCTG and TGCCACAA
ACCACCTGTATTTTAGAACCA; Fig. 2, region 3 (mouse Pou5f1), 2396/
2160, AGGCTAGGGCACATCTGTTTCAAGCTAGT and CCCAGCAGTC
CTGTCTGTATTCAATACC; Fig. 2, region 4 (mouse Pou5f1), 2098/1928
(encompassing CR4-B), GGAACTGGGTGTGGGGAGGTTGTA and AGCA
GATTAAGGAAGGGCTAGGACGAGAG; Fig. 2, region 5 (mouse Pou5f1),
1817/1570, CATGACAGAGTGGAGGAAACGGAAGA and CTGCCCTT
GAACTCCTGATAATTCTCCTG; Fig. 2, region 6 (mouse Pou5f1), 1412/
1163 (encompassing CR3), TGCTCTGGGCTTTTTGAGGCTGTGTGATT
and TGGCGGAAAGACACTAAGGAGACGGGATT; Fig. 2, region 7 (mouse
Pou5f1) 655/412, TCTACCAACCTGGACAACACAAGATGGAA and GC
CACTCCTCAGTTCTTGCTTACCCAC; Fig. 2, region 8 (mouse Pou5f1),
284/43 (encompassing CR1), AGCAACTGGTTTGTGAGGTGTCCGG
TGAC and CTCCCCAATCCCACCCTCTAGCCTTGAC; Fig. 2, region 9
(mouse Pou5f1), 54/141, GGATTGGGGAGGGAGAGGTGAAACCGT
and TGGAAGCTTAGCCAGGTTCGAGGATCCAC; Fig. 2, region 10 (mouse
Pou5f1), 1274/1478 (within intron 1), GGAGTCCCCTAGGAAGGCATTA
ATAGTTT and GGATTCTCTCGGCTTCAGACAGACTTT; Fig. 3, region A
(human POU5F1), 2613/2396, GGGGAACCTGGAGGATGGCAAGCTG
AGAAA and GGCCTGGTGGGGGTGGGAGGAACAT; Fig. 3, region B (hu-
man POU5F1), 1779/1563, CCTGCACCCCTCCACAAATCACTCGC and
TGCAATCCCCTCAAAGACTGAGCCTCAGAC; Fig. 3, region C (human
POU5F1), 237/136, GAGGGGCGCCAGTTGTGTCTCCCGGTTTT and
GGGAGGTGGGGGGAGAAACTGAGGCGAAGG; Fig. 7E and F, region A
(mouse Sox2), 4199/3964 relative to translation start site, ATTAGTCTGCT
CTTCCTCGGAATGGTTGG and TGATGCTTGTTAAAAACGCTTCGCT
CCT; Fig. 7E and F, region B (mouse Sox2), 3581/3421, CCCTGTTCCAA
GTCTCTTTCTGCTAGTCA and CACCGATTTCAATCCAACACCATCA
TAG; Fig. 7E and F, region C (mouse Sox2), 3515/3664, TTTTCGTTTTT
AGGGTAAGGTACTGGGAAG and CCACGTGAATAATCCTATATGCAT
CACAAT; Fig. 7H, region A (human SOX2), 3662/3862 relative to
translation start site, GGATAACATTGTACTGGGAAGGGACA and CAAA
GTTTCTTTTATTCGTATGTGTGAGCA; Fig. 7H, region B (human SOX2),
4464/4658, CCTCGGGATATTATTCTGCTCAATGA and TAACGCTCT
TTATTTAAAGTATGTGGTGGG.
Electrophoretic mobility shift assays (EMSAs). Nuclear extracts were pre-
pared from E14 mouse ESCs grown under feeder-free conditions using the
method of Dignam et al. (13) with modiﬁcations as described: cells were treated
with trypsin for 1 min and harvested in cold phosphate-buffered saline. After
centrifugation, cells were resuspended in cold buffer A (10 mM HEPES, pH 7.9,
1.5 mM MgCl2, 10 mM KCl, 0.5 mM dithiothreitol [DTT], protease inhibitor
cocktail [Roche]) and incubated on ice for 10 min. Cells were resuspended in
buffer A and lysed with a Wheaton homogenizer. Pelleted nuclei were resus-
pended in buffer B (20 mM HEPES, pH 7.9, 25% glycerol, 420 mM NaCl, 1.5
mM MgCl2, 0.2 mM EDTA, 0.5 mM DTT, 1% protease inhibitor cocktail) and
incubated on ice and vortexed for 15 s every 10 min, for a total of 30 min. After
centrifugation, supernatants were dialyzed against dialysis buffer (20 mM
HEPES, pH 7.9, 20% glycerol, 100 mM KCl, 0.83 mM EDTA, 1.66 mM DTT,
protease inhibitor cocktail) at 4°C for 1 h. Extracts were then stored at 80°C.
The concentrations of the nuclear extracts were determined by a NanoDrop
ND-1000 spectrophotometer.
For EMSA double-stranded DNA oligonucleotides (Proligo) labeled with
biotin at the 5 termini of the sense strands were annealed with reverse strands
in annealing buffer (10 mM Tris-HCl, pH 8.0, 50 mM NaCl, 1 mM EDTA) and
puriﬁed with an agarose gel DNA extraction kit (Roche). The sense strand
sequence is as follows: CR4-1S-CAGACAGCAGAGAGATGCATGACAAAG
GTGCCGTGATGGTTC. The gel shift assays were performed using a LightShift
Chemiluminescent EMSA kit (Pierce Biotechnologies). Four microliters (	15
g) of nuclear extract was added to a 10-l reaction mixture (ﬁnal) containing
3 ng of biotin-labeled oligonucleotide and 1 g of poly(dG-dC) (Amersham).
The ﬁnal binding buffer composition was 60% dialysis buffer. Binding reaction
mixtures were incubated for 10 min at room temperature. Where speciﬁed,
antibodies (Santa Cruz) were added after the initial incubation for a further 20
min as follows: 1 l of anti-Oct4 (sc-9081x), anti-Sox2 (sc-17320x), or anti-JunB
(sc-46x). For cooperativity binding studies, the probe was labeled with 32P and
the indicated amounts of overexpressed Oct4 or Sox2 were added for a further
20 min after the initial incubation. After separation of the different complexes on
the gel, the amount of bound DNA for each complex was measured with a
PhosphorImager (1). To calculate the predicted noncooperative interaction val-
ues, the amount of probe bound by a given concentration of Oct4 (in the absence
of Sox2) was multiplied by the amount of probe bound by a given concentration
of Sox2 (in the absence of Oct4). For example, the amount of ternary complex
expected to form is 1% if 10% of the probe is bound by Oct4 and Sox2 inde-
pendently. For competitive studies, a speciﬁed 600 ng of unlabeled double-
stranded competitor was added for a further 20 min after the initial incubation.
Binding reaction mixtures were resolved on prerun 5% native polyacrylamide
gels in 0.5 Tris-buffered EDTA. Gels were transferred to Biodyne B nylon
membranes (Pierce Biotechnologies) using Western blot techniques and de-
tected using chemiluminescence.
RESULTS
Conserved elements within the CR4 region of Pou5f1 pro-
moter. Previous work comparing the genomic sequences of
human, bovine, and mouse Pou5f1 identiﬁed four conserved
regions within 3 kb upstream of its transcription start site (CR1
to CR4) (30). CR4 is of particular interest as this region maps
to the previously characterized distal enhancer of Pou5f1,
which has been shown to be responsible for both mouse ESC
and early embryonic expression (51).
To enhance the phylogenetic footprint and aid us in identi-
fying speciﬁc cis-regulatory elements within this CR4 region,
we extended the comparative analysis to include three addi-
tional mammals (pig, dog, and rat). The six species in the
alignment are eutherian mammals, all of which have an ICM at
the blastocyst stage of development and presumably share sim-
ilar genetic regulatory architecture in regulating their pluripo-
tent phenotypes.
The alignment clearly showed three highly conserved con-
sensus sites (CR4-A, CR4-B, and CR4-C) within the CR4
regions between the six species (Fig. 1A). The CR4-A consen-
sus is C[T,C]GCCC[T,C]TCCCCC[T,C], and the CR4-B con-
sensus is A[A,G]ATGCAT[G,A]ACAAAGG, while the CR4-C
consensus is A[C,G]ATGG[C,T]T[G,A]GGGAGGGG[C,T]C
[C,T][C,T]. Intriguingly, within the CR4-B region, we identiﬁed
what clearly resembles the sox-oct composite element which is
involved in regulating the transcription of several other ESC-
speciﬁc genes (Fig. 1B). The sox element in the mouse se-
quence is identical to that found in Fgf4. Immediately adjacent
to this sox element is a strong consensus sequence for an
octamer element, differing only in the seventh position. Fur-
thermore, this sox-oct composite element of Pou5f1 varies be-
tween species at only 2 of the 15 positions (Fig. 1A), and both
of these positions are also the most variable positions between
the known sox-oct target genes (Fig. 1B). This evidence sug-
gested to us that Pou5f1 may also be a target of the Oct4/Sox2
complex.
To test the functional importance of these conserved con-
sensus sites, we cloned a 3-kb promoter fragment from a bac-
terial artiﬁcial chromosome containing POU5F1 (human) and
fused it upstream of a luciferase (Luc) gene. This promoter
fragment contains all conserved regions (CR1 to CR4). This
POU5F1-Luc reporter was then transfected into ES and 293T
cells to test for ESC-speciﬁc expression. The reporter showed
robust expression in ESCs but only background expression in
293T cells (Fig. 1C). Next, we generated stable ESC lines with
this promoter fragment driving the enhanced green ﬂuorescent
protein gene. The undifferentiated cells were green when ob-
served under the ﬂuorescence microscope, indicating a high
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FIG. 4. Oct4 and Sox2 bind to the composite sox-oct element in POU5F1. EMSAs were used to analyze the interactions between native Oct4
and Sox2 with a 42-bp double-stranded DNA probe containing the composite sox-oct element. (A) Sequence of the composite element and
corresponding mutations (lowercase and shaded) used in this study. (B) EMSA with the wild-type probe detected a speciﬁc Oct4 and Sox2 complex.
Lane 1 is without nuclear extract; all other lanes are with 15 g nuclear extract; lanes 3 through 5 are with the respective antibodies added; lane
6 is with 200-fold excess cold probe; lane 7 is with 200-fold excess cold nonspeciﬁc probe. The asterisk denotes nonspeciﬁc complex associated with
all four probes which cannot be competed out by an excess of nonspeciﬁc probe. (C) EMSA with probes containing mutations as shown in panel
A. O indicates Oct4/DNA binary speciﬁc complex, while S indicates Sox2/DNA binary complex. The asterisk denotes nonspeciﬁc complex
associated with all four probes which cannot be competed out by an excess of nonspeciﬁc probe. “ns” denotes a complex which cannot be
supershifted with either Oct4 or Sox2 antibodies. (D) EMSAs with the wild-type probe were performed in the presence of excess cold probes (WT,
oct mut, sox mut, or oct sox mut). WT, wild type. O, S, and the asterisk are as deﬁned for panel C. (E) The same mutations described in panel
A were tested for promoter activity within the context of the 3-kb POU5F1 promoter driving a luciferase reporter. These constructs were
transfected into mouse ESCs and tested for luciferase activity 2 days later. Activity is expressed relative to the wild-type promoter (POU5F1-Luc).
The CR4-B-deleted construct (Fig. 1) is included for comparison. (F) EMSA using overexpressed Oct4 or Sox2. Whole-cell lysates from 293T cells
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level of enhanced green ﬂuorescent protein expression. How-
ever, upon differentiation with RA treatment, the level of ﬂu-
orescence was drastically reduced (data not shown). Hence,
consistent with a previous report on mouse Pou5f1 promoter
characterization (51), our human reporter is also able to drive
ESC-speciﬁc expression.
Next, we engineered four reporter constructs harboring de-
letions of the individual CR4-A, CR4-B, and CR4-C sites as
well as one construct (CR4) with deletions in all three CR4
sites. The promoter activities of these constructs were all re-
duced to 40% of that of the wild type (Fig. 1D). This indicates
that each of the three CR4 motifs contributes to the overall
CR4 activity. We focused on characterizing the role of DNA
binding proteins that regulate Pou5f1 expression through
CR4-B, the site in which the composite sox-oct element is
contained.
transfected with Pou5f1 or Sox2 expression constructs were used in EMSAs. Oct4 and Sox2 are capable of forming speciﬁc complexes as conﬁrmed
by supershift analysis. (G) Analysis of the cooperativity of Sox2 and Oct4 binding to the composite sox-oct element. An increasing concentration
of Sox2 was added to the probe in the absence or presence of a ﬁxed amount of Oct4 (left panel). Quantitative representation of the DNA binding
data is presented in the right panel (a, Oct4/DNA complex in the presence of Sox2, lanes 5 to 7; b, Sox2/DNA complex in the presence of Oct4,
lanes 5 to 7; c, Oct4/Sox2/DNA complex, lanes 5 to 7; d, Sox2-DNA complex in the absence of Oct4, lanes 2 to 4; e, predicted amount of
Oct4/Sox2/DNA complex if Oct4 and Sox2 bind independently of each other and show no cooperativity). The x axis represents the different
amounts (microliters) of Sox2 added to the EMSA reaction mixtures. The amount of probe present was determined by PhosphorImager analysis
and expressed as the percentage of total probe for each sample (y axis, percent probe bound). (H) Analysis of the cooperativity of Oct4 and Sox2
binding to the composite sox-oct element. Oct4 was titrated with a ﬁxed amount of Sox2. Quantitative representation of the DNA binding data
is presented in the right panel (a, Oct4/DNA complex in the presence of Sox2, lanes 5 to 7; b, Sox2/DNA complex in the presence of Oct4, lanes
5 to 7; c, Oct4/Sox2/DNA complex, lanes 5 to 7; d, Oct4-DNA complex in the absence of Sox2, lanes 2 to 4; e, predicted amount of Oct4/Sox2/DNA
complex).
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Oct4 and Sox2 bind to the CR4 region in living mouse ESCs.
As the composite sox-oct element in the CR4-B region is
conserved throughout eutherian mammals, suggesting func-
tional signiﬁcance, we examined whether Oct4 and Sox2 bind
to this region in ESCs by using a ChIP assay. This assay allows
us to investigate the targets of DNA binding proteins in living
cells, as formaldehyde preserves the molecular interactions
between DNA and protein through covalent cross-linking. We
ﬁrst tested the speciﬁcity of antibodies used in this study by
Western blotting. The main antibodies used were N19 (anti-
Oct4, sc-8628) and Y17 (anti-Sox2, sc-17320) afﬁnity-puriﬁed
polyclonal antibodies that were raised against peptides. West-
ern blots of ESC nuclear extracts showed that both of these
antibodies recognized proteins of the correct sizes (Fig. 2A).
More importantly, each antibody recognized only one major
polypeptide in the total nuclear extracts.
E14 ESCs were used in our mouse ChIP assays. Undiffer-
entiated ESCs grown in feeder-free conditions were cross-
linked with formaldehyde, and the fragmented chromatin ly-
sates were subjected to immunoprecipitation with the Oct4 and
Sox2 antibodies. Ten pairs of primers, located sequentially
along the entire conserved promoter region and including the
ﬁrst exon, were used to quantify the ChIP-enriched DNA by
real-time PCR (Fig. 2B). A peak representing Oct4 and Sox2
binding was observed (approximately 30-fold above back-
ground) at the distal enhancer, indicating that this region was
speciﬁcally bound by the two transcription factors (Fig. 2C and
D). A control antibody showed no signiﬁcant enrichment over
the entire surveyed region (Fig. 2E). Identical results were
obtained when we used polyclonal antibodies raised against
other epitopes of Oct4 and Sox2, further conﬁrming the spec-
iﬁcity of this binding (data not shown). Thus, we conclude that
the Pou5f1 distal enhancer is a bona ﬁde target of Oct4 and
Sox2 in undifferentiated mouse ESCs.
RA treatment overrides the self-renewal properties of ESCs
and induces their differentiation. There is a corresponding
decrease in endogenous levels of Oct4 and Sox2 (Fig. 2F). We
analyzed the binding proﬁles of Oct4 and Sox2 on Pou5f1 in
this RA-induced differentiation model, as this also allowed us
to determine the speciﬁcity of the antibodies by analyzing the
binding in cells deﬁcient in these factors. ESCs at different
periods of RA treatment were cross-linked with formaldehyde,
and the occupancies of Oct4 and Sox2 on the Pou5f1 promoter
were analyzed by ChIP. Upon differentiation, the binding of
Oct4 and Sox2 to the Pou5f1 distal enhancer was reduced in
close correlation with the degree of differentiation (Fig. 2G
and H). By day 3 of RA treatment, the level of Oct4 binding
was reduced by almost 50%, and by day 6, no signiﬁcant en-
richment was detected. A mock ChIP using a control antibody
did not result in enrichment of the enhancer sequences (Fig.
2I). This indicated that the antibodies recognize speciﬁc com-
plexes found in ESCs but not in their differentiated derivatives.
From this, we conclude that Oct4 and Sox2 bind to the Pou5f1
enhancer when this gene is being actively transcribed in undif-
ferentiated, pluripotent mouse ESCs.
OCT4 and SOX2 bind to the CR4 region in human ESCs.
The conservation of the composite sox-oct element within the
eutherian mammals suggests that OCT4 and SOX2 also bind
to the POU5F1 enhancer in human ESCs. Gene expression
differences between mouse and human ESCs have previously
been described (15, 45, 49), although both are derived from the
ICM of the blastocyst and both express Sox2 and Pou5f1 (38).
These differences extend to cellular responsiveness to cyto-
kines, as human ESCs are not responsive to LIF and lack the
LIF receptor while LIF is crucial for the maintenance of mouse
ESCs. To determine if at least part of the underlying genetic
regulatory network of mouse and human ESCs is conserved,
we extended our investigation on the regulation of Pou5f1 to
include human ESCs.
To determine if OCT4 and SOX2 are bound to the CR4
region of the human POU5F1 promoter, we performed ChIP
on human ESCs (HUES-6) propagated and passaged on inac-
tivated mouse embryonic ﬁbroblasts. The growth of the human
ESCs on a mouse feeder cell layer did not complicate our
analysis, as these mouse cells do not express Oct4 or Sox2.
Moreover, the primers used to quantify the ChIP-enriched
DNA were speciﬁc to human sequences (Fig. 3A). Both the
OCT4 and SOX2 ChIP assays on human ESCs showed enrich-
ment of DNA fragments in the distal enhancer of POU5F1 in
FIG. 5. Regulation of POU5F1 promoter activity by Oct4 and Sox2.
(A) Schematic of the luciferase reporter constructs used to measure
the effects of RNAi. Construct I contains the Pou5f1 ORF fused
downstream of the luciferase reporter, while construct II contains the
Sox2 ORF fused downstream of the luciferase reporter. Construct III
comprises the POU5F1 promoter containing the sox-oct composite
element driving a luciferase reporter. (B and C) Speciﬁcity of Pou5f1
(B) and Sox2 (C) RNAi was tested by cotransfection of these con-
structs with their respective Luc-ORF reporter constructs into 293T
cells. (D) Effect of Pou5f1 or Sox2 RNAi on POU5F1 promoter activity
was tested by cotransfecting each RNAi plasmid along with the
POU5F1-Luc construct into mouse ESCs. In all, luciferase activity was
analyzed 2 days after transfection and was expressed relative to the
empty RNAi vector control. A Gfp RNAi was used as a nonspeciﬁc
control. Standard deviations are shown.
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which the composite sox-oct element is located (Fig. 3B). A
control antibody did not show any enrichment of these en-
hancer sequences (Fig. 3B). In summary, we have clearly
shown that Oct4/OCT4 and Sox2/SOX2 bind to the distal en-
hancer of Pou5f1/POU5F1 in living mouse and human ESCs.
Oct4 and Sox2 bind to the composite sox-oct element in
vitro, and the binding sites are important for POU5F1 pro-
moter activity. We examined whether native Oct4 and Sox2
bind to the CR4-B region in vitro by an EMSA. A 42-bp
CR4-B biotin-labeled double-stranded DNA containing the
composite sox-oct element was incubated with 15 g of nuclear
extract from undifferentiated feeder-free mouse ESCs. A ma-
jor complex between the probe and nuclear proteins was de-
tected (Fig. 4B, lane 2). The addition of Oct4 or Sox2 antibod-
ies led to a supershift of this complex (Fig. 4B, lanes 3 and 4).
Conversely, the control anti-JunB antibody did not affect the
mobility of this complex. Therefore, this indicated that the
DNA duplex was bound speciﬁcally by Oct4 and Sox2. The
anti-Sox2 supershifted complex was weaker than that formed
by the Oct4 antibody (Fig. 4B, lanes 3 and 4), suggesting that
the Sox2 antibody interfered with the protein-DNA interac-
tion. The addition of a 200-fold excess of unlabeled probe
successfully competed for binding to the Sox2/Oct4 complex
(Fig. 4B, lane 6), while an unrelated probe had no effect (Fig.
4B, lane 7). Thus, we conclude that, in vitro, Oct4 and Sox2
bind speciﬁcally to the CR4-B sequences as a ternary complex.
Next, we examined the requirement for the oct and sox
elements within CR4-B in the formation of the DNA-protein
complex. Mutations within the sox element resulted in the
formation of a complex of higher mobility than the Oct4/Sox2
complex (Fig. 4A and C, lanes 4 to 6). This complex was
disrupted by the addition of the Oct4 antibody but not the Sox2
antibody, indicating that the protein-DNA complex contained
Oct4 but not Sox2. The Oct4-DNA complex can be competed
out by an excess of speciﬁc unlabeled probe but not by an
unlabeled nonspeciﬁc probe (data not shown). Mutations
within the oct element similarly led to the formation of a
speciﬁc complex containing Sox2 and lacking Oct4, as demon-
strated by antibody interference assay and competition exper-
iment with unlabeled probes (Fig. 4C, lanes 7 to 9; data not
shown). EMSA with a double-stranded DNA probe containing
mutations in both the oct and sox elements indicated that
neither Oct4 nor Sox2 could bind to this probe (Fig. 4C, lanes
10 to 12). A complex did form with the oct-sox double mutant
probe, but this was not due to Oct4 or Sox2 binding, since
addition of the corresponding antibodies to the EMSA reac-
tion mixtures did not disrupt this (Fig. 4C, lanes 11 and 12).
From these results, it is evident that Oct4 and Sox2 are capable
of binding independently of one another to the oct and sox
elements of CR4, respectively. The speciﬁcities of the binding
were also veriﬁed by a competition assay using an excess of
unlabeled single or double mutant probes (Fig. 4D). The ad-
dition of probes mutated in the sox element reduced the Oct4-
containing complexes, while the probes mutated in the oct
element competed with the Sox2-containing complexes. These
individual mutations in the oct and sox elements, as well as the
double mutation, were introduced into our previously con-
structed POU5F1-Luc vector and transfected into mouse ESCs
to test for their effect on promoter activity. The single oct and
sox mutations resulted in promoter activities of approximately
60% of wild type whereas the sox-oct double mutation further
dropped the activity to 40% of wild type and was equivalent to
the activity found when the entire CR4-B region was deleted
(Fig. 4E). We conclude that maximal transcriptional activity of
POU5F1 in ESCs requires the binding of both Oct4 and Sox2
to the composite sox-oct element.
It has previously been shown that Sox2 can enhance the
binding of Oct4 to Utf1 and Fbx15 (36, 46). To address whether
these transcription factors also show cooperative binding to the
composite sox-oct element in POU5F1, we overexpressed Oct4
and Sox2 in 293T cells which do not normally express these
genes. With a 32P-labeled probe containing the composite sox-
oct element, EMSA allowed us to investigate cooperative bind-
ing using an approach described previously (1, 36). Oct4 and
Sox2 were each able to bind to the probe independently of one
another (i.e., form a binary complex; Fig. 4F, lanes 2 and 3).
When both factors were present in the same EMSA reaction
mixture, a Sox2/Oct4/DNA ternary complex was formed as
conﬁrmed by supershifts (Fig. 4F, lanes 4 to 6). As the mobil-
ities of the binary and ternary complexes were different, we
were able to resolve them in our assay. We carried out the
reciprocal experiments of adding an increasing amount of Sox2
to a ﬁxed amount of Oct4 (Fig. 4G, lanes 5 to 7) and an
increasing amount of Oct4 to a ﬁxed amount of Sox2 (Fig. 4H,
lanes 5 to 7). With the increase in Oct4 or Sox2, there was a
corresponding increase in the respective binary complex as
well as the Sox2/Oct4/DNA ternary complex. Most signiﬁ-
cantly, at the highest concentration of Oct4 or Sox2, the inten-
sity of the ternary complex was greater than that of the recip-
rocal Sox2 or Oct4 binary complex in the absence of Oct4 and
Sox2, respectively (Fig. 4G, compare lanes 7 and 8 for Oct4,
and Fig. 4H, compare lanes 7 and 8 for Sox2). Supplementing
these EMSAs with additional nuclear extract from mock-trans-
fected 293T cells did not enhance the formation of the Sox2/
Oct4/DNA ternary complex (data not shown), thus excluding
the possibility that an unknown factor in the 293T extract
enhanced the formation of this complex. Furthermore, we
quantitated the levels of the ternary complexes formed under
these different conditions and compared them with the calcu-
lated levels based on noncooperative interaction. The amount
of the ternary complex expected to form as a result of nonco-
operative binding of the Oct4 and Sox2 proteins was calculated
as the product of the amount of probe bound by Oct4 in the
absence of Sox2 and the amount of probe bound by Sox2 in the
absence of Oct4. By multiplying the values obtained from the
bound complexes of Sox2 (Fig. 4G, lanes 2 to 4) with bound
complex of Oct4 (Fig. 4G, lane 8), a graph representing the
predicted noncooperative interaction was obtained (Fig. 4G,
plot “e” in right panel). The levels of ternary complex formed
when the two proteins were mixed together were also quanti-
tated (Fig. 4G, plot “c” of the right panel). The data showed
that the actual amount of the ternary complex detected for
each point was greater than the amount predicted (Fig. 4G,
compare the proﬁles of “c” and “e”). A similar result was
obtained for the reciprocal experiment with a constant level of
Sox2 (Fig. 4H). Hence, the increased binding efﬁciency to the
composite sox-oct element by Sox2 and Oct4 when both tran-
scription factors are present suggests the cooperative nature of
this interaction.
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Regulation of the POU5F1 promoter. Having established the
interaction between Oct4 and Sox2 with the POU5F1 distal
enhancer, we sought to understand by a genetic approach the
functional role of these factors in the enhancer’s activity. Al-
though we showed that the binding events occurred speciﬁcally
in undifferentiated ESCs when POU5F1 is known to be most
transcriptionally active, it was still unclear whether Oct4 or
Sox2 was exerting a positive role on POU5F1 expression. To
answer this question, we chose a genetic approach that em-
ployed RNAi technology.
RNAi has emerged as a powerful tool to study gene function
by down-regulating the expression of a gene of interest. We
used the pSUPER vector containing the polymerase III H1-
RNA gene promoter for directing the synthesis of short inter-
fering RNAs of 19 nucleotides (7). When we expressed a short
hairpin RNA from this vector directed againstGfp, it efﬁciently
silenced Gfp expression derived from a cotransfected plasmid
(data not shown). Precautions were taken to make sure that
the RNAi effect was speciﬁc. For each gene, we screened at
least six regions for RNAi and used the best construct for
subsequent studies (see Materials and Methods). These re-
gions were selected based on their Reynolds scores and Ui-Tei
class values (37, 48). To ensure speciﬁcity, we also selected
regions that showed minimal sequence similarity to other
FIG. 6. Regulation of endogenous Pou5f1 expression by Sox2 in ESCs. (A) Schematic of the RNAi vector and a ﬂow chart of the corresponding
experiments. The vector contains a puromycin selection cassette. Location of the RNAi sequence is indicated by arrowheads. (B to D) Effects of
Pou5f1 (B) and Sox2 (C and D) RNAi on endogenous levels of Pou5f1 (B and D) and Sox2 (C) mRNA in ESCs. Endogenous mRNA levels are
expressed relative to the empty RNAi vector control. A nonspeciﬁc control Gfp RNAi was included. (E) Knockdown of the protein was conﬁrmed
by Western blotting. Actin served as a loading control. (F) Morphological changes of Pou5f1 or Sox2 knockdown cells. Note the presence of
ﬂattened epithelial-cell-like cells in knockdown cells not seen at all in vector control ESCs. (G) Alkaline phosphatase staining of Pou5f1 or Sox2
knockdown cells. Note that, in the knockdown cells, almost all the cells stain negatively for alkaline phosphatase. (H) Changes in gene expression
following Pou5f1 or Sox2 knockdown by RNAi. cDNAs were prepared from the knockdown cells and analyzed by real-time PCR with fold
differences measured against vector control ESCs.
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mRNAs by screening with BLAST searches against public da-
tabases. Only targets that did not share more than 15 bases of
identity with another mRNA were considered. All of the re-
gions we targeted were located within the open reading frame.
We ﬁrst assayed the ability of the RNAi constructs to knock
down the speciﬁc target mRNA in a heterologous system. To
this end, we cloned the Pou5f1 or Sox2 open reading frames
downstream of the luciferase (Luc) gene (Fig. 5A, constructs I
and II). These fusion constructs were then cotransfected with
the respective RNAi constructs into 293T cells. If the shRNA
was effective in targeting the Luc fusion transcript, it would
lead to a selective degradation of the target RNA, resulting in
a reduced luciferase activity. In this assay, we showed that our
RNAi constructs could mediate efﬁcient knockdown of the
coexpressed Luc-Pou5f1 or -Sox2 fusion transcripts and that
they were speciﬁc for the respective genes. The results for the
most effective RNAi constructs are shown (Fig. 5B and C).
Using the Pou5f1 RNAi construct, the level of luciferase ac-
tivity was reduced to less than 10% when measured 48 h after
transfection. With the Sox2 RNAi construct, the activity was
reduced to approximately 25% of the controls.
Having determined the efﬁciency and speciﬁcity of the RNAi
constructs, we proceeded to test the effect of these constructs
on a cotransfected POU5F1-Luc reporter (Fig. 5A, construct
III) in mouse ESCs. ESCs were harvested 60 h after transfec-
tion and measured for luciferase activity. Knockdown of either
Pou5f1 or Sox2 suppressed the expression of the transfected
POU5F1-Luc vector with an 85% reduction in luciferase activ-
FIG. 6—Continued.
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FIG. 7. Oct4 and Sox2 bind to the 3 enhancer of Sox2 and regulate its
activity. (A) The reporter construct used to assay for Sox2 enhancer
activity consisted of the Sox2 SRR2 site positioned 5 to the SV40 pro-
moter driving a luciferase reporter. (B) The SRR2 enhancer drives lucif-
erase expression speciﬁc to ESC. (C) The Sox2 luciferase reporter con-
struct was cotransfected into mouse ESCs with either empty vector or
RNAi constructs directed against Sox2, Pou5f1, or Gfp RNAi vector. The
knockdown effect is measured by relative luciferase activity 60 h after
transfection, with the empty vector set at 100%. The standard deviations
are shown. (D) Endogenous Sox2 mRNA levels in ESCs were measured
by real-time PCR after transfection with the respective RNAi constructs
containing a puromycin resistance gene. Cells were harvested 2 days
posttransfection after continuous puromycin selection. Endogenous Sox2
levels are expressed relative to the empty vector control. Standard devi-
ations are shown. (E) Schematic of mouse Sox2 genomic locus with the
single exon represented by an open box and the SRR2 region containing
the composite sox-oct element indicated. The relative locations of the
amplicons used to detect enriched ChIP fragments are shown (A to C).
(F) Measurement by ChIP analysis of Oct4 occupancy in regions of Sox2
in undifferentiated mouse ESCs and those induced to differentiate for 3
and 6 days by RA. Letters correspond to the amplicons indicated in panel
E. Standard deviations are shown. (G) Similar to panel F but for Sox2
occupancy. (H) Schematic of human SOX2 genomic locus with the single
exon represented by an open box and the SRR2 region containing the
composite sox-oct element indicated. The relative locations of the ampli-
cons used to detect enriched ChIP fragments are shown (A and B).
(I) Measurement by ChIP analysis of OCT4 and SOX2 occupancies on
SOX2 in living human ESCs. A glutathione S-transferase antibody (GST)
was used as a negative control. Standard deviations are shown.
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ity compared to the empty RNAi or Gfp RNAi vector control
(Fig. 5D). Similar results were obtained when we used a mouse
Pou5f1-Luc reporter containing the CR4 distal enhancer re-
gion (data not shown) (19), indicating a functional conserva-
tion between the mouse and human enhancers.
To determine whether our shRNAs designed against Pou5f1
and Sox2 silenced endogenous transcripts in ESCs, we trans-
fected these RNAi constructs in a vector containing a puro-
mycin selection cassette (Fig. 6A). Twenty-four hours after
transfection, cells were cultured in medium containing puro-
mycin for 2 days to selectively remove nontransfected ESCs.
Approximately 70% of the nontransfected cells were killed
after 2 days of selection. Total RNAs were puriﬁed from these
transfected cells, and the levels of Pou5f1 or Sox2 transcripts
were quantiﬁed by reverse transcription followed by real-time
PCR. We observed a 60% reduction of Pou5f1 transcripts
when RNAi was used against Pou5f1 (Fig. 6B). Similarly with
Sox2 RNAi, the level of Sox2 transcripts was reduced by 50%
relative to the control cells (Fig. 6C), and with this same RNAi
there was a corresponding reduction of Pou5f1 transcripts (Fig.
6D). In all these experiments, a signiﬁcant level of Pou5f1 and
Sox2 transcripts remained; these were likely derived from the
residual nontransfected ESCs or due to incomplete silencing of
the respective genes. Despite this, there was a clear reduction
in both Sox2 and Oct4 protein levels when either the Sox2 or
Pou5f1 RNAi construct was used, as validated by Western
blotting (Fig. 6E). We further assessed whether the reduction
in the transcripts and proteins of these factors led to differen-
tiation. After selection, both the Pou5f1 and the Sox2 RNAi-
transfected cells had altered morphology compared to trans-
fection controls and undifferentiated ESCs, with the formation
of ﬂattened epithelial-cell-like cells (Fig. 6F). We also per-
formed alkaline phosphatase staining on these cells (Fig. 6G).
In contrast to the control cells, the epithelial-cell-like cells
after either Pou5f1 or Sox2 knockdown showed drastically re-
duced alkaline phosphatase staining. The RNAs isolated from
these cells were reverse transcribed and analyzed by real-time
PCR to detect the presence of differentiated cell markers (Fig.
6H). Gene expression proﬁles for both the Pou5f1 and Sox2
knockdowns were very similar, and both showed an up-regu-
lation of the endoderm and trophectoderm markers such as
Gata6, Bmp2, Cdx2, and Hand1 (22, 29). In contrast, meso-
derm marker Brachyury and the neuroectoderm marker Nestin
were not induced. Our data on Pou5f1 knockdown in ESCs
were consistent with previous reports analyzing the gene ex-
pression changes when the Pou5f1 level was reduced (18, 24,
29). These results indicates that knockdown of either Pou5f1 or
Sox2 caused ESCs to differentiate. In summary, we showed that
the knockdown of both Sox2 and Pou5f1 mRNAs caused a
reduction in the POU5F1 distal enhancer activity and in en-
dogenous Pou5f1 transcript levels. This indicates that both
Sox2 and Oct4 are positively regulating Pou5f1.
Regulation of the enhancer element in Sox2. The importance
of the enhancer element at the 3 end of Sox2 has been dem-
onstrated by reporter assays and mutagenesis (47). This ele-
ment, also known as SRR2 (Sox regulatory region 2), contains
a composite sox-oct element. Although Oct6 and Oct4 have
been implicated to bind to SRR2 along with Sox2, it is not clear
if Oct4 and Sox2 are indeed bound to the SRR2 site in living
ESCs.
We further dissected the role of Oct4 and Sox2 in the en-
hancer activity of SRR2 by genetic manipulation through
RNAi. First, the SRR2 element was cloned upstream of an
SV40 promoter driving the Luc gene (Fig. 7A); the activity of
this construct was then tested in ESCs. This element enhanced
the activity of the SV40 promoter in ESCs but not in 293T cells
(Fig. 7B). The data are consistent with the ﬁnding that SRR2
functioned as an enhancer element when grafted to a heterol-
ogous promoter (47).
We then cotransfected our Pou5f1 or Sox2 RNAi constructs
along with this Sox2-SV40-Luc reporter into mouse ESCs and
assayed for luciferase activity 60 h after transfection. The ac-
tivity of this reporter was diminished with the knockdown of
either Sox2 or Pou5f1 mRNA, while control RNAi using an
empty RNAi vector or Gfp RNAi vector showed no effects on
this SRR2 reporter (Fig. 7C). In addition to demonstrating
that Oct4 and Sox2 positively regulate the SRR2 activity, we
showed by reverse transcription–real-time PCR that endoge-
nous Sox2 transcripts were also diminished in mouse ESCs
transfected with the Pou5f1 RNAi construct (Fig. 7D). Fur-
thermore, we conﬁrmed by ChIP experiments that Sox2 and
Oct4 bound to the SRR2 region of Sox2 in both mouse and
human ESCs (Fig. 7E to I) and that these interactions, at least
in the mouse, are speciﬁc to the undifferentiated ESCs. A
control antibody showed no signiﬁcant enrichment over the
entire surveyed region (data not shown). Taken together, our
data demonstrate that the SRR2 region containing the com-
posite sox-oct element in Sox2 is a bona ﬁde target for Oct4
and Sox2.
DISCUSSION
During early embryogenesis, Oct4 and Sox2 are found to be
coexpressed in several pluripotent cells such as the morula,
ICM, epiblast, and germ cells. Gene knockout studies revealed
that the primary defect for both the Pou5f1- and Sox2-null
animals is in the pluripotent epiblast, though there are slight
differences between the two null phenotypes. There is no epi-
blast development in the Pou5f1-null blastocyst, and the fate of
all cell types is towards trophectoderm lineage (26). On the
other hand, Sox2-null animals are capable of giving rise, at
least transiently, to the epiblast, as epiblast-derived extraem-
bryonic endoderm is detected (3). This transient epiblast for-
mation was suggested to result from maternally derived Sox2
protein. Both Pou5f1- and Sox2-null blastocysts are incapable
of giving rise to pluripotent ESCs.
In this study, we use ESCs as a model for understanding the
role of Oct4 and Sox2 in the genetic regulatory network of
pluripotent cells. We ﬁrst established the conditions under
which Oct4 and Sox2 interact with the Pou5f1 and Sox2 en-
hancers in order to understand the function of these regulators
at these cis-regulatory target sites. Using speciﬁc antibodies
against Oct4 and Sox2, we showed by ChIP that these two
transcription factors bind to both enhancer elements in mouse
and human ESCs (Fig. 2, 3, and 7). Hence, these enhancer
elements are the direct targets of their respective gene prod-
ucts and are reciprocally bound by the other regulator. As we
detected the highest level of binding in undifferentiated cells
when these genes are known to be most transcriptionally ac-
tive, we conclude that they are associated with the transcrip-
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tional activation of these genes and may play a role in posi-
tively regulating expression. This was further conﬁrmed
through a functional analysis of the interactions in genetic
studies.
Using RNAi with reporter gene constructs, we showed that
the silencing of Pou5f1 or Sox2 led to the down-regulation of
Pou5f1 and Sox2 enhancer activities (Fig. 5, 6, and 7). More
importantly, the endogenous transcripts and proteins were also
reduced by RNAi in a manner that was consistent with the
reporter studies. The effects of RNAi on the reporters may
have been indirect, as the silencing of endogenous Pou5f1 or
Sox2 led to the differentiation of ESCs and further caused the
level of endogenous Oct4 and Sox2 to decrease. However,
coupled with the observation that Oct4 and Sox2 directly bind
to these regulatory elements when the genes are active, our
results indicate that Oct4 and Sox2 play positive roles in the
expression of Pou5f1 and Sox2.
The interactions of this Sox2-Oct4 complex with the respec-
tive genes can be described as a transcriptional regulatory
network consisting of autoregulatory and multicomponent
loops (Fig. 8A) (21). A network motif is a fundamental unit
within a complex transcriptional regulatory network. In an
autoregulation model, the gene product binds to its own reg-
ulatory element (Fig. 8B). This may allow for self-perpetuation
and enhanced stability of gene expression. An additional rela-
tionship between Oct4 and Sox2 is depicted by a multicompo-
nent loop motif whereby a regulator binds to the regulatory
elements of another regulator in a closed loop (Fig. 8C). Such
a closed-circuit loop can efﬁciently generate a bistable system
with the ability to switch between two different states. For
ESCs, the two states may be the decision to undergo self-
renewal or to differentiate and exit from symmetrical division.
This model also requires that the concentrations of the two
factors remain relatively constant, as any slight change in the
abundance of one protein will destabilize the circuitry. Inter-
estingly, it has been shown that mouse ESCs are exquisitely
sensitive to the level of Oct4 (29). Increasing the level of Oct4
by 50% is sufﬁcient to induce differentiation of ESCs into
primitive endoderm and mesoderm. We show that mutating
either the oct or sox site in the distal enhancer does not com-
pletely abolish its enhancer activity, with 60% of the activity
still being retained (Fig. 4E). It is conceivable that the modest
reduction in Pou5f1 expression may have a signiﬁcant cellular
effect. It would also be of interest to determine whether the
alteration of Sox2 levels gives a similar phenotype.
Differential occupancy of the Oct4/Sox2 complex on the
various regulatory elements was suggested by the EMSA re-
sults. For instance, a direct comparison of ESC nuclear extracts
binding to Nanog and Fgf4 at the sox-oct composite elements
indicated clear differences in binary and ternary formation
between the two (39). In addition, the EMSA indicated that
Oct4 was incapable of binding by itself on the Fbx15 composite
element (46). This differential binding is likely attributed to
variations in the sox-oct composite element, given that the Fgf4
element contains an intervening 3 bp while the Fbx15 element
contains an A rather than a C in the otherwise invariant fourth
position in the octamer motif (Fig. 1B). Whether the differen-
tial binding (as observed in the EMSA) alters transcriptional
activity of the Oct4/Sox2 complex itself remains to be seen, but
gene-speciﬁc sequence conservation within these sox-oct com-
posite elements suggests functional signiﬁcance.
Although ESCs grown in culture may not mimic the physi-
ological conditions of cells within the ICM of the blastocyst,
they provide a good model for understanding the transcrip-
tional regulatory networks in pluripotent cells. Oct4 and Sox2
are key regulators for pluripotency in ESCs. We have recently
identiﬁed Nanog as a downstream target of Oct4 and Sox2
(39). This expands the list of genes (Fgf4, Utf1, Opn, and
Fbx15) which are potentially regulated by both Oct4 and Sox2.
It is also important to note that direct binding of these regu-
lators on the regulatory elements of Fgf4, Utf1, and Fbx15 has
not been demonstrated by ChIP. Nevertheless, it is apparent
that Oct4 and Sox2 are at the top of the hierarchy of transcrip-
tional regulators in ESCs. The cooperative binding of Oct4 and
Sox2 may thus be instrumental in recruiting various other in-
teracting protein partners. It should be emphasized that not all
Oct4 and Sox2 sites on the same regulatory region are syner-
gistic in transcriptional activation. For example, in the Opn
intron, a sox site 39 bp away from an inverted pair of Oct4 sites
acts antagonistically in transactivation by Oct4 (6). Repression
by Sox2 was shown to require DNA binding and a carboxy-
terminal transactivation domain. For Fgf4, Utf1, and Fbx15, the
regulatory elements contain Oct4 and Sox2 sites in proximity
(either 0- or 3-bp separation) and the Oct4/Sox2 complex is
implicated in transactivation. This raises the interesting possi-
bility that perhaps Oct4 and Sox2 collaborate to globally con-
trol ESC-speciﬁc gene expression through the sox-oct motifs.
To address this possibility, the direct targets of both regulators
have to be identiﬁed. One can then compare these two factors
and identify the commonality between them. It is also plausible
that the Oct4/Sox2 complex interacts with another factor(s) to
activate the network of ESC-speciﬁc genes. For example, the
Pou5f1 distal enhancer contains three distinct regions (CR4-A
to -C) that contribute to expression. Does the Oct4/Sox2 com-
plex communicate with the regulatory protein(s) bound to
CR4-A and CR4-C? Are they ubiquitous or ESC-speciﬁc fac-
tors? These questions require further characterization of the
regulators bound to CR4-A and CR4-C. It is also important to
note that there are other key regulators for maintenance of the
undifferentiated state of ESCs. The LIF/Stat3 pathway is es-
sential for self-renewal of mouse ESCs (23, 28, 35). The re-
moval of LIF leads to the inactivation of Stat3 and induces
differentiation. The other key regulator is Nanog. The removal
of Nanog via gene targeting or RNAi leads to differentiation of
mouse ESCs (10, 24, 39). Intriguingly, overexpression of
Nanog is sufﬁcient to bypass the LIF/Stat3 requirement. How-
ever, how Stat3 and Nanog interact with the Oct4/Sox2 path-
way remains to be studied.
An autoregulation mode can generate a self-perpetuating
cycle to maintain stable gene expression through a positive
feedback loop. The question is, how can this cycle be broken?
In the case of Pou5f1, one key answer is the involvement of a
repressor(s) that is induced in differentiated cells. The tran-
scription of Pou5f1 is down-regulated when ESCs differentiate
in vitro and when the epiblast differentiates during embryo-
genesis. There exists a mechanism to break out of the loop of
Pou5f1 expression. The promoter of Pou5f1 contains negative
regulatory elements which are required for repression when
embryonal carcinoma cells differentiate (4, 34, 42, 44). Inter-
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estingly, germ cell nuclear factor (Gcnf) has been shown to
mediate repression of the Pou5f1 proximal promoter (16). The
expression of Gcnf is inversely correlated with the Pou5f1 ex-
pression in embryonal carcinoma cells. More importantly, in
Gcnf-knockout mouse embryos, the Pou5f1 expression is no
longer conﬁned to the germ cell lineage and novel Pou5f1
expression domains are detected. The loss of Pou5f1 expres-
sion may subsequently extinguish Sox2 transcription and the
expression of other downstream target genes. It is not clear
whether Sox2 is similarly subjected to repression when ESCs
differentiate. Nevertheless, the ﬁnding highlights the impor-
tance of an active mechanism to shut down a key regulator(s)
upon differentiation.
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          Appendix 2 
   Paper II 
The Oct4 and Nanog transcription network regulates
pluripotency in mouse embryonic stem cells
Yuin-Han Loh1,2,7, Qiang Wu1,7, Joon-Lin Chew1,2,7, Vinsensius B Vega3, Weiwei Zhang1,2,
Xi Chen1,2, Guillaume Bourque3, Joshy George3, Bernard Leong3, Jun Liu4, Kee-Yew Wong5,
Ken W Sung3, Charlie W H Lee3, Xiao-Dong Zhao4, Kuo-Ping Chiu3, Leonard Lipovich3,
Vladimir A Kuznetsov3, Paul Robson2,5, Lawrence W Stanton5, Chia-Lin Wei4, Yijun Ruan4,
Bing Lim5,6 & Huck-Hui Ng1,2
Oct4 and Nanog are transcription factors required to maintain the pluripotency and self-renewal of embryonic stem (ES) cells.
Using the chromatin immunoprecipitation paired-end ditags method, we mapped the binding sites of these factors in the mouse
ES cell genome. We identiﬁed 1,083 and 3,006 high-conﬁdence binding sites for Oct4 and Nanog, respectively. Comparative
location analyses indicated that Oct4 and Nanog overlap substantially in their targets, and they are bound to genes in different
conﬁgurations. Using de novo motif discovery algorithms, we deﬁned the cis-acting elements mediating their respective binding
to genomic sites. By integrating RNA interference–mediated depletion of Oct4 and Nanog with microarray expression proﬁling,
we demonstrated that these factors can activate or suppress transcription. We further showed that common core downstream
targets are important to keep ES cells from differentiating. The emerging picture is one in which Oct4 and Nanog control
a cascade of pathways that are intricately connected to govern pluripotency, self-renewal, genome surveillance and cell
fate determination.
ES cells are pluripotent cells derived from the inner cell mass (ICM)
of the mammalian blastocyst. They are capable of indeﬁnite self-
renewing expansion in culture. Depending on culture conditions,
these cells can differentiate into a variety of cell types1. The ability
to steer ES cell differentiation into speciﬁc cell types holds great
promise for regenerative medicine2–4.
Oct4, Sox2 and Nanog are key regulators essential for the formation
and/or maintenance of the ICM during mouse preimplanta-
tion development and for self-renewal of pluripotent ES cells5–10.
Oct4 is a POU domain–containing transcription factor encoded by
Pou5f1. In the absence of Oct4, pluripotent cells in vivo (epiblast)
and in vitro (ES cell) both revert to the trophoblast lineage. This
implicates Oct4 as an important regulatory molecule in the initial cell
fate decisions during mammalian development. Additionally, increas-
ing the expression of Oct4 above the endogenous levels in ES cells
leads to differentiation toward the extraembryonic endoderm lineage7.
These divergent effects of Oct4 suggest that Oct4 transcriptionally
regulates genes involved in coordinating multiple cellular functions.
Oct4 is known to bind to a classical octamer sequence, ATGCAAAT,
and in ES cells, it often binds in partnership with Sox2, which binds to
a neighboring sox element11,12. Nanog, a homeodomain–containing
protein, was identiﬁed as a factor that can sustain pluripotency
in ES cells even in the absence of leukemia inhibitory factor
(LIF)9,10. Nanog-null embryos seem to be able to initially give rise
to the pluripotent cells, but these cells then immediately differen-
tiate into the extraembryonic endoderm lineage. During develop-
ment, Nanog function is required at a later point than the initial
requirement for Oct4, but both are required for the maintenance
of pluripotency.
To understand how Oct4 and Nanog maintain pluripotency, we
sought to identify the physiological targets of these transcription
factors in mouse ES cells. We made use of the recently developed
paired-end ditag (PET) technology to characterize chromatin immu-
noprecipitation (ChIP)-enriched DNA fragments and achieved
unbiased, genome-wide mapping of transcription factor binding
sites. This method extracts a pair of signature tags from the 5¢ and
3¢ ends of each DNA fragment, concatenates these PETs for efﬁcient
sequencing and maps them to the genome13,14. Here we combine this
ChIP-PET identiﬁcation of Oct4 and Nanog binding sites with RNA
interference (RNAi) analyses to demonstrate the regulation of target
gene expression. Overexpression of Nanog in ES cells further identiﬁed
upregulated or downregulated genes. This comprehensive analysis
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uncovers a complex network connecting the regulators important in
maintaining ES cell pluripotency.
RESULTS
Global mapping of Oct4 and Nanog binding sites by ChIP-PET
To better understand the roles of Oct4 and Nanog in self-renewal and
pluripotency, we set out to determine the downstream targets of these
transcription factors in undifferentiated mouse ES cells by the ChIP-
PETmethod (Fig. 1 and Supplementary Note online)14. Although the
majority of the PETs were located in the genome discretely (classiﬁed
as PET singletons), about 25% of PETs from both ChIP-PET libraries
were found overlapping with other PETs, thus representing clusters.
These PET cluster–deﬁned genomic loci represent potential interac-
tion sites in the genome. We hereafter refer to PET clusters with two
overlapping members as PET2, for clusters with three overlapping
members as PET3, and so forth.
Next, we empirically determined the minimum required size of a
PET cluster to identify an authentic binding site with high conﬁdence
(that is, not a result of background noise). For the Oct4 dataset, we
selected 115 PET clusters for validation (Supplementary Figure 1 and
Supplementary Table 1 online). All of the clusters with ﬁve or more
overlapping members (‘PET5+’) and 38 of the 40 PET4 clusters
showed enrichment above background. Among the PET3 clusters,
Oct4 bound three out of the 34 loci tested. As 91% of the PET3
clusters were not enriched, a cluster size of at least four PETs was
selected as a cutoff for maximum identiﬁcation of high-conﬁdence
Oct4-binding sites; 1,083 clusters with four or more overlapping
members (PET4+) were identiﬁed (Supplementary Table 2 online).
In further validation of the Oct4 ChIP-PET data, we found that the
PET proﬁle precisely paralleled that detected by real-time PCR on two
previously characterized targets of Oct4, Pou5f1 and Nanog15 (Sup-
plementary Figure 2 online). This attests to the reliability of this
approach for high-resolution mapping of transcription factor binding
sites in living ES cells.
For the Nanog data set, we selected 100 PET clusters for validation
(Supplementary Figure 3 online). All PET5+ clusters and 20 out of
the 21 PET4 clusters showed enrichment above background. Among
the PET3 clusters, Nanog bound 12 out of the 16 loci tested. As 25%
of the PET3 clusters were not enriched, we chose clusters of PET4+ as
high-conﬁdence Nanog binding loci; 3,006 of these were identiﬁed
(Supplementary Table 2). To exclude the possibility that the poly-
clonal antibody we used cross-reacted with other proteins, we further
validated these 100 loci by repeating the ChIP-PCR assay using an ES
cell line expressing hemagglutinin (HA)-tagged Nanog (Supplemen-
tary Figure 4 online). Notably, we observed PET clusters over the
regulatory regions for Pou5f1, Sox2 and Nanog (Supplementary
Figure 5 online), and the binding proﬁles were validated by real-
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Identification of downstream target genes important
to maintain the pluripotency of mouse ES cells
Figure 1 Schematic diagram of genome-wide mapping of Oct4 and Nanog
binding sites using ChIP-PET. Mouse embryonic stem cells cultured under
feeder-free conditions were treated with formaldehyde to mediate covalent
cross-links between DNA and proteins. The chromatin was fragmented by
sonication. Immunoprecipitation using a speciﬁc antibody was used to
capture the transcription factor bound to target sites (shown in red). The
ChIP-enriched DNA was ﬁrst cloned into a plasmid-based library, and we
then used restriction enzymes to transform this original library into one that
contained concatenated paired-end ditag (PET) sequences13. Each tag is 18
bp in length, and each ditag represents the 5¢-most and 3¢-most ends of the
ChIP-enriched DNA fragments cloned into the original library. This second
library increases the throughput of analysis, as each sequencing read
identiﬁes 10 to 15 PETs representative of 10 to 15 ChIP-enriched
genomic fragments. We refer to this as the ChIP-PET methodology14. The
concatenated PETs were sequenced and their locations were mapped to the
mouse genome to demarcate the boundaries of transcription factor ChIP-
enriched DNA. PET overlaps of four or more members were empirically
determined to be high-conﬁdence transcription factor binding sites. Random
recovery of genomic DNA was observed in the form of PET singletons. To
further establish the importance of the selective downstream targets of Oct4
and Nanog, we depleted the transcripts encoding these factors by RNAi and
demonstrated their roles in maintaining ES cells in a nondifferentiated state.
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Figure 2 Distribution of Oct4 and Nanog binding sites. (a) Schematic
diagram illustrating the deﬁnition of the location of a binding site in relation
to a transcription unit. 5¢ distal, 5¢ proximal, 3¢ proximal and 3¢ distal
regions are depicted in the 100 kb upstream and 100 kb downstream of
the transcriptional unit. (b) Locations of Oct4 binding sites relative to the
nearest transcription units. The percentages of binding sites at the
respective locations are shown. (c) Locations of Nanog binding sites relative
to the nearest transcription units. The percentage of binding sites at each
location is shown.
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Binding site distribution relative to gene structure
As a ﬁrst step to identify genes that are potentially regulated by Oct4
or Nanog, we annotated all the binding site loci with positional
information relative to the nearest gene. For loci within 100 kb of a
gene, their relative positions were annotated as 5¢ distal (10–100 kb
upstream), 5¢ proximal (0–10 kb upstream), intragenic (contained
within the respective genes), 3¢ proximal (0–10 kb downstream) or
3¢ distal (10–100 kb downstream; Fig. 2a and Supplementary
Table 2). Loci mapping 4100 kb away from the nearest gene were
annotated as residing in gene deserts. All the distinct genes associated
with the binding sites were further annotated with the Panther
classiﬁcation system16.
About 44% of the Oct4 binding sites mapped within a gene,
with 437 mapping to introns and 25 to exons (Fig. 2b). The 5¢
proximal region contained 196 Oct4 loci (19%), whereas 140 Oct4
loci (13%) mapped in the 5¢ distal regions of genes. The number of
Oct4 binding sites mapped downstream of genes was 79 in the 3¢
proximal (including Sox2) and 104 in the 3¢ distal regions. Of
the Nanog clusters, 2,786 clusters were located within 100 kb of
transcription units (Fig. 2c). Nine hundred forty-four (31%) of
the Nanog binding sites were found within introns. Six hundred
forty-one loci (21.3%) and 386 loci (12.8%) were bound by Nanog
at 5¢ distal and 5 proximal regions, respectively. Seven hundred
ﬁfty-eight Nanog loci (25.3%) were found at 3¢ downstream regions
of the genes.
Targeting of Oct4 and Nanog to the genome
As Oct4 and Nanog are among the key regulators in ES cells, we
examined whether there is cross-talk between the two factors and how
they extend their circuitries to the different genes. Notably, Nanog was
found to bind to an extended region of the Pou5f1 promoter covering
conserved regions 2 to 4, whereas Oct4 was found only at conserved
region 4 (Fig. 3a)15,17. To further investigate the relationship of Nanog
and Oct4 occupancies on a global scale, we generated a list of genes
containing Nanog and Oct4 binding sites anywhere within the vicinity
of 50 kb of a transcription unit (Fig. 3b). A substantial proportion of
the genes (345, representing 44.5% of Oct4-bound genes) were
occupied by both Nanog and Oct4 (Supplementary Table 3 online).
The result also showed Nanog-Oct4 colocalization as well as indepen-
dent binding of Nanog and Oct4 to the targeted genes (Fig. 3c).
Besides protein-coding genes, both Oct4 and Nanog localized to
genes encoding microRNAs (Fig. 3d). Nanog binds to sites within 6 kb
of four microRNA genes: mir296, mir302, mir124a and mir9-2. For
mir296,mir124a andmir9-2, there were no other known genes in close
proximity to the Nanog loci. For mir135, the Nanog cluster was found
to bind 30 kb away. Oct4 bound in juxtaposition with Nanog at sites
near the mir296 and mir302 genes.
Deﬁning the cis elements mediating Oct4 and Nanog binding
The ChIP-PET method provides high-resolution mapping of binding
sites, and the average length of the PET cluster overlaps for binding
loci was around 100 bp. This high resolution
increases the likelihood of ﬁnding motifs
using de novo motif discovery algorithms
such as Weeder and NMICA18,19. Notably,
the predominant motif found in our compu-
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Figure 3 Oct4 and Nanog binding site
conﬁgurations at genomic locations. (a) A screen
shot of the T2G browser showing Oct4 (upper
panel) and Nanog (lower panel) PET clusters at
Pou5f1. Each horizontal green line represents
a DNA fragment mapped to the genome. PET
density (in brown) shows the proﬁle of the
transcription factor binding and is based on the
number of overlapping DNA fragments. The peaks
of Nanog binding are highlighted by red arrows,
and the peak of Oct4 binding is highlighted by
a blue arrow. CR2 refers to conserved region 2.
CR4 contains a Sox2-Oct4 motif15. (b) Common
targets (overlap) between Nanog- and Oct4-bound
genes (analyzed 50 kb upstream and 50 kb
downstream of each gene) (c) Different
conﬁgurations of Oct4 (blue block) and Nanog
(red block) binding to genes. Exons are depicted
as gray boxes. The arrow indicates the direction
and body of a gene, extending from ﬁrst exon to
last exon based on University of California, San
Diego mouse genome coordinates. The numbers
on the right indicate the window span represented
by each plot. (d) Plots showing the presence of
Oct4 binding sites (blue block), Nanog (red
block) binding sites or both at genomic regions
containing microRNA genes. The microRNAs are
depicted as gray blocks. Each arrow represents
a gene. The numbers on the right indicate the
window span represented by each plot. All known
genes within the respective windows are shown.
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was a perfect match to the sox-oct composite element consensus
derived from six previously characterized Oct4-Sox2 target genes15.
This motif, discovered by both algorithms, was present in a high
percentage of the Oct4 binding loci (Supplementary Note), suggest-
ing a Sox2-Oct4 binary complex binding to these target genes.
Sequential ChIP of Oct4 and Sox2 at six loci (Supplementary Figure
6 online), three of which had not previously been described (Tcf3,
Trp53, Mycn), further demonstrates that both Sox2 and Oct4 bind to
these sites. We therefore suggest that one of the main mechanisms for
targeting Oct4 to its genomic sites is through the sox-oct motif via a
cooperative interaction with Sox2.
We also predicted a CATT-containing motif enriched over genomic
background in the Nanog ChIP-PET dataset using the NMICA
algorithm (Fig. 4b)19. Notably, this CATT-containing motif has
some overlap with an ATTA motif previously deﬁned biochemically10.
The interaction between Nanog and this CATT-containing motif was
conﬁrmed by EMSA using probes to a number of the Nanog binding
loci (Supplementary Figure 7 online). Notably, this motif was not
found by Weeder, which we suspect is due to the algorithm (Supple-
mentary Note) and may be related to the strength or length of the
speciﬁc signal.
Genome-wide analyses of gene regulation by Oct4 and Nanog
To determine the functional relevance of the Oct4 and Nanog binding
sites on the transcriptional regulation of their associated genes, we
perturbed Oct4 and Nanog expression in mouse ES cells by two
methods. First, we induced ES cells to differentiate. As our goal is to
examine the change in expression proﬁles associated with differentia-
tion, we used three chemical treatments (retinoic acid (RA), dimethyl
sulfoxide (DMSO) and hexymethyl-bis-acetamide (HMBA)) to avoid
chemical-speciﬁc modulation of gene expression. Microarrays with
over 16,000 gene probes were used to interrogate gene expression
changes. We ﬁrst clustered the gene expression to separate differentia-
tion-induced and differentiation-repressed genes (Supplementary
Note). Both Oct4 and Nanog were substantially repressed in all
three treatments. We subsequently scanned all of these genes (50 kb
upstream to 50 kb downstream) for the presence of the Oct4 and
Nanog binding sites that we had identiﬁed by ChIP-PET (Supple-
mentary Table 4 online). The data showed enrichment of Oct4- or
Nanog-bound genes that were induced and repressed upon differen-
tiation (Fig. 5). This suggests that Oct4 and Nanog can activate or
repress transcription. The genome-wide analysis also showed that
there are more Oct4- or Nanog-bound genes downregulated than
induced upon differentiation, suggesting that Oct4 and Nanog have a
dominant role in activating the transcription of ES cell–speciﬁc genes.
In addition, a third plot interrogates the presence of both factors and
showed that binding of two factors was more strongly correlated with
genes that were downregulated upon differentiation than with genes
that were upregulated.
The second method to determine functional relevance of binding
sites was to deplete ES cells of Oct4 or Nanog by RNAi and examine
differential gene expression again by microarray analysis. Our Oct4
and Nanog siRNAs were speciﬁc, as the effects of knockdown could be
rescued by coexpression of the respective RNAi-immune ORFs (Sup-
plementary Figures 8 and 9 online). For each differentially expressed
gene, we determined if a Oct4 or Nanog binding site was present
(Fig. 6a,b). Of the 4,711 statistically selected genes (median false
discovery rateo 0.001) from the Pou5f1 knockdown experiment, 394
contained Oct4 binding sites (Supplementary Table 5 online). After
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Figure 4 De novo prediction of motifs that mediate speciﬁc transcription
factor–DNA interaction. (a) A Sox2-Oct4 joint motif identiﬁed from the Oct4













































Figure 5 Genome-wide association of Oct4 and Nanog binding sites with
differentiation proﬁles of mouse ES cells. Hierarchical clustering was
performed on gene expression data for 16,223 probes obtained from
differentiated mouse ES cells. Genes are rank ordered by degree of
induction (red) and repression (green) by RA, DMSO and HMBA, relative to
undifferentiated control cells at days 2, 4 and 6 (leftmost panel). The three
plots at right show the corresponding numbers (moving averages) of gene
probes that have associated Oct4 and/or Nanog binding sites. The pink
and light green shaded areas indicate those genes that have Oct4 and/or
Nanog binding sites at frequencies signiﬁcantly greater than background
(P o 10–6). A value of 0.16 on the y-axis means that 320 genes were
bound in a sliding window of 2,000. The dashed line (background level)
indicates the expected average (that is, the ratio of number of gene
probes with associated binding regions over total number of interrogating
gene probes).
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OE (0.3 µM RA)
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REST (inhibitor of lineage specific genes)
Sox2, Esrrb, Tcf3, Jarid2, Ehmt1,
Sall1 (transcription regulators)
Rif1 (DNA damage response pathway)
Trp53bp1 (DNA damage response pathway)
Mycn (cellular proliferation)Foxd3, Nr0b1(transcription regulator)
(Growth regulator) Bmp4
Control RNAi Nanog RNAi
Figure 6 Genome-wide association of Oct4 and Nanog binding sites with expression proﬁles of mouse ES cells depleted of Oct4 or Nanog. (a) Expression
proﬁle of genes differentially expressed after Pou5f1 knockdown that were selected using Signiﬁcance Analysis of Microarrays (SAM) analysis. The genes
were sorted by the average expression ratio and mean centered. The horizontal black lines denote the presence of Oct4 binding sites. At right is the moving
window average of number of probes associated with Oct4 binding sites. The expected number of genes with binding site association is deﬁned as the ratio
of the number of genes with binding sites over the total number of genes interrogated (vertical blue line). (b) The same analysis described in a was also done
for Nanog. Blue line represents background level. (c) Expression proﬁles of the genes that were differentially expressed in both Pou5f1 and Nanog RNAi
experiments. The upper panel shows the expression proﬁle of the genes differentially expressed from the Nanog RNAi experiment, the lower panel shows
genes that are differentially expressed from the Pou5f1 RNAi experiment and the center panel shows the expression proﬁles of the 77 genes bound and
differentially regulated by both factors. (d) Validation of change in expression of Dkk1 after Pou5f1 or Nanog RNAi. (e) Upregulation of Oct4-bound genes
Cdx2 and Cldn4 after Pou5f1 RNAi. (f) Changes in gene expression after Oct4 or Nanog depletion. The levels of the transcripts were normalized against
values derived from control RNAi-transfected ES cells. Trp53 and Foxh1 were bound by Oct4 but not Nanog. (g) Depletion of Nanog induced Nrp2 and Klf6
expression. (h) Changes in gene expression after Nanog overexpression (OE). (i) Changes in gene expression after Nanog overexpression and Nanog
overexpression with RA-induced differentiation. (j) Induction of Dkk1 in treated cells from i. b-actin was used as an internal control for all real-time PCR
measurements. (k) Model of how Oct4 and Nanog regulate genes involved in different pathways. Oct4 and Nanog occupy Trp53bp1 and Mycn, but Nanog
does not regulate their expression (link shown as blue arrow). Black arrows signify regulation by the transcription factors, as shown by RNAi depletion.
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bound by Nanog (Supplementary Table 5). These genes thus repre-
sent direct targets regulated by the respective factors. As those genes
whose expression was affected in the knockdown experiments did not
preferentially contain binding sites within the 5¢ proximal region
(Supplementary Figure 10 online), functional transcription factor
binding seems not to be limited to the proximal promoter region. Our
analysis also identiﬁed 77 genes that were bound and regulated by
both Oct4 and Nanog (Fig. 6c and Supplementary Table 6 online).
Rcor2, Esrrb and Phc1 are examples of transcriptional regulators
positively regulated by both factors. The Dkk1 gene, encoding for a
Wnt antagonist, is negatively regulated by both Oct4 and Nanog
(Fig. 6d). One interesting demonstration of Oct4-repressed genes is
that of the trophectoderm marker genes Cdx2 and Cldn4: both were
markedly upregulated upon Pou5f1 reduction (Fig. 6e).
Among the Nanog-bound genes, notable ones are Pou5f1, Sox2, Rif1
and REST. Depletion of Nanog resulted in downregulation of their
expression (Fig. 6f), indicating that Nanog activates transcription of
these genes. Our previous work has shown that the Oct4/Sox2 binary
complex has a role in regulating Pou5f1, Sox2 and Nanog. The data
presented here showed the reverse links from Nanog to Pou5f1, Sox2
and Nanog. Notably, we found that Nanog can also have a repressive
role in transcription. For example, neuropilin 2 (Nrp2) and core
promoter element binding protein (Klf6, also known as Kruppel-like
factor 6) were induced after Nanog depletion (Fig. 6g).
In addition to the knockdown experiment, we performed the
reciprocal experiment, that of Nanog overexpression. This was to
determine if the expression of any of the genes associated with Nanog
binding sites was altered. Gene expression was compared between two
ES cell lines, both stably transfected, one with a Nanog expression
construct and the other with a parental vector control. Quantitative
real-time PCR indicated that mRNA levels of Pou5f1, Esrrb, Foxd3,
Tcfcp2l1, Nr0b1 and BMP4 were all increased to at least 150% of that
of the control cells (Fig. 6h). The expression of other genes with
associated Nanog binding sites remained unchanged (Sox2, Rif1, Sall1,
REST, Tcf3 and Jarid2). A third group of genes was downregulated
upon Nanog overexpression (Nrp2, Klf6 and Dkk1). These data suggest
that a higher cellular concentration of Nanog within ES cells can
modulate the transcription of a subset of target genes, though not all
target genes.
It is known that ES cells overexpressing Nanog are resistant to
differentiation induced by RA9. We asked whether Nanog can sustain
the expression of several key genes identiﬁed in our study in the
presence of RA. The cells were treated with 0.3 mM of RA for 2 d to
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Figure 7 Regulation of pluripotency by downstream targets of Oct4 and Nanog. (a) Knockdown (KD) of Esrrb or Rif1 led to differentiation of ES cells. Note
the presence of ﬂattened epithelial-like cells in the knockdown cells not seen in the vector control and REST knockdown ES cells. Cells were stained for
alkaline phosphatase (pink), which is characteristic of nondifferentiated cells. (b) The levels of Esrrb or Rif1 after knockdown using three constructs that
target different regions of the respective genes were determined by real-time PCR quantiﬁcation of reverse-transcribed RNAs. The third graph shows the level
of REST after REST knockdown (a). (c) Reduction of ES cell marker Rex1 after Esrrb or Rif1 knockdown by RNAi. (d) Induction of trophectoderm marker
Hand1 after Esrrb or Rif1 knockdown by RNAi. (e) Oct4 and Nanog regulatory network controlling pluripotency in ES cells. Transcription factors are
represented by ovals, and the genes (printed in italics) are represented by rectangles. A black arrow indicates a transcription factor binding to a gene and
positively regulating that gene. These links are largely based on evidence derived from ChIP and RNAi experiments. Esrrb and Rif1 were also bound by
Sox2 (data not shown). Gray arrows denote the synthesis of gene products from their respective genes. The genes printed in red (Esrrb and Rif1) are novel
functional nodes in this network. All the factors shown in this model are required to maintain ES cell pluripotency. Foxd3 and ESET have been shown to
be important in maintaining pluripotency of mouse ES cells39,41.
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morphology and became ﬁbroblast-like in appearance. However, most
of the Nanog-overexpressing cells retained ES cell morphology (Sup-
plementary Figure 11 online).
The expression of Pou5f1, Sox2, Esrrb, Rif1 FoxD3, Tcfcp2l1, Sall1,
REST, Jarid2, Tcf3 and Nr0b1 was reduced by a smaller amount
compared with the reduction of expression of these genes in the
control cells treated with RA (Fig. 6i). This indicates that Nanog was
able to sustain the expression of these genes. Consistent with the
repression of Dkk1 transcription by Nanog, the induction of Dkk1
upon RA induction was lower for Nanog-overexpressing cells (Fig. 6j).
However, genetic manipulations such as RNAi-mediated knockdown
or overexpression may have had indirect effects.
In summary, we show that Oct4 and Nanog bind to and regulate
diverse classes of genes. Of particular interest are genes encoding
transcriptional regulators, growth factors, signaling molecules, DNA
damage response sensors and suppressors of lineage-speciﬁc genes
(Fig. 6k). It is noteworthy that there are genes such as Trp53bp1 and
Mycn that are bound by Nanog but are not regulated by it, as observed
through genetic manipulation. Hence, independent validations such
as these knockdown experiments are critical in distinguishing func-
tional from nonfunctional circuitries.
Functional importance of downstream targets
Oct4 and Nanog are two important regulators in the maintenance of
pluripotency in ES cells, targeting a core set of 345 genes (Fig. 3b).
Among these genes, 30 of them encode known or putative DNA-
binding regulators, including key genes Pou5f1, Sox2 and Nanog. To
determine if the regulatory network identiﬁed in our study has
additional functional nodes, we asked if other common targets of
Oct4 and Nanog are required to maintain mouse ES cells in a
nondifferentiated state (Fig. 7). Esrrb, Rif1 and REST are genes
shown to be regulated by both Oct4 and Nanog (Fig. 6f). Notably,
the Esrrb and Rif1 knockdown cells became ﬂattened and ﬁbroblast-
like, with a loss of alkaline phosphatase staining of nondifferentiated
ES cells (Fig. 7a,b). REST knockdown changed neither the morphol-
ogy of ES cells nor the level of alkaline phosphatase. The expression of
the ESC-speciﬁc gene Zfp42 was reduced in Esrrb and Rif1 knockdown
cells, whereas the trophectoderm marker Hand1 was induced (Fig.
7c,d). The effect of RNAi was speciﬁc, as we observed the same
phenotypic change with three siRNA targeting different regions of the
Esrrb or Rif1 genes. Scrambled siRNA sequences had no effect on the
ES cells (Fig. 7b–d; Supplementary Figure 12 online). In summary,
we identiﬁed two new nodes in the Oct4 and Nanog circuitries that are
important for maintaining the nondifferentiated state of mouse
ES cells.
Oct4 and Nanog circuitries in mouse and human ES cells
Recently, the binding sites of OCT4 and NANOG at promoter regions
in human ES cells have been reported20. Although the two studies used
different approaches to identify binding sites, it is useful to compare
the Oct4 and Nanog circuitries in mouse and human ES cells (Fig. 8
and Supplementary Table 7 online). First, we compared the bound
genes identiﬁed in that study20 with ours. Notably, we found that only
9.1% of Oct4-bound genes and 13% of Nanog-bound genes over-
lapped between the two studies (Fig. 8a,c). From our Oct4 ChIP-PET
data set, we found 233 Oct4 sites in the 10-kb upstream regions of
known genes (we termed these ‘promoters’), and of these, only 33 of
the corresponding human promoters were bound by OCT4 (Fig. 8b).
Among the 434 Nanog sites within mouse promoters, NANOG bound
to 92 of the corresponding human promoters (Fig. 8d). The limited
overlap between the mouse and human datasets suggests that there
may exist differences in the networks controlled by Oct4 and Nanog
between species. For instance, here we have found Oct4 and Nanog
binding to the proximal promoter of Mycn in mouse ES cells21, but
these interactions have not been detected in human ES cells20.
Nevertheless, the human promoter datasets provides us with a
unique opportunity to investigate the Oct4 and Nanog binding
circuitries conserved in pluripotent cells from two mammalian species.
There are 32 genes that were bound by Oct4 and Nanog in
both mouse and human ES cells. Among this list, 18 of them
encode for transcription regulators (Fig. 8e), including Nanog, Sox2
and Rif1, further highlighting the importance of these genes in
mammalian ES cells.
DISCUSSION
Unbiased mapping of binding sites in ES cells by ChIP-PET
An unbiased genome-wide location mapping approach is very power-
ful in elucidating the physiological targets of transcription
regulators22–27. In the context of mammalian systems, this is particu-
larly important because regulatory elements do not always fall within
the 5¢ proximal region of the ﬁrst exon22. Our method is unique in
that the technique allows for the detection of overlapping ChIP
fragments that can then be used to precisely deﬁne the binding sites
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Figure 8 Conserved and diverged Oct4 and Nanog circuitries of mouse
and human ES cells. (a) Venn diagram showing the overlap between Oct4
putative gene targets in mouse (red) and OCT4 putative gene targets in
human ES cells (blue). (b) Venn diagram showing the overlap between
Oct4 bound mouse promoters (red) and the promoters bound by OCT4
(blue) in human ES cells. Of the 1,083 Oct4 binding sites in mouse,
233 (22%) fall in the promoter region of known genes (deﬁned as being less
than 8 kb upstream and less than 2 kb downstream of transcription start
site). Out of these, only 33 can be associated to a human promoter-bound
region. (c) Venn diagram showing the overlap between Nanog putative gene
targets in mouse (red) and NANOG putative gene targets in human
ES cells (blue). (d) Venn diagram showing the overlap between Nanog-bound
mouse promoters (red) and the promoters bound by NANOG (blue) in
human ES cells. Of the 3,006 Nanog binding sites in mouse, 434 (14%)
fall in the promoter region of known genes. Out of these, only 92 can be
associated to a human promoter-bound region. (e) Common genes that
encode for transcription regulators bound by Oct4 and Nanog in both
mammalian ES cells.
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only PET clusters with at least four overlaps of the PET fragments, we
obtained about 1,000 and 3,000 high-conﬁdence binding sites for Oct4
and Nanog, respectively.
We ﬁnd that Sox2 sites are present to a great extent at Oct4-bound
genomic loci. It has been shown that Sox2 and Oct4 occupy key
regulatory regions of Pou5f1, Sox2, Nanog, Fgf4, Fbxo15 and Utf1 at
adjacent cis elements15,28–33. The predominant motif uncovered by a
de novo motif prediction algorithm is a sox-oct composite element
present in approximately 70% of the Oct4 ChIP-PET clusters contain-
ing six or more PET overlaps (Supplementary Note). We also show
empirical evidence for the in silico prediction that Oct4 and Sox2
occupy the same binding sites. Indeed, using Sox2 ChIP, we have
detected Sox2 binding at the majority of Oct4-bound loci (J.-L.C. &
H.-H.N., unpublished data). Sequential ChIP analysis for a number of
genes further demonstrated that Oct4 and Sox2 are bound to the same
target DNA molecules (Supplementary Note). The evidence we
presented suggests that Oct4 and Sox2 work in tandem to regulate
gene expression for a majority of their target genes.
Similarly, we have predicted de novo a Nanog motif from the Nanog
ChIP-PET data. Nanog belongs to the Q50 homeoprotein family with
the amino acid glutamine at position 50 of the homeodomain making
direct contact with the nucleotides just 5¢ of the ATTA sequence34,35.
The ATTA tetramer has been reported to be the preferred sequence for
Nanog10. Using a combination of mutagenesis and EMSA experi-
ments, we determined that the CATT residues within the Pou5f1
Nanog binding region are important for interaction between Nanog
and DNA. Sequences containing a related CATTmotif are also bound
by Nanog in vitro.
Regulation of gene expression by Oct4 and Nanog
The global survey approach in this study demonstrated the targeting
of two structurally unrelated transcription factors to genes on an
extensive scale, indicating a high degree of cooperation between the
two factors. Our data shows, for the ﬁrst time, the different conﬁg-
urations of Oct4 and Nanog binding sites (Fig. 3c). This study
represents a starting point of how to decipher the combinatorial
binding site architectures of mammalian genes.
In order to understand transcription regulation by these factors, we
must understand whether the bound genes are indeed regulated, as
binding alone does not imply regulation. Using genome-wide micro-
array analysis, we ﬁnd a notable association of Oct4 or Nanog binding
sites with genes that are repressed and induced during differentiation.
As an additional level of validation that the bound genes are bona ﬁde
targets, we examined the transcripts in cells with and without RNAi
depletion of the respective factors. The data indicate that only a subset
of the bound genes is regulated by Oct4 or Nanog. The nonresponsive
genes could reﬂect nonfunctional sites or functional redundancy of
transcription regulators.
Oct4 and Nanog circuitries in mouse and human ES cells
There are several plausible explanations for the limited conservation of
Oct4 or Nanog-bound sites and genes between species. First, on the
basis of transcriptome analyses that include microarrays, serial analysis
of gene expression (SAGE) and massively parallel signature sequencing
(MPSS), it is known that mouse and human ES cells show key
differences36,37. Second, the disparity may arise from the scope of the
transcription factor binding sites being mapped. A previous study20 has
surveyed 10-kb upstream regions of approximately 18,000 annotated
genes, roughly 6% of the human genome. Previous work on mapping
transcription factor binding sites using unbiased approaches shows that
certain mammalian transcription factors can target sites outside
proximal promoter elements14,22,38. Here we have performed unbiased
surveys of transcription factor binding sites and ﬁnd that Oct4 and
Nanog binding sites are not restricted to upstream regions of genes.
Third, different technology platforms and reagents may contribute
to the discrepancy. We chose a cutoff of four or more overlapping PET
clusters to ensure495% true positive binding sites. Clearly, there are
true positives in PET clusters with three or fewer overlaps.
How do Oct4 and Nanog maintain pluripotency?
Both binding and genetic evidence presented in this study showed that
Nanog regulates the expression of Pou5f1 and Sox2. One likely
mechanism for how Nanog sustains self-renewal and the undiffer-
entiated state is through the modulation of Oct4 and Sox2 levels.
These two transcription factors in turn control the downstream genes
important for maintaining pluripotency or inhibiting differentiation
(Fig. 7e). In addition, Nanog also controls important molecular
effectors of ES cell fate, as exempliﬁed by Foxd3 and Setdb1. Foxd3
encodes for a transcriptional repressor important for the maintenance
of the inner cell mass or epiblast and the in vitro establishment of ES
cell lines39,40. The Setdb1 gene encodes for a histone H3 Lys9
methyltransferase that is required for survival of mouse ES cells41.
Oct4 and Nanog both bind toMycn, which has recently been reported
to be among the key mediators in the self-renewal and proliferation of
ES cells21. Further illustrating the central role of Oct4 and Nanog as
key regulators, we have identiﬁed two downstream targets, Esrrb and
Rif1, that are important for maintaining pluripotency of mouse ES
cells. Essrb belongs to the superfamily of nuclear hormone receptors,
and homozygous mutant embryos show abnormal trophoblast pro-
liferation, precocious differentiation toward the giant cell lineage and
reduction in primordial germ cells42,43. Rif1 is an ortholog of a yeast
telomeric protein and is upregulated in mouse ES and germ cells44. In
human cells, Rif1 associates with dysfunctional telomeres and has a
role in DNA damage response45,46. Notably, Rif1 is also a target of
OCT4 and NANOG in human ES cells, further implicating its
functional importance in ES cell biology. The exact nature of how
Esrrb and Rif1 regulate pluripotency of mouse ES cells remains to be
studied. The location maps generated in this study should serve as
useful guides in identifying additional components in the regulatory
network important for self-renewal, pluripotency and differentiation
of ES cells.
METHODS
Cell culture. E14 mouse ES cells, either cocultured with mouse primary
embryonic ﬁbroblast feeders or cultured under feeder-free conditions, were
maintained in Dulbecco’s modiﬁed Eagle medium (DMEM; GIBCO), supple-
mented with 15% heat-inactivated fetal bovine serum (FBS; GIBCO), 0.055
mM b-mercaptoethanol (GIBCO), 2 mM L-glutamine, 0.1 mM MEM non-
essential amino acid, 5,000 units/ml penicillin/streptomycin and 1,000 units/ml
of LIF (Chemicon). HEK293T cells were cultured in DMEM supplemented
with 10% FBS and maintained at 37 1C with 5% CO2. Detection of alkaline
phosphatase, which is indicative of the nondifferentiated state of
ES cells, was carried out using a commercial ES Cell Characterization Kit
from Chemicon.
ChIP-PETanalysis. Afﬁnity-puriﬁed polyclonal Nanog antibody was purchased
from Cosmo Bio and characterized as shown in the Supplementary Note.
Antibodies against Oct4 and Sox2 have been characterized previously15. ChIP
was performed as described previously15. The ChIP-PET analysis was per-
formed as previously described14. The locations of the ChIP-enriched DNA
present in the library were visualized using our in-house genome browser (T2G
browser) which was implemented in the context of the University of California,
Santa Cruz (UCSC) genome browser.
438 VOLUME 38 [ NUMBER 4 [ APRIL 2006 NATURE GENETICS





































Electrophoretic mobility shift assays (EMSA). Full-length mouse Nanog
cDNA and mutants were ampliﬁed with appropriate primers, and the resulting
DNA fragments were cloned into the expression vector pET42b (Novagen). The
recombinant Nanog proteins were expressed in BL21 after induction with
0.2 mM IPTG at 20 1C and puriﬁed with GST beads followed by Ni-NTA beads.
The puriﬁed proteins were dialyzed against dialysis buffer (20 mM HEPES, pH
7.9, 20% glycerol, 100 mM KCl, 0.83 mM EDTA, 1.66 mM DTT, Protease
Inhibitor Cocktail (Roche)) at 4 1C for 4 h. The concentrations of the proteins
were measured with a Bradford assay kit (Bio-Rad). Oligonucleotides labeled
with biotin at the 5¢ termini of sense strands were annealed with reverse strands
in annealing buffer (10 mM Tris-HCl, pH 8.0, 50 mM NaCl, 1 mM EDTA) and
puriﬁed with an agarose gel DNA extraction kit (Qiagen). EMSA was
performed in 10-ml mixtures containing 10 mM HEPES, pH 7.5, 10 mM
KCl, 10 mM MgCl2, 1 mM DTT, 1 mM EDTA, 10% glycerol, 0.5 ng of biotin-
labelled oligonucleotide, 100 ng recombinant proteins and 1 mg of poly(dI-dC).
If indicated, antibodies or unlabeled competitor DNA were added after the
initial incubation for additional 20 min. After incubation for 10 min at RT, the
binding mixtures were subjected to electrophoresis on pre-run 5% native PAGE
gels in 0.5 TBE buffer. The gels were transferred to Biodyne B nylon
membranes (Pierce Biotechnologies) and the binding signal was detected with
LightShift Chemiluminescent EMSA kit (Pierce Biotechnologies).
RNA extraction, reverse transcription and quantitative real-time PCR. Total
RNA was extracted using TRIzol Reagent (Invitrogen) and puriﬁed with the
RNAeasy Mini Kit (Qiagen). Reverse transcription was performed using
SuperScript II Kit (Invitrogen). DNA contamination was removed by DNase
(Ambion) treatment, and the RNAwas further puriﬁed by an RNAeasy column
(Qiagen). Quantitative PCR analyses were performed in real time using an ABI
PRISM 7900 Sequence Detection System and SYBR Green Master Mix as
described15. Two pairs of primers were used to quantify the amount of cDNA,
and both primer pairs showed identical results. For all the primers used, each
gave a single product of the right size. In all our controls lacking reverse
transcriptase, no signal was detected (Threshold cycle (Ct) 435). Each RNAi
experiment was repeated at least twice with different batches of ES cells. For
ChIP experiments, relative occupancy values were calculated by determining
the apparent IP efﬁciency (ratios of the amount of ChIP enriched DNA over
that of the input sample) and normalized to the level observed at a control
region, which was deﬁned as 1.0. The error bars shown are 1 s.d. and were
calculated from technical replicates based on triplicate real-time PCR measure-
ments of DNA. The validation for ChIP-PET data was performed at least twice
from independent ChIP. The sequences of the primers are available
upon request.
Accession codes. GEO: GSE4189.
Note: Supplementary information is available on the Nature Genetics website.
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Supplementary Figure 2. Profiles of Oct4 binding revealed by ChIP-PET 
Validation of known Oct4 occupied genes in mouse ES cells. A capture of the T2G 
browser showing PET clusters at Pou5f1 (upper panel of a) and Nanog (upper panel of 
b) with 9 overlaps and 4 overlaps respectively. Each horizontal green line represents a 
DNA fragment mapped to the genome. TFBS density (colored in brown) is a plot 
showing the profile of the transcription factor binding and is based on the number of 
overlaps of the DNA fragments. Conventional Oct4 ChIP and realtime PCR were carried 
out using Pou5f1 and Nanog genes specific primers to confirm the Oct4 binding sites 
shown by our ChIP-PET analysis. Graphs depicting the mapping of the Oct4 (red circles) 
and control (Ena-1 antibody, light blue circles) binding sites across the chromosomal 
locations of PET clusters are shown (lower panels of a and b). Fold enrichment is the 
relative abundance of DNA fragments at the regions shown (relative to the position of 
the respective gene as illustrated in the browser) over a control region as quantified by 
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Supplementary Figure 5. Validation of Nanog binding profiles at Pou5f1, Sox2 and 
Nanog upstream regulatory regions 
Conventional Nanog ChIP and real-time PCR were carried out using Pou5f1, Sox2 and 
Nanog gene specific primers to confirm the Nanog binding sites shown by the ChIP-PET 
analysis. A capture of the T2G browser showing PET clusters at Pou5f1 (a) and Sox2 (e)
and Nanog (i). Each horizontal green line represents a DNA fragment mapped to the 
genome. TFBS density (colored in brown) is a plot showing the profile of the 
transcription factor binding and is based on the number of overlapping DNA fragments. 
The locations of the amplified products (black boxes) of the primer sets used to detect 
the ChIP-enriched DNA fragments shown in the context of the genomic structure of 
Pou5f1, Sox2 and Nanog (b, f, i). Amplicons are numbered in order relative to their sites 
along the gene (b, f, i). Open boxes represent exons. Fold enrichment is the relative 
abundance of DNA fragments at the regions shown (relative to the position of the 
respective gene as illustrated in the browser) over a control region as quantified by real-
time PCR. The locations of the known regulatory regions are indicated. CR1 to CR4 are 
conserved regions upstream of Pou5f1 (b). Region D is a regulatory region upstream of 
Sox2 (f). SRR2 is regulatory region downstream of Sox2. Standard deviations are 
shown. The graphs depict the mapping of the Nanog and GST (mock control) binding 
sites across the indicated regions (c, g, j). The ChIP experiment also was conducted 
using anti-HA and anti-GFP (mock control) antibodies on extracts from ES cell-line 
expressing HA-tagged Nanog (d, h, j).
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Supplementary Figure 6. Co-occupancies of Oct4 and Sox2 on target sites 
(a) Schematic diagram illustrating Oct4 and Sox2 co-occupancy as carried out in 
sequential ChIP. First ChIP using Oct4 (N19) antibody will purify for fragments bound by 
Oct4, as well as non-specific DNA. A second ChIP using the Sox2 (Y17) antibody will 
further purify the pool of DNA to yield DNA fragments bound by both Oct4 as well as 
Sox2. Sequential ChIP using (b) Oct4 antibody followed by Sox2 antibody and vice 
versa, i.e (c) sequential ChIP using Sox2 antibody followed by Oct4 antibody. Fold 
enrichment represents the abundance of enriched DNA fragments over a control region 
not enriched for the respective targets. O: Oct4 ChIP, C: control Ena-1 ChIP, S: Sox2 
ChIP, OS: Oct4 ChIP followed by Sox2 ChIP, OC: Oct4 ChIP followed by control Ena-1 
ChIP, SO: Sox2 ChIP followed by Oct4 ChIP, SC: Sox2 ChIP followed by control Ena-1 

















































































GGGAGCCATCCTGGCCCATTCAAGGGTTGAGTACT  WT 
GGGAGCCATCCTGGGGGTGGGAAGGGTTGAGTACT  mut1 
GGGAGTTTTAATGGCCCATTCAAGGGTTGAGTACT  mut2 
GGGAGCCATCCTGGCCCCCTCAAGGGTTGAGTACT  mut3 
GGGAGCCATCCTGGCCCACCCAAGGGTTGAGTACT  mut4 
GGGAGCCATCCTGGCGGATTCAAGGGTTGAGTACT  mut5 
GGGAGCCATCCTGGCCGGTTCAAGGGTTGAGTACT  mut6 
GGGAGCCATCCTGGCCCGGTCAAGGGTTGAGTACT  mut7 
GGGAGCCATCCTGGCCCAGGCAAGGGTTGAGTACT  mut8 
GGGAGCCATCCTGGCCCATGGAAGGGTTGAGTACT  mut9 
GGGAGCCATCCTGGCCCATTGGAGGGTTGAGTACT  mut10 
a
b
  GGCCCAGTCTGAGGATCCCATTACTGGCCTGGTGCTTAGT  Pou5f1 CR3 
    GGGAGCCATCCTGGCCCATTCAAGGGTTGAGTACT   Pou5f1 CR2 
    CCTCCCAATTTCTATACATTCATTGTGGAACAGTGCCATAG  Pou5f1 CR4 
  CCCAGAGGACCCACTTAACATTCCTTTCCCCACCCACA  Nanog 1 
CATCTAGACGCCCTCCTCCCTATTCAAACCGCTTCCC   Nanog 2 
    TTAACCACTCGCCAACCATTCCGAGGAAGAGCAGA   Sox2 1 
     TCCAGTTAACAAGGGCATTCTCCGAGACTCTGCAG  Sox2 2 
     TCCACTCCAAAGGATCATTAACAGATCCTGACTGT  Esrrb 
     CACACAATGCGCTCCCATTAACAGGTTTAAAGTGT  Tcf3 
      CTCTCGCTTATACTCATTCATTCTTTGACCTTCTC  Zic3 
   CTCACATATGTAAAACCCATTACCTTTGCAAAAGCCTT  Nmyc 
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Supplementary Figure  7. Binding of Nanog to DNA containing CATT motifs 
(a) Electrophoretic mobility shift assays (EMSA) were used to analyze the interactions 
between Nanog and a 35 bp dsDNA Pou5f1 CR2 probe containing a variant of the 
Nanog motif. Lane 1 is without purified recombinant Nanog; Lanes 3 and 4 are with the 
respective antibodies added; Lane 5 is with 100-fold excess unlabelled probe; Lane 6 is 
with 100-fold excess unlabelled non-specific probe. 
(b) EMSA result showing the effects of mutations on Nanog / DNA interaction. 
(c) Sequences of probes used in (b). The mutations were highlighted in gray. 
(d) EMSA using probes shown in (e). 
(e) Sequences of probes derived from other PET clusters. The conserved residues 
(common in at least 8 out of 12 sequences) were identified manually and highlighted in 











































































































































































Supplementary Figure 8.  Rescue experiments demonstrate the specificity of the 
Pou5f1 RNAi results 
(a) Phenotypic rescue of Pou5f1 knockdown. ES cells with Pou5f1 knockdown showed 
differentiation (upper left panel), while control ES cells transfected with construct 
expression GFP siRNA retained ES cell morphology (lower left panel). Co-transfection of 
Pou5f1 RNAi construct with a construct expressing Pou5f1 ORF with mutations that 
destroy the target site of Pou5f1 siRNA sequence prevented the ES cells from 
differentiation (upper right panel). ES cells were also co-transfected with the mutant 
Pou5f1 ORF and GFP RNAi constructs (lower right panel). (b) ES marker (Nanog)
rescue. Pou5f1 knockdown reduced endogenous Nanog transcript. Co-transfection with 
a mutant Pou5f1 ORF expression construct restored the level of Nanog transcript. (c)
Differentiation marker (Cdx2) rescue. Pou5f1 knockdown activated the expression of 
Cdx2 transcript. Co-transfection with a mutant Pou5f1 ORF expression construct 
suppressed this induction. (d) Differentiation marker (Hand1) rescue. Pou5f1 knockdown 
activated the expression of Hand1 transcript. Co-transfection with a mutant Pou5f1 ORF 
expression construct suppressed this induction. (e) Pou5f1 reporter rescue. Pou5f1
knockdown reduced the activity of a co-tranfected Pou5f1-luciferase reporter1. A 
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Supplementary Figure 9. Specificity of Nanog siRNA  
(a) Specificity of Nanog siRNA was tested by co-transfection of the Nanog expression 
vector with constructs expressing control, Nanog, Oct4 or Sox2 siRNA into 293T cells. 
The cell lysates were analyzed by Western blot with anti-Nanog.  ß actin served as a 
loading control. (b) Nanog siRNA did not affect Sox2 expression. Nanog or control 
knockdown constructs were co-transfected with the Sox2 expression vector into 293T 
cells. The lysates were analyzed by Western blot with anti-Sox2 or anti-ß actin 
antibodies. (c) Nanog siRNA did not affect Pou5f1 expression. Nanog or control 
knockdown constructs were co-transfected with the Pou5f1 expression vector into 293T 
cells. The lysates were analyzed by Western blot with anti-Oct4 or anti-ß actin 
antibodies. (d) Nanog knockdown reduced Nanog in ES cells. Nanog or control (GFP
and empty vector) knockdown constructs were transfected into ES cells. The level of 
Nanog transcript was determined by reverse transcription followed by real-time PCR. 
Standard deviations are shown. (e) Nanog knockdown reduced Nanog in ES cells. 
Nanog or control knockdown constructs were transfected into ES cells. The lysates were 
probed using anti-Nanog or anti-ß actin antibodies.  (f) Nanog knockdown induced 
differentiation. The Nanog and control knockdown cells were stained for alkaline 
phosphatase. Note the presence of flattened epithelial-like cells in the knockdown cells 
not seen in the vector control ES cells. (g) Validation of RNAi-immune Nanog rescue 
construct. Silent mutations were introduced into the Nanog open reading frame. The 
mutated region was no longer fully complementary to the siRNA, this rendered the 
transcript resistant to RNAi. Constructs expressing Nanog siRNA or mock siRNA were 
co-transfected with or without the Nanog rescue ORF vector in ES cells. The levels of 
Nanog were detected by reverse transcription followed by real-time PCR. (h) Nanog
rescue construct prevented ES cells from differentiation after endogenous Nanog
knockdown. The morphologies of the cells (G) were monitored by microscopy. (i) Nanog
rescue construct could restore Pou5f1. The levels of Pou5f1 from cells treated in G were 
measured. (j) Nanog rescue construct could inhibit expression of Gata6. The levels of 
Gata6 from cells treated in G were measured. (k) Nanog rescue construct could 
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Supplementary Figure 10. Locations of ChIP-PET clusters relative to genes that 
are differentially expressed after Pou5f1 (top graph) or Nanog (bottom graph) 
RNAi knockdown.
The percentages of binding sites at the respsective locations are shown. 5’ proximal 
refers to sites within the 10 kb proximal region, while 5’ distal refers to sites from 10 kb to 
































Supplementary Figure 11. Characterization of Nanog overexpressing ES cell-line 
(a) Cell lysates of ES cells overexpressing Nanog (OE) and control ES cells without the 
Nanog insert were analyzed by Western blot using anti-Nanog and anti- ßactin 
antibodies. The higher molecular weight of over-expressed Nanog was due to the 
presence of an epitope-tag. The band representing endogenous Nanog also was 
indicated. (b) Nanog over-expressing ES cells (OE) and control ES cells were grown in 
the presence of LIF (+LIF) or absence of LIF (-LIF) for 60 hours. (c) Nanog over-
expressing ES cells (OE) and control ES cells were grown in the presence 0.3 µM RA (+ 
RA) or no RA (-RA) for 48 hours.
Esrrb scrambled 1Control Esrrb scrambled 2
Rif1 scrambled 2Rif1 scrambled 1
Esrrb Scrambled 1: GAAGGCAGUUUAUUCAGUA
Esrrb siRNA 1:     GAUUCGAUGUACAUUGAGA 
Esrrb Scrambled 2: GCCCUACCUGAAAUGUUAU 
Esrrb siRNA 2:     GAUCGUCUCGAAUCUACUA 
Rif1 Scrambled 1: GAUGGACUACCAAUAAACU 
Rif1 siRNA 1:     GAACCGUAUUCAGAAUCAA 
Rif1 Scrambled 2: GGUAUGAUGUGAAACUAUA 
Rif1 siRNA 2:      GAGUACAAUAAGUGUUGAU 
a
b
Supplementary Figure 12. ES cells expressing scrambled Esrrb or Rif1 siRNA
sequences retained non-differentiated cell morphology 
(a) Morphologies of cells after transfection with constructs that expressed scrambled 
Esrrb or Rif1 siRNA sequences. (b) Scrambled sequences of Esrrb and Rif1 siRNAs. 
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21. Characterization of antibodies 
Crucial to the success of the ChIP-PET procedure is the specificity of the 
antibody. We have previously characterized the Oct4 antibody that we used for ChIP in 
this study1. The Nanog antibody recognized a distinct band of the appropriate size, as 
detected by Western blotting, in ES cell nuclear extracts and in 293T cells over-
expressing Nanog (see below). 
Western blots using ES cell nuclear extracts, whole cell lysates from 293T cell over-expressing HA 
tagged Nanog, whole cell lysates from 293T cell over-expressing Oct4 and whole cell lysates from 
293T cell over-expressing Sox2. Western blots to confirm expression of Sox2 and Oct4 in 293T 
transfected with the respective expression plasmids. 
2. Oct4 ChIP-PET library 
Approximately 80,000 randomly selected clones were sequenced, generating 10 
to 15 PETs per sequence read for a total of 1,088,836 PET sequences. These PET 
sequences were then mapped to the mouse genome to define the boundaries of the 
Oct4 ChIP DNA fragments (Figure 1). From this, 515,717 (47%) PETs were mapped to 
specific locations on the mouse genome (build mm5) and the rest of the PETs either did 
not map to the genome (469,032; 43%) or were mapped to multiple locations (109,087; 
10%) as they were derived from repetitive sequences. The 515,717 PET-mapped 
locations were grouped into 366,639 unique genomic loci, as it is highly unlikely to have 
two independently generated PETs mapping to identical locations due to the random 
nature of DNA shearing used in the ChIP protocol, the redundantly mapped PETs are 
likely a result of amplification events during the ChIP-PET cloning process. 
With the depth of sequencing performed in this study, true Oct4 binding sites 
should be distinguishable from background noise by virtue of multiple overlapping PETs 
mapping to specific locations within the genome. Of the 366,639 PETs mapping to 
unique genome locations, the majority (275,767; 75%) were represented by single non-
overlapping PETs (singletons). These singletons likely represent background noise 
rather than authentic Oct4 binding sites. The remainder of these PETs (90,872 or 
24.7%) were found to overlap with others and comprised 37,623 distinct PET clusters. 
The total number of PETs in these clusters ranged from 2 PETs for 29,451 of these 
clusters to 17 PETs represented by one cluster. Some of these clusters, particularly 
3those containing few PETs, may represent background noise from random sampling of 
genomic DNA. 
3. Nanog ChIP-PET library 
From the Nanog ChIP-PET library, 61,937 sequencing reads were generated. Of 
the 659,404 total PET sequences, 624,278 are unique PET sequences. From 
them,  318,386 PETs have unique mapping locations on mm5 genome and are 
equivalent to 265,676 unique ChIP fragments analyzed. The remaining PETs were either 
mapped to repetitive sequences or not mapped to the genome. The majority (193,059 ; 
73% ) of the distinct PET fragments existed as non-overlapping fragments (denoted as 
PET singletons). However, 72,617 (27.3%) PET fragments were found to overlap with 
each other and they were further grouped into 25,181 distinct PET clusters. To 
normalize for any variation between individual ChIP experiments, we did 10 ChIP 
experiments for each of Oct4 and Nanog, and pooled the ChIP DNA together (minimal 
total of 150 ng of DNA) prior to cloning and sequence analysis. 
4. Validation of Oct4 ChIP-PET data 
As there are eight Oct4 DNA binding sites thus far been identified in mouse ES 
cells (5 of which were previously validated by ChIP), we were next interested to 
determine the ability of the ChIP-PET method to detect these sites. Of particular interest 
is the Oct4 regulation of three key transcription factors essential to the ES cell 
phenotype, namely the Oct4 gene itself (Pou5f1), Sox2, and Nanog as previously 
characterized by us and others1-6. The ChIP-PET method did indeed reveal Oct4 binding 
to these three genes where 9 PET overlaps mapped to Pou5f1, 5 PET overlaps mapped 
to Sox2, and 4 PET overlaps mapped to Nanog. Furthermore, the PET overlap region 
mapping to each of these genes encompassed the known Oct4 binding sites as shown 
and confirmed by conventional ChIP-realtime PCR. The Oct4 ChIP with its 
corresponding PET overlaps showing the binding sites on Pou5f1 and Nanog are 
depicted in Supplementary Figure 2. Control ChIP using an antibody against yeast Ena-
1 protein showed no enrichment with the same primers (Supplementary Figure 2). In 
addition, the ChIP-PET method also identified a fourth previously known Oct4 target 
gene, that being Fbxo155, with 4 PET overlaps spanning the known Oct4 binding site 
located 530 bp 5’ to the transcription start site of this gene. 
The other 4 previously reported Oct4 binding sites were not identified by the 
ChIP-PET method, suggesting that not all Oct4-DNA interactions occurring in mouse ES 
cells are detectable and included with the stringent cutoff that we applied in this 
approach. There were no PETs, singletons or otherwise, spanning the Oct4 binding sites 
in Fgf4, Zfp42, or Spp1 and only a singleton spanning the known Oct4 site of Utf1.
Realtime PCR analysis of the Oct4 ChIP DNA showed that there was enrichment of 5, 
12 and 19 fold above background for Fgf4, Zfp42 and Utf1 respectively. However, we did 
not detect binding of Oct4 to the Spp1 site. It is possible that with deeper sequencing, 
we may uncover these sites and our method tends to identify sites with higher Oct4 
occupancy as defined by fold enrichment. Despite this, the ChIP-PET method detected 
1,083 loci with 4 PET overlaps or greater of which approximately 96% will represent 
authentic Oct4 binding sites, providing a catalogue of more than 100 times the number 
of sites previously known in mouse ES cells. It should be noted that clusters with 3 to 1 
PETs contain true positives, although the proportion of positives are substantially lower 
4than that in the higher PET clusters. Inherent to all large-scale genome wide 
experimentations, our strategy will contain a certain level of false negatives and 
positives. These limitations may arise from the masking of epitopes leading to a failure to 
capture certain protein complexes or certain problematic sequences refractory to 
cloning. 
5. Validation of Nanog ChIP-PET data 
There were two major peaks of Nanog binding over the 5’ regulatory region of 
Pou5f1 (Supplementary Figure 5a). One peak centered at conserved region 2 (CR2) 
while the second extended over the CR3 and CR4 regions. CR2 is an important 
regulatory region of Pou5f1 expression in epiblasts, and CR4 contains Oct4 and Sox2 
binding sites important for driving Pou5f1 expression in ES cells (Supplementary Figure 
5b) 1,4,7-8. A peak of Nanog binding was observed at a region 3.7 kb upstream of the first 
exon of Sox2 (Supplementary Figure 5e). This peak fell within a previously identified 
regulatory region, region D6 (Supplementary Figure 5f). Two other peaks were detected 
at 4.9 kb and 80 bp upstream of the first exon of Nanog (Supplementary Figure 5i). 
Conventional ChIP-PCR quantitation validated the ChIP-PET profile of Nanog binding to 
Pou5f1 and Sox2 (Supplementary Figure 5c, g). Control mock ChIP using anti-GST 
antibody showed only background enrichment. The HA ChIP-PCR from ES cells over-
expressing the HA-tagged Nanog mirrored that of anti-Nanog ChIP (Supplementary 
Figure 5d, h). The occupancy of Nanog at the 5’ region of Nanog was also confirmed 
(Supplementary Figure 5j). 
To exclude the possibility that the polyclonal Nanog antibody we used cross-
reacted with other proteins, we further validated the 100 loci (Supplementary Figure 4) 
by repeating the ChIP-PCR assay using an ES cell-line over-expressing hemagglutinin 
epitope (HA)-tagged Nanog. All the Nanog-bound loci identified using the Nanog 
antibody were enriched by anti-HA antibody recognizing HA-tagged Nanog, but not by 
an anti-GFP antibody. We conclude that our ChIP-PET approach can identify Nanog 
binding sites with a high degree of confidence and that the PET clusters reflect the 
binding of endogenous Nanog to its genomic targets. 
6. De novo prediction of Oct4 motif using Oct4 ChIP-PET dataset 
To attenuate the noise and ensure prominence of motifs relevant to the Oct4 
ChIP, we took the sequences from clusters containing a minimum of 7 overlaps (a total 
of 90 loci) and masked the repeat regions as annotated in the mouse genomic sequence 
from the UCSC genome browser (build mm5). Using the motif discovery algorithm 
Weeder9, the motif TTGTTATGCAAA and its variants were found to be overrepresented 
in the sequences (see below). 
Interestingly, this motif contained almost the entire conventionally accepted 
canonical Oct4-binding motif (ATGCAAAT). Furthermore, the sequences immediately 
upstream resembled the last 5 bases of the Sox2 binding site consensus (CATTGTT). 
Neighboring sox-oct elements are known to be important in driving the pluripotent 
5expression of Nanog, Pou5f1, Sox2, Fbxo15, and Utf1. The current implementation of 
the Weeder algorithm limits the motif search to a maximum of 12 bp. The apparent 
resemblance of the discovered motif to the sox-oct composite element led us to extend 
this motif two bases upstream and one base downstream of the 12 bp. Coupling that 
with an Expectation-Maximization method of refinement, we arrived at a more precise 
model of the sox-oct site (see below). 
The most prominent configuration resembled that of the known Sox2-Oct4 
binding sites. The data also showed that other variations can occur. Using this refined 
model, we calculated the frequency of it occurring across all the identified Oct4 binding 
loci (see graph below). For loci with an overlap size of 6 or greater, 69 % were found to 
contain this motif. For those of 5 or less, the frequency of this motif reduced with the 



































As we observed that the true positive rate for identifying bound sites is higher 
than the occurrence of the recognition motifs, this suggests that there are true positive 
regions not bound directly by either Nanog or Oct4. These may represent examples of 
the recruitment of transcription factors to genomic sites independent of DNA binding 
activities. 
Details for motif finding are described in the following paragraphs. The masked 
sequences were fed into the motif discovery algorithm Weeder9, setting MM (Mus 
musculus) as the background genome, searching both strands, allowing multiple motif 
occurrences in each sequence, and running the most thorough search (i.e. analysis type 
= “extra”). As the Weeder algorithm only allows for a maximal motif length of 12 bp, we 
extended the motif two basepairs upstream and one nucleotide downstream to obtain 
one that resembles a full Sox2-Oct4 site. We extracted the good quality sites (i.e. 90% 
similarity to the main discovered motif), as determined in the Weeder output, while at the 
same time extending several basepairs out from each arm of the main discovered motif. 
From these sequences, a Position Weight Matrix (PWM) M was built to model the joint 
6Sox2-Oct4 binding sites (shown below). This PWM was used to predict the label of a 
sequence. If a given sequence contained a site scored at least T under PWM M, the 
sequence was labeled as positive (i.e. contained Sox2-Oct4 binding sites), otherwise it 
was labeled as negative. 
Weight Matrix for Oct4-Weeder 
 Nucleotide Frequency 
Position A C G T 
1 18 44 2 44 
2 58 1 3 46 
3 0 2 4 102 
4 12 0 3 93 
5 12 30 58 8 
6 33 2 3 70 
7 32 30 10 36 
8 96 0 4 8 
9 3 1 0 104 
10 1 0 96 11 
11 4 69 9 26 
12 86 2 0 20 
13 77 3 21 7 
14 98 4 6 0 
15 17 16 10 65 
Next, we further refined the Sox2-Oct4 motif using a refinement strategy akin to 
the Expectation-Maximization optimization procedure10. A collection of 1000 random 
promoter sequences and 1000 random coding sequences with an average length of 
about 1800bp was used as a background set (sequence set B1). A positive set 
(sequence set P1) containing the PET6+ overlap sequences (including 10bp flanking 
sequences) was constructed. The following steps were done iteratively: 
1. Use the background set B1 to calculate the appropriate PWM scoring cutoff T
such that the false discovery rate is at most 1e-3. 
2. Scan the positive set P1 for occurrences of the Sox2-Oct4 motifs using the 
current PWM M and the cutoff score T.
3. Calculate the statistical significance (p-value) p of motif overrepresentation in the 
set P1 against B1, in terms of predicted sites per nucleotides, using the current 
PWM M and cutoff score T.
4. Construct a new PWM M’ using the discovered sites. 
5. Calculate threshold T’ for M’ using background set B1 such that the false 
discovery rate is at most 1e-3. (similar to step 1) 
6. Compute the p-value, p’, of set P1 being enriched, in terms of predicted sites per 
nucleotides, for sites scoring better than T’ under the matrix M’.
7. If p’ is smaller than p than use M’ as M for the next iteration and go back to step 
1, else output M as the final matrix. 
Two other sets were created to test whether the refined matrix identified 
overrepresented sites in Oct4 ChIP PET sequences. PET5 clusters sequences were 
used as the positive set P2 (which did not intersect with P1), while for the 
background/negative set B2, another 1000 random promoters and 1000 random coding 
sequences (non-overlapping to sequence set B1) were extracted. Varying the cutoff 
7score T produced different sensitivity and specificity. We compared the performance of 
the seed matrix and the refined matrix by stratifying the threshold T and plotting the 
Receiver Operating Characteristic (ROC) curves, as shown below. The refined matrix 
well outperformed the original seed matrix. 
In addition, we also used the NestedMICA (NMICA) algorithm to derive at a 
similar motif that Weeder predicted (the search parameter was fixed as 15 bp). The 
weight matrix for Oct4 is shown below: 
Weight Matrix for Oct4-NMICA 
 Nucleotide Frequency 
Position A C G T 
1 67 1 2 30 
2 2 2 0 96 
3 1 10 0 89 
4 0 31 67 2 
5 34 4 1 61 
6 4 44 35 17 
7 60 2 3 35 
8 0 0 2 98 
9 2 0 75 23 
10 15 70 7 8 
11 46 4 0 50 
12 75 3 22 1 
13 80 1 15 4 
14 30 3 7 60 
15 17 27 38 18 
Motif discovery programs like MEME and Weeder utilize a consensus based 
algorithm that enumerates all the oligos up to a maximum length and collects their 
occurrences from the input sequences. Initially it will find the strongest motif in a set, 
scan for all its instances, next masking these out, and finally re-running the process on 
the remaining sequences. The motifs found by such methods are usually refined (or 
clustered) by expectation-maximization. This strategy is greedy ("Greedy algorithm" is 
the name for a class of algorithms) and it is unclear whether its behavior will be optimal. 
8The other issue is that the binding sites found by Weeder tend to be strongly local in 
nature, i.e. the optimization concentrates on regions of the probability landscape close to 
their starting point. In other words, these programs are good in finding over-represented 
and strong motif binding sites but they are not proficient in locating sparse transcription 
factor binding sites. 
On the other hand, NMICA overcomes those issues by utilizing a different 
framework known as independent component analysis to learn models for multiple 
motifs simultaneously. By using an alternative Bayesian inference strategy known as 
nested sampling (which samples an ensemble of states compared to traditional Markov 
Chain Monte Carlo methods) which is likely to find a globally optimal model in a single 
run. As the Expectation-Maximization optimization procedure was meant to increase the 
specificity of the motif by presenting more instances for model building, this additional 
step is not required for NMICA as it will find all the strong and sparse motif instances at 
one go. Hence we did not subject the motif discovered by NIMCA to Expectation-
Maximization refinement. 
7. Co-occupancies of transcription factors (sequential ChIP) 
The de novo prediction of a Sox2-Oct4 motif prompted us to investigate whether 
Oct4 and Sox2 indeed bound to the same genomic locus in ES cells rather than each 
binding individually to different populations in different cells. To address this possibility, 
we performed sequential ChIP analysis (Supplementary Figure 6). The sequential ChIP 
experiments for all the 6 loci we selected for analysis (Pou5f1, Sox2, Nanog, Trp53,
Tcf3, and Nmyc1) detected further enrichment (Supplementary Figure 6). A non-specific 
antibody (Ena-1) used as a control in the second round of ChIP did not show any further 
enrichment of these targets. We concluded that Oct4 and Sox2 are bound together to 
the same genomic locus in vivo for these 6 target genes. 
Details of how sequential ChIP was performed are as follows: antibodies were 
crosslinked to protein G sepharose beads using DMP to prevent the leaching of antibody 
during SDS elution. The beads were then incubated with chromatin extracts overnight. 
Subsequently, the beads were washed and eluted with 1% SDS elution buffer at 37°C
for 45 minutes. The eluate was diluted to a final SDS concentration of 0.1% and 
incubated with fresh antibody-bound beads for the second IP. For the final round of IP, 
washed beads were eluted with 1% SDS elution buffer at 68°C for 30 minutes. Eluate 
was decrosslinked in the presence of pronase and heated at 68°C for 6 hours and DNA 
was purified by phenol:chloroform extraction. Cross-linked chromatin extracts were first 
immunoprecipitated with either the Oct4 or Sox2 antibody. Recovered material from this 
first ChIP was then subjected to a second ChIP using the other antibody. Significant 
enrichment after the second ChIP was indicative of Oct4 and Sox2 co-occupancy. 
Despite the reduced fold enrichment from the first ChIP, resulting from cross-linking of 
the antibody to the protein G-sepharose by dimethyl pimelimidate (DMP), binding was 
still detectable after this first round with both the Oct4 and the Sox2 antibodies. 
As we detected a peak of Nanog and Oct4 binding at the CR4 region of Pou5f1,
we also investigated whether Nanog and Oct4 co-bind together at this region or in a 
mutually exclusive manner. Chromatin extracts were first immunoprecipitated using the 
anti-Oct4 antibody. The eluants were then subjected to a second ChIP using an anti-
Nanog antibody or a control antibody. Further enrichment after the second ChIP 
9indicated Nanog and Oct4 co-occupancy (see diagram below). A non-specific antibody 
used as a control in the second round of ChIP did not show any further enrichment of the 
Pou5f1 sequence. The reciprocal immunoprecipitation experiment in which the order of 
antibodies was swapped showed the same result. We conclude that Oct4 and Nanog co-
occupied the Pou5f1 upstream region. 
A plot to summarize the binding sites of Oct4 (blue block), Nanog (red block) and Sox2 (green 
block) at the Pou5f1 gene. Exons are depicted as grey boxes. The arrow represents the direction 
and body of the Pou5f1 gene, extending from first exon to last exon based on UCSD mouse 
genome coordinates. CR2 refers to conserved region 2. CR4 contains a Sox2-Oct4 motif1.
Sequential ChIP of Oct4 and Nanog. ChIP was performed using Oct4 (bars 1 to 3) or Nanog (bars 
4 to 6) antibody. A second round of ChIP was performed using either specific (bars 2 and 5) or 
control (bars 3 and 6) antibody. Fold enrichment represents the abundance of enriched DNA 
fragments over a control region not enriched for the respective targets. O: Oct4 ChIP, C: control 
Ena-1 ChIP, N: Nanog ChIP, ON: Oct4 ChIP followed by Nanog ChIP, OC: Oct4 ChIP followed by 
control Ena-1 ChIP, NO: Nanog ChIP followed by Oct4 ChIP, NC: Nanog ChIP followed by control 
Ena-1 ChIP. 
8. De novo prediction of Nanog motif 
The NestedMICA (NMICA) algorithm was used to identify a motif for Nanog. We 
ran a complete set of PET8+ mouse sequences for Nanog clusters, with the default 
options, requesting motifs up to 12 bp. A four-class mosaic background model, learned 
from a large set of mouse upstream regions (each of the 1000 bps), was chosen for the 
motif search. It has been shown in that a four-class mosaic background model is ideal 
for motif finding on mammalian genome sequence11. The mouse upstream regions are 
taken from the build 33 assembly of the mouse genome (mm5, May 2004) in UCSC 
Genome data downloads from the Mouse Genome Sequencing Consortium. The set of 
motifs learned are visualized as a position weight matrix (shown below), which treats 
each position in the motif independently and records a probability distribution that can be 
observed at that position. The PWMs are visualized as a pictogram (or in “logo” 
representation) where each position is represented by a stack of letters whose height is 
proportional to the information content of that position. 
Weight Matrix for Nanog 
 Nucleotide Frequency 
Position A C G T 
1 20 15 55 10 
2 21 12 61 6 
3 24 1 74 1 
4 34 36 29 1 
5 8 62 0 29 
10
6 1 98 1 0 
7 98 1 0 1 
8 3 0 3 94 
9 0 1 0 99 
10 16 2 33 49 
11 20 62 10 8 
12 0 100 0 0 
Plotting the frequency of this Nanog motif occurring across the different PET 
clusters showed that this motif is enriched in the higher PET clusters compared to 
random or PET1 sequences (see the graph below). Although we presented a motif 
enriched over genomic background in the Nanog ChIP-PET dataset, it is possible that 
there exist other variants of this motif or Nanog could bind to different sequences. 
Further refinement on the way we perform de novo prediction should uncover other 
potential Nanog recognition sites or co-occurring motifs. Using the PWM based on the 
de novo motif output by NMICA, we scanned the whole mouse genome with a cut-off 

































Using the de novo motif discovered with our ChIP-PET dataset, we found that 
there are 241,487 putative Nanog sites in the mouse genome. Hence, there are more 
Nanog recognition sites than actual Nanog-bound sites in living ES cells and only 1% of 
these recognition sites are bound by Nanog. Like many homeobox transcription factors, 
Nanog may partner with co-factors to achieve additional levels of specificity. Binding of 
transcription factor to selective binding sites has also been observed in the yeast 
genome13.
9. Binding of Nanog to CATT-containing sequences 
Given the prominence of the CATT nucleotides within the de novo predicted 
Nanog motif, we searched the peak region in the CR2 region of Pou5f1 for a similar 
sequence. Interestingly, a 35 bp DNA fragment containing this sequence was able to 
bind to recombinant Nanog (Supplementary Figure 7a). The Pou5f1 CR2/Nanog 
complex was specific as it could be supershifted by an anti-Nanog antibody but not by 
an anti-Oct4 antibody. Furthermore, the addition of an excess of specific unlabelled 
probe competed out this complex, while a non-specific probe had no effect. To establish 
the importance of the CATT residues, we mutated these sites within the CR2 probe 
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(Supplementary Figure 7b, c, highlighted in yellow). A gross mutation (mut1) that 
destroyed these 6 basepairs completely abolished Nanog binding, while mutation at 
another region (mut2) did not reduce binding. We further used a series of double 
basepair mutations (mut 3 to mut 10) to disrupt the CATT sequence. Except for mut 10 
in which only the last C was mutated to G, the other mutations abolished binding 
completely (mut 3 to 9). Taken together, we conclude that the binding of Nanog to DNA 
required the entire core sequence CATT. In addition, we searched the peak regions 
revealed by our Nanog ChIP-PET data for similar sequences containing CATT motifs 
(Supplementary Figure 7d, e). All the sequences identified were also found to 
specifically bind to Nanog in vitro. These complexes could be supershifted by the anti-
Nanog antibody and competed out by their corresponding specific unlabelled probes 
(data not shown). The 12th residue of the Nanog motif is C (Figure 4b), however, it’s 
significance is not clear as probes without this cytosine could still be bound by Nanog in
vitro (Supplementary Fig. 7d,e). Based on the mutagenesis experiment, we can only 
conclude that the CATT residues are critical for Nanog / DNA interaction (Supplementary 
Fig. 7b,c). Hence, it is likely that only a subset of the CATT-containing motifs is 
discovered by NMICA algorithm. 
10. Mouse and human binding sites comparison 
10.1 Target list comparison (Oct4) 
We started from the list of 720 genes next to the OCT4 bound human promoter 
regions14 (Boyer et al. 2005, Table S1). Using the KnownGene, RefSeq, MGCGenes, 
VegaGenes and EnsemblGenes tracks from the UCSC browser15, we recovered the 
genomic coordinates of these genes on the human build hg17. Using the tool liftOver, 
also from the UCSC browser, with a minimum ratio of remap bases of 10%, we 
successfully converted 690 (96%) of these gene segments into orthologous gene 
segments on the mouse genome (build mm5). Next, we looked for the presence of at 
least one ChIP-Pet binding cluster in the neighborhood (inside or within 20Kb) of these 
human-defined gene segments on the mouse genome. Using these criteria we found 
that 75 human-defined gene segments had an adjacent mouse-binding site. 
To account for the fact that many of the binding sites identified in the current 
study are more than 20Kb away from their target, we also directly compared the list of 
Mouse targets to the list of Human targets using the Homologene database 
(www.ncbi.nlm.nih.gov). For Oct4, 653 of the 965 mouse targets (68%) and 603 of the 
718 human targets (84%) where found in this database but only 56 were identified as 
being homologous. Of these, only 13 were not already part of the list of 75 common 
targets (see above). This leads to a total list of 88 common targets of Oct4 identified in 
both Mouse and Human (see Supplementary Table 7). 
10.2 Target list comparison (Nanog) 
Using the same approach as for Oct4, we started from the list of 1950 genes next 
to the NANOG bound human promoter regions14 (Boyer et al. 2005, Table S4). We 
successfully converted 1879 (96%) of these human gene segments into orthologous 
gene segments on the mouse genome (build mm5). We found that 282 human-defined 
gene segments had an adjacent mouse-binding site (within 20Kb). For Nanog, 1581 of 
the 2544 Mouse targets (62%) and 1602 of the 1950 Human targets (82%) could be 
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found in the Homologene database but only 189 were identified as being homologous. 
Of these, only 50 were not already part of the list of 282 common targets (see above). 
This leads to a total list of 332 common targets of Nanog identified in both Mouse and 
Human (see Supplementary Table 7). 
11. Microarray analysis of differentiation profiles: correlation with Oct4 or 
Nanog loci 
To further investigate the association between Oct4 and/or Nanog binding loci 
with gene expression, we utilized microarray data from an independent study aimed at 
identifying genes involved in ES differentiation induced by three different chemical 
treatments. To induce differentiation of E14 mouse ES cells (cultured under feeder free 
conditions), the cells were grown in mouse ES medium with 15% FBS in the absence of 
LIF and with either 0.1M retinoic acid (RA), 1% dimethyl sulfoxide (DMSO) or 3mM 
hexa-methylene-bis-acetamide (HMBA). Total RNAs were extracted from differentiation-
induced E14 culture using the TRIzol (Life Technology, Cat# 15620016) protocol and 
cleaned up with Qiagen RNeasy Purification Kit (Qiagen; Cat# 75144). 
These arrays contain probes designed by Compugen (MOULIB96T probe 
version). For each treatment, molecular profiles of the treated cells were contrasted to 
that of the untreated cells using two-channel microarrays across three time points. To 
attenuate dye bias, a reciprocal dye-swap labeling was done for each array hybridized. 
In total, 18 microarrays data were available for our use. Prior to any downstream 
analysis, the expression data was log transformed and median-center normalized. In this 
analysis, dye-swap labeling was treated as replicate, treatment and time factors were 
ignored. 
All 21,106 probes on the microarray were mapped to the mouse genes (based on 
Known Genes and Reference Sequence genes from UCSC mm5 annotation database) 
by aligning the probe sequences to the mouse genome (UCSC mm5) using BLAT and 
taking the best alignment in terms of the number of mismatches and the number of gaps. 
The best alignment loci were then used to query the mouse genes annotations and 
assign a gene to each probe. A probe is said to be associated with Oct4 and/or Nanog
binding regions if there is at least one Oct4 and/or Nanog PET4+ clusters within 50kbp 
upstream or downstream of the assigned gene. Probes with more than 25% missing 
values were excluded from the analysis. The remaining 16,223 probes were then ranked 
based on the absolute of average log expression ratio across 18 arrays, sorting them 
based on the consistency and level of expression ratio after differentiation (see 
Supplementary Table 4). A sliding window plot (window size is 2,000) was used to 
display the enrichment of transcription factor bound genes. 
To assess the significance of association between the ranking and the presence 
of associated Oct4 and/or Nanog bindings, we employed the GSEA16 using the absolute-
mean ranking and the probes associated with Oct4/Nanog PET4+ clusters as the 
positive sets. Under the null hypothesis that the probes associated with binding regions 
are not correlated to the ranking of the probes, GSEA framework calculates an 
enrichment score (ES) which indicates the association of a probe set with a ranked list of 
probes, with higher ES denoting that the probe set is concentrated among the top 
ranked probes of the list. To compute the nominal p-value, a one million iteration of 
Monte Carlo simulation, permuting the ranked list and computing the ES for each 
permutated set was carried. The fraction of time randomly generated ranked list 
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produced an ES score at least as good as the observed ES was reported as the p-value. 
Our experiments showed that high ranking of the genes were positively correlated with 
Oct4 PET4+ clusters (p<1e-6) and Nanog PET4+ clusters (p<1e-6), strongly suggesting 
that presence of Oct4 or Nanog bindings are related with differentiation genes. 
12. Microarray analysis of gene expression profiles after knockdown of 
Oct4 and Nanog 
12.1 Knockdown of Pou5f1 
 The construct for Pou5f1 RNAi has previously been reported1. To demonstrate 
the specificity of the siRNA construct, we performed rescue experiments by co-
transfecting of Pou5f1 RNAi construct with a construct expressing Pou5f1 ORF with 
mutations that destroy the target site of Pou5f1 siRNA sequence. This construct 
prevented ES cells from differentiating in the presence of Pou5f1 siRNA (Supplementary 
Figure 8). Gene-specific oligonucleotides for RNAi were designed according Reynolds et 
al. (2004)17 and Ui-Tei et al. (2004)18.  The 19-nucleotide hairpin-type shRNAs with a 9- 
nucleotide loop were cloned into pSUPER.puro (Bgl II and Hind III sites, Oligoengine). 
The oligonucleotides used for GFP RNAi are 5’ -  
GATCCCCGAACGGCATCAAGGTGAACTTCAAGAGAGTTCACCTTGATGCCGTTCTT
TTTA - 3’ and 5’-
AGCTTAAAAAGAACGGCATCAAGGTGAACTCTCTTGAAGTTCACCTTGATGCCGTTC
GGG - 3’. 
12.2 Knockdown of Nanog 
The level of Nanog was depleted by transfecting ES cells with a plasmid 
expressing Nanog siRNA. In order to reduce the possibility of off target interference, the 
Nanog siRNA sequence was selected to have minimal complementarity to other known 
cDNAs. The oligonucleotides used for Nanog RNAi 5’ -
GATCCCCGAACTATTCTTGCTTACAATTCAAGAGATTGTAAGCAAGAATAGTTCTTTT
TA- 3’ and 5’-
AGCTTAAAAAGAACTATTCTTGCTTACAATCTCTTGAATTGTAAGCAAGAATAGTTCG
GG- 3’. To determine the effectiveness and specificity of our Nanog siRNA, we first 
assayed for knockdown in a heterologous system. A construct expressing Nanog open 
reading frame (ORF) was co-transfected with vectors expressing either siRNA against 
Nanog, Pou5f1, Sox2 or GFP into 293T cells. Cell lysates were harvested and the levels 
of Nanog protein were analyzed by Western blotting. Only Nanog siRNA could reduce 
Nanog protein levels (Supplementary Figure 9a) and Nanog siRNA did not reduce the 
level of co-expressed Sox2 or Oct4 (Supplementary Figure 9b, c). These experiments 
showed that the Nanog siRNA was specific towards Nanog without affecting the other 
two important regulators Pou5f1 and Sox2. ES cells transfected with the construct 
expressing Nanog siRNA and selected with puromycin followed by Western blotting 
showed that the level of Nanog was greatly reduced at both RNA and protein levels 
(Supplementary Figure 9d, e). At the same time, ES cell morphology was lost 
(Supplementary Figure 9f) while alkaline phosphatase staining was drastically reduced 
in Nanog knockdown cells. Finally, we were able to rescue the Nanog knockdown 
phenotype by co-transfecting a construct expressing an RNAi-immune Nanog
(Supplementary Figure 9g, h). In addition, the Pou5f1 transcript was restored as 
detected by realtime PCR and the induction of differentiation associated genes such as 
GATA6 and Nrp2, was inhibited in the rescued cells (Supplementary Figure 9i, j, k). 
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Hence, we established that our siRNA construct could effectively and specifically deplete 
Nanog in ES cells. 
12.3 Microarray analyses 
Feeder free mouse ES cells were transfected with constructs expressing Pou5f1
or Nanog siRNA as described1. Parental plasmid was used for control experiment. Total 
RNAs were extracted directly from the cells using the TRIzol (Life Technology, Cat# 
15620016) protocol and cleaned up with Qiagen RNeasy Purification Kit (Qiagen; Cat# 
75144). We used Affymetrix Mouse Genome 430 2.0 Array arrays to profile the 
transcriptome of the control and knockdown cells. For the Pou5f1 knockdown 
experiment, we had four replicates. For the control and Nanog knockdown experiments, 
we had five replicates for each. The probes for hybridization were prepared by 
GeneChip One-Cycle Target Labeling kit (Affymetrix). The microarray data files are 
deposited at GEO database. RMA (Robust Multichip Averaging) method was employed 
to normalize the array data19. After the normalization we used Significance Analysis of 
Microarray (SAM) statistics to select differentially expressed genes from the two 
groups20. SAM (http://www-stat.stanford.edu/~tibs/SAM) uses permutations of the 
repeated measurements to estimate the percentage of genes identified by chance. The 
selected genes have a median FDR (false discovery rate) of less than 0.001. For each 
probe, we obtained the genomic location of the respective genes. Oct4 or Nanog binding 
sites were then mapped to within 50 kb of the differentially expressed genes (i.e. 50 kb 
upstream and downstream of each gene). The data for Figures 6a,b and c can be found 
in Supplementary Tables 5 and 6 respectively. 
13. Characterization of Nanog overexpression ES cell-line 
To over-express Nanog, we used a vector with a CAG promoter driving an HA 
epitope-tagged Nanog and generated stable clones. Nanog ORF plus 3 X Hemagglutinin 
tag (HA) were inserted into pCAGIpuro. This construct was then transfected into clone 
47. The positive clone was selected with puromycin (1ug/ml) and neomycin (350ug/ml) 
for 5 days. The expression of Nanog was detected with Western blotting using both anti-
Nanog (Cosmo Bio, REC-RCAB0002P-F) and anti-HA antibody (sc-7392, Santa Cruz). 
Western blotting showed that the level of the exogenous Nanog was approximately 8 
fold higher than endogenous Nanog (Supplementary Figure 11a). More importantly, this 
cell-line was more resistant to differentiation upon LIF withdrawal or retinoic acid (RA) 
treatment (Supplementary Figure 11b, c). These results confirmed the findings from 
previous studies21.
14. Knockdown of Esrrb, Rif1 and REST in mouse ES cells 
19-bp gene-specific regions for RNA interference were designed based on 
Reynolds et al.17 and Ui-Tei et al.18. Oligonucleotides were cloned into pSUPER.puro 
(Bgl II and Hind III sites, Oligoengine), which expresses 19-nucleotide hairpin-type 
shRNAs with a 9-nucleotide loop, as described previously22. All sequences were 
analyzed by BLAST search to ensure that they did not have significant sequence 
similarity with other genes. Transfection of ES cells for the knockdown experiment was 
done as described previously1.
The sequences of the Esrrb, Rif1 and REST targeted for RNAi were as follows: 
Esrrb RNAi 1: GATTCGATGTACATTGAGA 
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Esrrb RNAi 2: GATCGTCTCGAATCTACTA 
Esrrb RNAi 3: GAGGACTGTACTAGTGGTA 
Esrrb Scrambled 1: GAAGGCAGTTTATTCAGTA
Esrrb Scrambled 2: GCCCTACCTGAAATGTTAT 
Rif1 RNAi 1: GAACCGTATTCAGAATCAA 
Rif1 RNAi 2: GAGTACAATAAGTGTTGAT 
Rif1 RNAi 3: GAAGATCTCTACAGTTACA 
Rif1 Scrambled 1: GATGGACTACCAATAAACT 
Rif1 Scrambled 2: GGTATGATGTGAAACTATA 
REST RNAi: GTGTAATCTACAATACCAT 
The scrambled sequence contains randomized sequence but retains the same 
percentage of A or T as the original sequence. Constructs expressing these sequences 
were used as controls and they did not cause knockdown or induce ES cell 
differentiation (Figure 7b, c ,d and Supplementary Figure 12). 
15. Supplementary discussion 
Among the Oct4 and Nanog bound targets, it is of interest to highlight how some of the 
target genes provide new insights into ES cell biology: 
a) Oct4 as a repressor of the trophoblast lineage 
A particularly noteworthy Oct4 binding site identified in this study was located within an 
intron of Cdx2, which encodes for a caudal-type homeodomain transcription factor 
required for the specification of the TE fate23. Substantial genetic evidence has shown 
an inverse relationship between the expression of Cdx2 and Oct424. We provide the 
direct biochemical evidence linking Oct4 to the repression of Cdx2 expression in ES 
cells. Oct4 binding to other genes also support its role as a suppressor of the trophoblast 
lineage. For instance, we found an Oct4 binding site located 88 kb proximal to Eomes.
Eomes is another transcription factor essential for proper TE development25. In addition, 
Cldn4, which is expressed in trophoblastic stem cells and in the blastocyst but not in ES 
cells (based on ESTs), was also identified as an Oct4 target. As a claudin this gene 
product is a major player in tight junction function and therefore implicated in TE 
epithelial integrity. Thus our data provides biochemical evidence which suggests that 
Oct4 is acting as a repressor of the trophoblast lineage and can explain in biochemical 
terms, particularly through the repression of Cdx2, the phenotype of the Oct4 null 
blastocysts and Pou5f1 depleted ES cells. 
b) Nanog and signaling pathways 
It is striking, for instance, that Nanog-associated genes are involved in regulating 
signaling pathways such as Wnt and TGF . Dkk1, Fzd2, Fzd5, Fzd8, Wnt3, Wnt8a,
Catnal1, Gsk3b, Tle1, Tle3, Tle4, Tcf3, Tcf4 and Lef1 are components of the Wnt-
signaling pathways. Our knockdown analysis showed that Nanog positively regulates 
Tcf3 and Lef1 while suppressing the expression of Dkk1. In addition, mediators of the 
TGF  pathways such as Smads, Tgfb2, Tgif, Tgif2 are also represented in the list of 
Nanog bound genes. Additionally, it is noted that Nanog positively regulates BMP4,
another member of the TGF  superfamily of genes. BMP4 has recently been shown to 
induce the expression of Inhibitor of differentiation (Id)26 and BMP4 with LIF is sufficient 
to sustain ES self renewal in serum-free media. We suggest that one explanation for 
how over-expression of Nanog inhibits induction of differentiation is through its control of 
the TGF  network including activation of the BMP4 autocrine pathway. Our data shows 
that Nanog also binds to a disproportionately high number of genes related to neural 
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function and neurogenesis. These targets include Ngfb, Ntn1, NCam1, Nedd4l, Nedd4,
Nrg4, Nrxn1, Nrxn3, Nf1, Nef1, Nsg2, Negr1, Nrp2, Ntf3. To a large extent, the transcript 
database revealed that in ES cells, these genes were either expressed at low levels or 
not at all compared to neurospheres. The implication of this observation is that Nanog 
generally appears to be suppressing genes needed for specific tissue differentiation and 
function. One question raised is why it should be necessary at this early stage to 
suppress these genes. 
c) DNA damage response pathway upregulated by transcription factors in ES cells 
 Unlike somatic cells, the genetic information of the epiblast is passed on to the 
next generation through its development into the germ cell lineage. Kehler et al. (2004) 
also found that the loss of Oct4 function led to apoptosis in primordial germ cells27.
Hence a mechanism for monitoring and maintaining genetic integrity is likely to be 
important. Here we showed that the transcription of Trp53 is positively regulated by 
Oct4. p53 has recently been implicated in playing a role in maintaining genetic stability in 
ES cells by eliminating DNA-damaged cells from the replicating ES cell pool28. It appears 
therefore that ES specific transcription factors such as Oct4 and Sox2 can exert a 
protective role for the ES cell genome by specifically upregulating p53 to high levels in 
order to maintain a heightened level of vigilance against genomic insults. In addition, we 
also identified Trp53bp1 and Rif1 as novel Oct4 targets. p53BP1 is a p53 binding protein 
and functions as a key transducer of the DNA damage checkpoint signal and monitoring 
of dysfunctional telomeres29,30. Rif1 is also localized to dysfunctional telomeres and sites 
of double-strand breaks in mammalian cells31,32. Interestingly, the cellular localization of 
Rif1 is dependent on p53BP1, further highlighting the functional association between
Rif1 and p53BP1. Hence, the specific upregulation of a related class of genes, Trp53,
Trp53BP1 and Rif1 by Oct4 constitute a DNA damage response pathway in ES cells, 
such as one required for the maintenance of proper telomere functions and DNA repair. 
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Embryonic stem (ES) cell pluripotency is dependent upon sustained expression of the key transcriptional regulators Oct4,
Nanog, and Sox2. Dissection of the regulatory networks downstream of these transcription factors has provided critical
insight into the molecular mechanisms that regulate ES cell pluripotency and early differentiation. Here we describe a role
for Zic3, a member of the Gli family of zinc ﬁnger transcription factors, in the maintenance of pluripotency in ES cells.
We show that Zic3 is expressed in ES cells and that this expression is repressed upon differentiation. The expression of
Zic3 in pluripotent ES cells is also directly regulated by Oct4, Sox2, and Nanog. Targeted repression of Zic3 in human and
mouse ES cells by RNA interference–induced expression of several markers of the endodermal lineage. Notably, the
expression of Nanog, a key pluripotency regulator and repressor of extraembryonic endoderm speciﬁcation in ES cells,
was signiﬁcantly reduced in Zic3 knockdown cells. This suggests that Zic3 may prevent endodermal marker expression
through Nanog-regulated pathways. Thus our results extend the ES cell transcriptional network beyond Oct4, Nanog, and
Sox2, and further establish that Zic3 plays an important role in the maintenance of pluripotency by preventing endoder-
mal lineage speciﬁcation in embryonic stem cells.
INTRODUCTION
The transcription factors Oct4, Nanog, and Sox2 are key
regulatory players in embryonic stem (ES) cell biology.
These core factors contribute to the hallmark characteristics
of ES cells by 1) activation of target genes that encode
pluripotency and self-renewal mechanisms and 2) repres-
sion of signaling pathways that promote differentiation
(Orkin, 2005). In ES cells Oct4, Nanog, and Sox2 co-occupy
promoters of hundreds of genes that are both expressed and
repressed in the pluripotent state (Boyer et al., 2005; Loh et
al., 2006). This suggests complex regulatory circuitry in
which Oct4, Nanog, and Sox2 collectively and uniquely
regulate downstream genes to control ES cell differentiation.
However, it remains unclear what are the downstream ef-
fectors of these transcription factors that contribute to main-
taining the pluripotent status of ES cells. It also not under-
stood how these “master regulators” of pluripotency are
involved in controlling lineage-speciﬁc differentiation of ES
cells. It is therefore useful to elucidate the transcriptional
networks surrounding Oct4, Nanog, and Sox2, where de-
tailed knowledge of these pathways remain key to harness-
ing the potential to direct differentiation of ES cells into
therapeutically useful cell types.
To expand our understanding of the transcriptional net-
works that control stem cell differentiation, we have looked
at transcription factors whose expression is directly regu-
lated by Oct4, Nanog, and Sox2. We have identiﬁed Zic3
(Zinc ﬁnger protein of the cerebellum 3) as a transcription
factor of interest for two main reasons. First, Oct4, Nanog,
and Sox2 binding have been mapped to the Zic3 promoter
regions in ES cells (Boyer et al., 2005; Loh et al., 2006),
implying that these key factors may regulate Zic3 expres-
sion. The overlap between mouse and human ES cells
further highlights the signiﬁcance of Zic3 and suggests
possible conservation of the gene’s pathways between the
two species. Second, Zic3 demonstrates differential gene
expression between the pluripotent and early differentia-
tion phases, where its expression is higher in the pluripo-
tent state (Brandenberger et al., 2004; Wei et al., 2005). The
changes in gene expression between these states suggest a
potential role for Zic3 in controlling differentiation of mouse
and human ES cells.
Zic3 belongs to the GLI superfamily of transcription fac-
tors and is a vertebrate homologue of the Drosophila pair-
rule gene odd-paired (opa; Aruga et al., 1996a). The ﬁve
known mammalian Zic genes (Zic1-5) encode ﬁve tandem
C2H2 zinc ﬁnger domains that are highly conserved across
species (Herman and El-Hodiri, 2002; Grinberg and Millen,
2005). Although the expression of Zic3 is restricted to the
cerebellum of adult mammals, dynamic patterns of expres-
sion have been observed during embryonic development in
mouse (Herman and El-Hodiri, 2002), Xenopus (Nakata et al.,
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1997, 1998), chick (Warner et al., 2003), and zebraﬁsh (Grinblat
and Sive, 2001). The expression of Zic3 in the embryonic
ectoderm and mesoderm during gastrulation (Kitaguchi et
al., 2002; Elms et al., 2004), and throughout the tailbud, retina
and limb bud during neurulation and organogenesis (Herman
and El-Hodiri, 2002; Orkin, 2005), suggests an important role
for this transcription factor in embryonic ectoderm and me-
soderm development. This is further supported by molecu-
lar pathways in which Zic3 has been implicated. For exam-
ple the mesoderm-associated gene Brachyury induces Zic3
expression in Xenopus (Kitaguchi et al., 2002), and the em-
bryonic patterning gene Nodal is regulated by Zic3 during
gastrulation through interaction with an upstream enhancer
region in mouse and Xenopus embryos (Ware et al., 2006a). In
ectodermal development, Zic3 is a potent inducer of Xenopus
proneural and neural crest genes (Nakata et al., 1997) and is
induced directly downstream of transcription factors Pbx1b
and Meis1 in the Xenopus ectoderm (Maeda et al., 2002; Kelly
et al., 2006).
Zic3 mutations are associated with X-linked heterotaxy, a
disorder characterized by disruptions in embryonic lateral-
ity and midline developmental ﬁeld defect (Gebbia et al.,
1997). In Zic3 mutant organisms situs ambiguus is frequently
observed, encompassing failure in lateralization of internal
organs, mirror-image inversions, and left-right isomerism
(Aylsworth, 2001). Several mutations have been identiﬁed in
humans that render the Zic3 protein unstable and absent in
cells or incapable of nuclear localization where its transcrip-
tional effect is exerted (Gebbia et al., 1997; Ware et al., 2004).
Consistent with its expression in the involuting mesoderm
and presumptive neural plate during gastrulation, Zic3 is
involved in regulating left–right asymmetry and neural tube
development. Zic3-null mice exhibit a wide spectrum of
phenotypes. Fifty percent of null mice succumb to embry-
onic lethality over different gestational stages, and 30% to
perinatal lethality as a result of congenital heart defects,
pulmonary isomerism, and defects in the CNS (Purandare et
al., 2002). The earliest and most profound Zic3-null defects
have been attributed to failure in establishment of the ante-
rior-posterior axis by the anterior visceral endoderm (AVE)
before gastrulation (Ware et al., 2006b). In less severely af-
fected embryos, abnormalities are observed at gastrulation
in the distribution and accumulation of excess mesoderm
tissue. Taken together, the defects in embryonic lethal mice
demonstrate a key role for Zic3 in early embryonic pattern-
ing that encompasses anterior visceral endoderm formation,
initiation of gastrulation, and primitive streak morphogen-
esis (Ware et al., 2006b).
The varying degrees of severity in failure to complete
gastrulation displayed by Zic3 null mice may perhaps be
attributed to compensatory mechanisms in developing em-
bryos, as indicated by the distinct and partially overlapping
expression patterns exhibited by members of the Zic gene
family (Nagai et al., 1997; Elms et al., 2004). It is important to
note that Zic3 shares overall 64 and 59% homology with Zic1
and Zic2, respectively, and this homology increases to 91%
within the zinc ﬁnger domain. Thus members of Zic family
are strong candidates for redundancy in molecular signaling
owing to the high degree of homology and overlapping
expression observed among the members of this family.
Although Zic3 expression has been implicated in embry-
onic development, still lacking is a detailed understanding
of what regulates Zic3 expression and what the downstream
effectors of Zic3 are. The Zic3 gene has been identiﬁed as a
target of Oct4, Nanog, and Sox2 in ES cells (Boyer et al., 2005;
Loh et al., 2006), and Zic3 is preferentially expressed in
pluripotent state (Brandenberger et al., 2004; Wei et al., 2005).
Questions arising from these data are as follows: 1) How do
Oct4, Nanog, and Sox2 interact with the Zic3 regulatory
region, and what results from this interaction and, 2) what
Table 1. List of marker genes used to assess lineage development in ES cells
Gene symbol Description Lineage
Sox17 SRY-box containing gene 17 Endoderm
PDGFRA Platelet-derived growth factor receptor, alpha Endoderm
Gata4 GATA binding protein 4 Endoderm
Gata6 GATA binding protein 6 Endoderm
Foxa2 Forkhead box A2 Endoderm
GSC Goosecoid Mesendoderm
Nodal Nodal Mesendoderm
MixL1 Mix1 homeobox-like 1 Mesendoderm
Hand1 Heart and neural crest derivatives expressed 1 Mesoderm
Nkx2.5 NK2 transcription factor related, locus 5 Mesoderm
Gata2 GATA binding protein 2 Mesoderm
Nestin Nestin Ectoderm
GFAP Glial ﬁbrillary acidic protein Ectoderm
Pax6 Paired box gene 6 Ectoderm
TDGF1 Teratocarcinoma-derived growth factor/Cripto Ectoderm
Sox1 SRY-box containing gene 1 Ectoderm
REST RE1-silencing transcription factor Ectoderm
CoREST REST Co-repressor 1 Ectoderm
FGF5 Fibroblast growth factor 5 Ectoderm
BMP4 Bone morphogenetic protein 4 Trophectoderm
CDX2 Caudal type homeobox 2 Trophectoderm
DKK3 Dickkopf homolog 3 Wnt pathway
Gsk3beta Glycogen synthase kinase 3 beta Wnt pathway
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role does Zic3 play in the embryonic stem cell? We have
addressed these questions using the loss-of-function ap-
proach for Zic3 and the key regulatory genes in ES cells. In
this study, we examined the function of Zic3 as a regulatory
target of Oct4, Nanog, and Sox2 in ES cells. We report that
Zic3 shares signiﬁcant overlap with the Oct4, Nanog, and
Sox2 transcriptional networks and is important in maintain-
ing ES cell pluripotency by preventing differentiation of cells
into endodermal lineages. Thus our results extend the cur-
rent knowledge of the ES cell transcriptional circuitry be-
yond Oct4, Nanog, and Sox2.
MATERIALS AND METHODS
ES Cell Maintenance
Feeder-free E14 Mouse ES cells were maintained on 0.1% gelatin-coated
dishes in E14 proliferative medium containing DMEM/15% ES FBS (Invitro-
gen, Carlsbad, CA), 0.1 mM MEM nonessential amino acids (Invitrogen), 2
mM l-glutamine (Invitrogen), 0.1 mM -mercaptoethanol (Invitrogen), and
Chinese hamster ovary-Leukaemia Inhibitory Factor (CHO-LIF) (1000 U/ml).
Feeder-free undifferentiated HuES9 human ES cells were maintained on
matrigel-coated dishes in conditioned medium containing knockout DMEM/
10% serum replacement (Invitrogen), 0.1 mM MEM nonessential amino acids
(Invitrogen), 1 mM l-glutamine (Invitrogen), 0.1 mM -mercaptoethanol (In-
vitrogen), 8% plasmanate (National University Hospital Pharmacy, Singapore),
12 ng/ml LIF, and 10 ng/ml human recombinant basic ﬁbroblast growth factor
(bFGF; Invitrogen). Conditioned medium was obtained by culturing mouse
embryonic ﬁbroblast (MEF) cells with HuES9 media. The medium was collected
at 24 h intervals, ﬁlter sterilized, and further supplemented with 8 ng/ml bFGF
for HuES9 cell culture.
RNA Interference and Establishment of Clonal
Knockdown Lines
Small Interfering RNA (siRNA) Experiments. RNA interference (RNAi) experi-
ments were performed with Dharmacon siGENOME SMARTpool reagents
(Boulder, CO) against human or mouse Zic3. The Dharmacon siCONTROL
nontargeting siRNA pool was used as a negative control. Mouse ES cells were
transfected according to manufacturer’s instructions in 12-well plates at a
density of 2  105 cells per well. Retransfections were performed on pre-
adherent cells at 48-h intervals, and RNA expression analysis was performed
on samples from day 5. Human ES cells were transfected in 12-well plates
with 2  105 cells, in suspension, per well. Subsequent retransfections were
performed on adherent cells at 24-h intervals and RNA was harvested for
analysis at day 5.
Short Hairpin RNA (shRNA) Experiments. The Oct4 and Nanog RNAi exper-
iments were previously published (Loh et al., 2006). The Zic3 shRNA con-
struct was designed as described (Chew et al., 2005) with a target sequence of
5-GAATTCGAAGGCTGTGACA-3. E14 cells in six-well plates were trans-
fected with 2.0 g pSUPERpuro vector or Zic3-pSUPER.puro (OligoEngine,
Seattle, WA) at a density of 4  105 cells per well. Puromycin selection was
introduced 1 d after transfection at 1.0 g/ml and was maintained for 3 d before
RNA isolation. ES cells were maintained in proliferative medium at all times.
Clonal Zic3 knockdown lines were established by transfection of shRNA
constructs as described above. The Zic3 knockdown and vector control colonies
were picked after 7 d of puromycin selection (1.0 g/ml). Colonies were disso-
ciated into single-cell suspensions by treatment with 0.05% Trypsin (Invitrogen)
and plated on puromycin-resistant mitomycin-inactivated DR4 MEFs (ATCC,
Manassas, VA). In total, 15 Zic3 clonal knockdown and 7 vector control lines
were established and maintained under constant puromycin selection. The lines
analyzed in this article were maintained feeder-free in ES cell proliferative media
on 0.1% gelatin-coated dishes over a period of eight passages.
Secondary ES Colony-replating Assay
ES cells were transfected with Zic3- or empty pSUPER shRNA constructs and
selected 24 h later with puromycin at 1.0 g/ml over 4 d. At the end of 4 d few
cells remained in the untransfected control wells indicating that selection was
effective. The surviving cells were trypsinized and resuspended in E14 medium
without LIF. Ten thousand or 20,000 cells were plated onto mouse feeder layers
in six-well plates for secondary ES cell-colony formation. After 7 d, emerging
colonies were stained with the Wright-Giemsa (Sigma, St. Louis, MO) stain. The
extent of differentiated colonies was deﬁned as the percentage of unstained
colonies out of the total number of colonies in the well.
RNAi Rescue Experiments
The Zic3 open reading frame (ORF; NM_009575) was cloned from reverse-
transcribed cDNA from mouse embryonic stem cells, using the primers
indicated in Supplementary Table 1A. The PCR product was subsequently
cloned into a vector driven by the CAG promoter. The RNAi-immune Zic3
ORF R3M (Supplementary Figure 1) was generated from this template using
site-speciﬁc mutagenesis. To perform the rescue experiments, 4  105 mouse
ES cells were seeded per well in six-well plates and transfected according to
the scheme in Supplementary Table 1B. Hygromycin selection (1.0 g/ml)
was introduced 1 d after transfection.
RNA Extraction, cDNA Synthesis, and Quantitative
Real-Time PCR
To minimize genomic DNA contamination, RNA was extracted with TriZol
reagent (Invitrogen) and further puriﬁed with the RNeasy minikit (Qiagen,
Chatsworth, CA). cDNA was synthesized with 1.0 g total RNA using the
High Capacity cDNA Archive kit (Applied Biosystems, Foster City, CA). For
each qPCR reaction, cDNA samples diluted 10 times in water were mixed
with 5.0 l TaqMan Universal PCR Master Mix reagent (Applied Biosystems)
and 0.5 l of a single TaqMan probe from the following list: Zic3, Oct4,
Nanog, Sox2, or the lineage markers in Table 1 (20 TaqMan Gene Expression
Figure 1. A proﬁle of Zic3 expression in differentiating E14 cells.
(A) Real-time PCR analysis of differentiation induced by retinoic
acid. Samples were assayed at 2-d intervals (untreated control, and
treated samples day 2, day 4, and day 6). Mean levels 
 SE are
expressed as percentages relative to undifferentiated E14 cells
(100%). The assays were conducted in duplicate and normalized to
-actin control. (B) Veriﬁcation of Zic3 protein expression during
the process of RA differentiation. (C) A summary of ChIP mapping
of Oct4, Nanog, and Sox2 binding sites on the Zic3 regulatory
regions in mouse ES cells (Loh et al., 2006; Sox2, Ng, unpublished
data) and human ES cells (Boyer et al., 2005). We examined tran-
scription factor binding sites within 100 kb up- and downstream of
the Zic3 coding region. In human ES cells, Oct4, Nanog, and Sox2
binding sites were located within 3.5 kb upstream of the Zic3
transcription start site, whereas in mouse ES cells, the Nanog bind-
ing site was found within 18.5 kb upstream, and the Oct4 and Sox2
binding sites were within 9.5 kb downstream of the gene, respec-
tively (Loh et al., 2006). Each unit on the scale represents 10 kb.
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Assay reagents; Applied Biosystems) with a ﬁnal volume of 10 l. Quantita-
tive real-time PCR analysis was conducted in 384-well clear optical reaction
plate (Applied Biosystems) on the ABI Prism 7900 machine (Columbia, MD).
Western Blots and Immunocytochemistry
Zic3 protein detection was performed with goat-anti-Zic3 antibody (1:800
dilution; C-12, Santa Cruz Biotechnology, Santa Cruz, CA) and donkey anti-
goat horseradish peroxidase (HRP; 1:5000; Santa Cruz Biotechnology). Load-
ing consistency was determined with mouse anti--actin (1:3000; Invitrogen)
and goat anti-mouse HRP (1:5000; Santa Cruz Biotechnology). For immuno-
cytochemistry, cells were seeded at a density of 1.0  105 cells per well on
ﬁbronectin-coated chamber slides, ﬁxed in 4% paraformaldehyde, and per-
meabilized with 0.3% Triton X-100. Blocking was performed with 5% fetal
bovine serum and 1% bovine serum albumin in PBS solution for 30 min. Cells
were stained with the following primary antibodies (1:100): goat or mouse
anti-Oct4 (Santa Cruz Biotechnology, N-19 and C-10, respectively), rabbit-
anti-Nanog (Chemicon, Temecula, CA; AB5731), goat anti-FoxA2 (M-20,
Santa Cruz Biotechnology), goat-anti-Gata6 (C-20, Santa Cruz Biotechnology),
or mouse anti-CD140a (PDGFRA; eBioscience, San Diego, CA; 16-1401). This
was followed by the appropriate secondary antibodies detecting mouse or
goat IgG Alexa Fluor 488 (Molecular Probes, Eugene, OR; 1:500) for Oct4
staining, rabbit IgG Alexa Fluor 594 (Molecular Probes; 1:500) for Nanog
staining, or Qdot 655 anti-goat or anti-mouse antibodies (Molecular Probes)
for FoxA2, Gata6, and PDGFRA staining (1:150) according to the manufac-
turer’s protocol. Images were captured with the Zeiss LSM 5 Duo inverted
confocal microscope (Zeiss, Thornwood, NY).
Luciferase Reporter Construct and Assays
The 300-base pair Zic3 enhancer region containing the Nanog-binding site
was cloned from mouse genomic DNA. The primers used were as follows:
forward, 5 ATATAacgcgtTTAGAGGTCAAACCAT-3 and reverse, 5-
TATATagatctTAGTAGTCAAACTGGATT-3 with restriction sites indicated
in lower case letters. The PCR fragment was digested with MluI and BglII and
cloned into the pGL3-Basic vector (Promega, Madison, WI) containing a basal
promoter comprising the 500-bp region immediately upstream of the mouse
Oct4 gene. The following constructs were transfected into cells 2.5  104 cells
in 96-well plates for the luciferase assay: 100 ng ﬁreﬂy luciferase reporter, 1.0
ng of the Renilla luciferase vector, pRL-SV40 plasmid normalization control,
and 250 ng of the respective knock-down construct. Puromycin selection (1.0
g/ml) was introduced 20 h after transfection and cultured for 2 d. Luciferase
activity measured using the Dual Luciferase System (Promega) in a Centro
LB960 96-well luminometer (Berthold Technologies, Natick, MA).
RESULTS
Zic3 Expression Is Associated with ES Cell Pluripotency
Comprehensive expression proﬁling of mouse and human
ES cells has identiﬁed numerous genes that are expressed in
undifferentiated cells and quickly repressed upon differen-
tiation (Brandenberger et al., 2004; Wei et al., 2005). Among
these genes are transcription factors Oct4, Nanog, and Sox2,
which are required to maintain pluripotency of ES cells.
Zic3, a zinc-ﬁnger transcription factor, was also found to be
expressed in undifferentiated ES and suppressed in differ-
entiated cells, and thus, may play a role in regulating ES cell
differentiation. We assayed the expression of Zic3 in mouse
ES cells induced to differentiate over 6 d by addition of
retinoic acid (RA; Figure 1A). Similar to the trends observed
for Oct4, Nanog, and Sox2 genes, Zic3 transcript levels de-
creased between 1.5- and 10-fold for each 2-d interval (D2,
D4, and D6), relative to the undifferentiated control. Zic3
Figure 2. Oct4, Sox2, and Nanog regulate Zic3 expres-
sion. (A) Changes in endogenous gene expression levels
of Oct4, Nanog, and Sox2 after gene-speciﬁc RNAi and
(B) corresponding changes in endogenous Zic3 gene
levels. cDNAs were prepared from the RNAi knock-
down ES cells and analyzed using real-time PCR. The
levels of the transcripts were normalized against values
derived from control RNAi-transfected ES cells (100%).
(C) Changes in ES cell endogenous Zic3 gene level after
Nanog overexpression with RA induced differentiation.
Nanog overexpression cell line and control cell line
were treated with no RA or 0.3 M RA for 2 d. Tran-
script levels of 0.3 M RA-treated sample were normal-
ized against no RA treatment sample. (D) Diagram of
the construct with putative Zic3 enhancer region fused
upstream of a minimal Pou5f1 promoter and ﬁreﬂy
luciferase gene. (E) The effects of luciferase activity in
deletion of the putative Nanog binding site on Zic3
enhancer were tested by transfecting into ES cells. Ac-
tivity were measured relative to the minimal promoter
only (MP) construct without the Nanog enhancer. (F)
Effects of Nanog RNAi on Zic3 enhancer activity were
tested by cotransfecting the Nanog RNAi with the re-
porter construct into ES cells and luciferase activity
measured. Activity were normalized against the Con-
trol RNAi with mOct4 promoter-only construct. An
RNAi targeting the GFP sequence was used as a non-
speciﬁc control.
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RNA levels were also signiﬁcantly decreased in mouse ES
cells differentiated by treatment with HMBA (hexamethyl-
ene bisacetamide) or dimethyl sulfoxide, and also by aggre-
gation into embryoid bodies (data not shown). The decrease
in Zic3 mRNA correlated with a comparable decrease in
protein expression (Figure 1B). Thus, Zic3 gene expression is
associated with the mouse ES pluripotent state and its ex-
pression decreases as cells differentiate.
Chromatin immunoprecipitation experiments in both
mouse and human ES cells have identiﬁed binding sites for
the transcription factors Oct4, Nanog, and Sox2 at the Zic3
gene locus (Figure 1C; Boyer et al., 2005; Loh et al., 2006). The
binding of these transcription factors, which are demon-
strated regulators of pluripotency, suggests that Zic3 is a
direct target for regulation by these TFs and may play a role
in regulating ES cell differentiation.
Regulation of Zic3 by Oct4, Sox2, and Nanog
To further validate that Oct4, Sox2, and Nanog regulate Zic3
expression, we performed gene expression knockdown ex-
periments in mouse ES cells using RNA interference. Mouse
ES cells were thrice transfected with gene-speciﬁc siRNAs
against Oct4, Sox2, and Nanog on alternate days to achieve
80–90% reduction in expression of the targeted gene (Figure
2A). Down-regulation of Oct4 and Sox2 reduced the level of
endogenous Zic3 to 25%, whereas Nanog RNAi reduced
the level of Zic3 to 70% (Figure 2B). These data indicate that
Zic3 expression is regulated by Oct4, Sox2, and Nanog.
It has been shown that Nanog-overexpressing ES cells are
resistant to differentiation induced by LIF withdrawal and
RA addition (Chambers and Smith, 2004). As the endoge-
nous levels of Zic3 decreased in the presence of RA-induced
differentiation (Figure 1), we were interested in determining
if Nanog overexpression would sustain Zic3 levels under
RA treatment. ES cells were stably transfected with a con-
struct that expresses Nanog from a constitutively active
promoter. The Nanog-expressing cells and cells transfected
with empty vector were treated for 2 d with 0.3 M RA.
Vector-only control cells showed a decrease in Zic3 RNA
levels typical of RA-induced differentiation. In contrast,
mouse ES cells overexpressing Nanog sustained the level of
Zic3 at greater than 80%, relative to the control ES cell line
(Figure 2C). Thus, overexpression and knockdown of Nanog
in ES cells results in an increase and decrease, respectively,
of Zic3, suggesting that Zic3 expression is regulated by
Nanog, perhaps directly or indirectly.
Our previous study identiﬁed a Nanog binding site in the
enhancer region, 16.4 kb upstream of the transcription start
site, of the Zic3 gene (Loh et al., 2006). As this DNA region
was available for further study in our lab, we sought to
determine if Zic3 expression was directly regulated by
Nanog. We fused the 292-base pair portion of the Zic3
enhancer that contains the Nanog-binding site upstream of a
minimal Pou5f1 promoter driving the ﬁreﬂy luciferase gene
(Figure 2D). The minimal promoter was weakly active in ES
cells, whereas activity of the Zic3 enhancer region linked to
the minimal promoter was ninefold up-regulated as quan-
tiﬁed by luciferase (Figure 2E). When the sequences of this
putative Nanog binding site were deleted from the Zic3
enhancer the corresponding reporter activity decreased (Fig-
ure 2E). We then transfected Nanog RNAi together with the
wild-type reporter construct and showed that the activity of
the Zic3 enhancer decreased fourfold relative to the controls
(Figure 2F). Collectively, our data show that Zic3 expression
is directly regulated by Nanog and thus, may be a down-
stream effector in controlling ES cell differentiation.
Effect of Zic3 Depletion on ES Cell Differentiation
To investigate the role of Zic3 in ES cells, we used RNAi to
achieve knockdown of gene expression. Both the siRNA and
shRNA methods resulted in a 70% reduction of Zic3 tran-
script levels relative to the nontargeting controls (Figure
3A). Zic3 protein levels reﬂect this decrease in gene expres-
sion after Zic3 RNAi treatment, whereas protein expression
remained high in vector-only–treated cells (Figure 3B).
Zic3 RNAi transfections resulted in a marked decrease in
pluripotent colonies that stained for alkaline phosphatase
(AP) relative to the mock RNAi control (Figures 3, C and D).
The extent of differentiation was quantiﬁed with secondary
replating assays that revealed a three- to ﬁvefold increase in
differentiated colonies in comparison with the nontargeting
control (Figure 3E). To assess the differentiation state of Zic3
Figure 3. Effect of Zic3 RNAi on endogenous Oct4, Nanog, and
Sox2 levels. (A) Zic3 levels were depleted by RNAi using siRNA
and shRNA in mouse E14 cells and siRNA in human HuES9 cells.
RNA was harvested between 4 and 5 d of transfection and transcript
levels assayed by real-time PCR. Shown in this ﬁgure are the levels
of Zic3 transcript and the corresponding changes in Oct4, Nanog,
and Sox2 expression. Mean values 
 SE are plotted as percentages
relative to the nontargeting control (100%). The samples were as-
sayed in duplicate and normalized to endogenous -actin. (B) Cor-
responding decrease in protein levels after Zic3 RNAi treatment.
The Zic3 protein species was depleted in the Zic3 RNAi sample,
whereas -actin protein levels remained high in the control. -actin
protein was used as a loading control. (C and D) Alkaline phospha-
tase staining revealed that the extent of differentiation in Zic3 RNAi-
treated cells was greater than mock-transfected cells. (E) Secondary
replating assays were used to quantitate the extent of differentiation
in Zic3 RNAi cells. A 3- to 5-fold increase in differentiated colonies
were observed with Zic3 RNAi relative to mock-transfected control.
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knockdown cells, we assayed for changes in expression of
key pluripotency genes (Figure 3A). Though the mouse ES
cells showed clear morphological changes (Figure 3, C and
D), surprisingly, there were only modest decreases (15–25%)
in the expression of the key pluripotency genes Oct4 and
Sox2 (Figure 3A), whereas Nanog expression decreased 40%
relative to the nontargeting control. We performed the same
experiment with human ES cells (HuES9). Although there
was 70% decrease in Zic3 transcript levels, Oct4 and Sox2
transcript levels remained unchanged and Nanog levels de-
creased by 25% (Figure 3A). These results indicate that Zic3
plays a role in maintaining ES cell pluripotency and its
action is downstream of the dominant pluripotency factors
Oct4, Sox2, and Nanog.
It is interesting that targeted repression of Zic3 induced
morphological differentiation of ES cells while maintaining
the expression of pluripotency marker genes in the transient
knockdown experiments. We were interested in assessing
the role of Zic3 in the maintenance of pluripotency. To
determine the differentiation status of these cells we assayed
by Q-RT-PCR for expression of markers that represent lin-
eage-speciﬁc ES cell differentiation (Table 1). Zic3 knock-
down in mouse and human ES cells resulted in an up-
regulation of a panel of endodermal markers: Sox17 (3.5-fold),
PDGFRA (3.2- to 5.5-fold in mouse ES cells; 2.7-fold in
human ES cells), and Gata6 (2.5- to 3.5-fold; Figure 4). In
addition, two more endodermal lineage genes Gata4 and
Foxa2 were up-regulated in the E14 RNAi cells (2.5-fold).
We also assayed the expression of mesendodermal, meso-
dermal, ectodermal, trophectodermal and Wnt-pathway
markers in Zic3 RNAi cells. These markers remained un-
changed relative to the nontargeting control in both mouse
and human RNAi experiments (Figure 4). These results in-
dicate that Zic3 could play a speciﬁc role in maintaining ES
cell pluripotency by suppressing endodermal speciﬁcation.
Rescue of RNAi-induced Zic3 Phenotype
Our RNAi experiments have established a link between the
expression of Zic3 and suppression of endodermal lineage
speciﬁcation. We observed consistent results using multiple
siRNAs and shRNAs in both mouse and human ES cells.
However, there is still concern that ES cell differentiation
and marker gene expression were due to off-target effects of
the RNAi. To address this concern we designed a Zic3
expression construct that was immune to RNAi and tested
whether this construct could rescue the knockdown pheno-
types.
The Zic3 RNAi-immune expression construct was engi-
neered with ﬁve silent mutations in protein coding domain
sequence (Supplementary Figure 1). As such, this construct
(mutZic3) produces functional Zic3 protein, but with the
added feature that it is resistant to RNAi targeting and
Figure 4. Effect of Zic3 RNAi on lineage marker
gene expression. The panel of genes above was se-
lected for their lineage speciﬁcity. Transcript levels
of genes from the endodermal (ENDO), mesend-
odermal (MESENDO), mesdodermal (MESO), ecto-
dermal (ECTO), trophectordermal (TROPH), and
Wnt pathways in mouse and human ES cells were
assayed by real-time PCR after Zic3 depletion by
RNAi. (A) siRNA in mouse E14 cells. (B) shRNA in
mouse E14 cells. (C) siRNA in human HuES9 cells.
Mean levels 
 SE are expressed as percentages rel-
ative to the nontargeting control (100%). The assays
were read in duplicate and results were normalized
to -actin.
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degradation. Using this mutZic3 construct, we determined
the speciﬁcity of the endodermal lineage speciﬁcation pro-
duced by Zic3 knockdown. First, the expression levels of
endodermal markers Foxa2, Gata4, and Sox17 were induced
in ES cells cotransfected with empty vector and Zic3-RNAi,
compared with cells cotransfeceted with empty vector and
GFP-RNAi (6.5-, 10.1-, and 8.7-fold, for Foxa2, Gata4, and
Sox17, respectively, Figure 5, A–C). However, ES cells that
express the mutZic3 (RNAi immune construct) showed no
induction of endodermal markers by Zic3-RNAi. (Figure 5,
A–C). These experiments indicate that our RNAi results are
not due to off-target effects and further support our conclu-
sions that Zic3 plays a role in maintaining the pluripotency
of ES cells.
Effects of Simultaneous Reduction of Zic2 and Zic3
Expression
Zic2 is another member of the Zic-family of transcription
factors. Zic2 is expressed in ES cells and its expression is
down-regulated upon differentiation (Brandenberger et al.,
2004; Wei et al., 2005). Zic2 may also be regulated by Oct4,
Sox2, and Nanog as binding sites for these TFs have been
mapped to the Zic2 gene by chromatin immunoprecipitation
(ChIP; Supplementary Figure 2). It was interesting that Zic3
RNAi resulted in a twofold increase in Zic2 (Figure 6A), and
this raised the possibility that Zic2 may be compensating for
the reduction in Zic3 levels. Knockdown of Zic2 expression
by siRNA (75% reduction in RNA levels) did not produce
any effect on lineage marker expression (Figure 6B). To
determine if Zic2 compensated for the absence of Zic3, we
performed a double RNAi experiment with Zic2 and Zic3 in
ES cells. The double knockdown prevented Zic2 levels from
increasing in a compensatory manner as observed in the
Zic3 single knockdown (Figure 6C). Interestingly, endoder-
mal speciﬁcation was markedly enhanced after the Zic2 and
Zic3 double knockdown as demonstrated by increased ex-
pression of Sox17 (4.7-fold), PDGFRA (8.7-fold), and Gata4
(3.1-fold), which is more robust than observed for all three
markers (Sox17, 3.1-fold; PDGFRA, 3.3-fold; Gata4, 1.5-fold)
when Zic3 alone was reduced (Figure 6D). Thus, we dem-
onstrate that in the absence of Zic3, Zic2 is able to compen-
sate at least partially to reduce the extent of endodermal
speciﬁcation in ES cells.
Zic3 Clonal Knockdown Lines Show Enhanced
Endodermal Speciﬁcation
To determine if endodermal markers were up-regulated in
the same cells in which Zic3 was depleted, three clonal lines
were generated that stably expressed Zic3 shRNA. As antic-
ipated, Zic3 expression in the clonal lines was down-regu-
lated 60% relative to vector-only control lines (Figure 7A).
This knockdown is slightly less robust than in the transient
Zic3 knockdowns where depletion of Zic3 expression by
70–80% was observed (Figure 3A). The pluripotency genes
Oct4 and Sox2 were reduced between 20 and 30% relative to
controls in all three clonal knockdown lines, whereas Nanog
was reduced by 80% (Figure 7A). The endodermal genes
PDGFRA, Gata4, Gata6, and Sox7 were 30-fold higher than
in the controls, whereas Sox17 was up-regulated between
60- to 80-fold and FoxA2 was increased by 80- to 120-fold in
all three Zic3 knockdown lines (Figure 7B). The induction of
endodermal markers here was substantially greater than
observed in the transient Zic3 knockdowns. Markers of the
mesendoderm, mesoderm, ectoderm, trophectoderm, and
Wnt pathways remained essentially unchanged (2-fold) in
the Zic3 knockdown lines (Figure 7C). Thus the speciﬁc
up-regulation of endodermal gene expression in the clonal
lines is consistent, in fact more pronounced, with our obser-
vations in the transient knockdowns (Figure 4).
To ascertain if there were corresponding increases in
endodermal protein levels, immunocytochemistry was per-
formed against FoxA2, Gata6, and PDGFRA in the clonal
lines. The Zic3 knockdown lines consistently demonstrated
robust endodermal marker staining (Figure 8A) that was
absent in the vector control lines (Supplementary Figure 3).
Oct4 staining was also observed in the cells that were pos-
itive for endodermal marker expression (Figure 8A). Inter-
estingly, although the Zic3 clonal knockdown lines ex-
pressed Oct4 and SSEA-1 (Figure 8B), Nanog protein
expression was signiﬁcantly reduced relative to the vector
control lines (Figure 8C). This agreed with the down-regu-
lation observed in Nanog gene expression levels in the Zic3
knockdown lines (Figure 7A) and raises the possibility that
Nanog gene expression is regulated by Zic3.
DISCUSSION
The work presented here demonstrates that Zic3 plays a key
regulatory role in controlling ES cell differentiation. In this
article, we have demonstrated that the expression pattern of
Zic3 in ES cells corresponds closely with that of known
regulators of pluripotency Oct4, Nanog, Sox2, which have
high levels of expression in the undifferentiated state and
decrease rapidly upon differentiation (Figure 1). Our ﬁnd-
ings in mouse ES cells are consistent with results from
human ES cells (Brandenberger et al., 2004). The differences
we observed in Zic3 expression levels between pluripotent
and early differentiation phases imply a potentially signiﬁ-
cant role for Zic3 in ES cell pluripotency. In addition, ChIP
mapping by us and others has revealed Oct4, Nanog, and
Figure 5. Zic3-immune construct speciﬁcally
reverses changes in lineage marker expression
levels caused by Zic3 RNAi. (A–C) Zic3 rescue
experiments demonstrating the speciﬁcity of
Zic3 RNAi and reversibility of lineage marker
expression. E14 cells cotransfected with the Zic3
RNAi-immune overexpression construct and
Zic3 RNAi vector demonstrated notable sup-
pression of endodermal markers Foxa2, Gata4,
and Sox17, relative to Zic3 RNAi cotransfected
with the empty vector control. Zic3 immune
real-time PCR analysis was conducted 3 d after
transfection. -Actin was used as an internal
control for normalization. The measurements
were done in duplicates and the average of the normalized ratio of target gene/-actin was calculated and presented with SD. Relative expressions
calculated with respect to the control experiment (Vector  control RNAi) at 100%. Transfection schemes are represented in Supplementary Table 1b.
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Sox2 co-occupancy on the Zic3 regulatory region, suggesting
that Zic3 may be coordinately regulated by Oct4, Nanog,
and Sox2 in mouse and human ES cells (Boyer et al., 2005;
Loh et al., 2006; Figure 1C). These observations together led
to our hypothesis that Zic3 functions to maintain the pluri-
potent state of ES cells. Here we characterized the relation-
ship of Zic3 with that of the key stem cell regulatory factors
and uncovered a role for Zic3 in the maintenance of ES cell
pluripotency.
Our ﬁrst objective was to assess the nature of interactions
between Oct4, Nanog, and Sox2 with the Zic3 regulatory
region. In constructing the transcriptional network around
the key pluripotency genes, it is important to establish the
outcome of transcription factor binding on downstream
genes. We addressed this using a combinatorial approach
encompassing the results of ChIP mapping and RNAi, dem-
onstrating that ablation of Oct4, Nanog, and Sox2 in mouse
ES cells resulted in a signiﬁcant decrease in Zic3 expression
(Figure 3A). Because Zic3 has already been implicated as a
target of Oct4, Nanog, and Sox2 in ChIP experiments (Boyer
et al., 2005; Loh et al., 2006), the concern of nondirect or
secondary effects of RNAi was signiﬁcantly reduced (Blais
and Dynlacht, 2005). We thus concluded that the interaction
of Oct4, Nanog, and Sox2 with the regulatory region of the
Zic3 gene serves to enhance target gene expression. In other
words, the key pluripotency regulators function as tran-
scriptional activators of Zic3 in ES cells (Figure 9). This point
is underscored by our results with Nanog overexpression
and binding site mutagenesis assays, which demonstrate a
positive association between Nanog binding and Zic3 ex-
pression. We thus demonstrate positive functional interac-
tions between the key pluripotency regulators and the Zic3
gene regulatory region.
Because transcriptional networks are also known to fea-
ture autoregulatory loops (Lee et al., 2002; Blais and
Dynlacht, 2005), we also asked if the inverse relationship
was true, that is, whether Zic3 regulates expression of the
key regulatory genes. We observed that Oct4 and Sox2 levels
remained largely unperturbed by the ablation of Zic3 ex-
pression (Figures 3A and 7A). In the absence of clear
changes despite a robust Zic3 knockdown, our data places
Zic3 downstream of Oct4 and Sox2 in the ES cell transcrip-
tional networks as illustrated in Figure 9. In addition, we
found that Nanog expression decreased signiﬁcantly in the
Zic3 clonal knockdown lines (Figures 7A and 8C). It remains
to be determined whether Zic3 directly regulates the expres-
sion of Nanog in embryonic stem cells.
ES cells are derived from the inner cell mass of the blas-
tocyst and, as such, are able to undergo unlimited self-
renewal and differentiation into the three germ layers of the
Figure 6. Effect of Zic2 and Zic3 double knockdown.
The genes were assayed by real-time PCR in triplicate
and normalized to a -actin control. Mean levels 
 SE
are expressed as percentages relative to the nontarget-
ing control. (A) Zic2 gene expression increased twofold
with Zic3 transient knockdown 4 d after transfection. (B)
Zic2 knockdown by siRNA was speciﬁc but did not
produce changes in lineage markers assayed. (C) Zic2
and Zic3 coknockdown produced speciﬁc knockdown
of Zic3 and at the same time prevented compensatory
increase of Zic2 expression in ES cells. (D) The expres-
sion of endodermal lineage markers Sox17, PDGFRA,
and Gata4 showed a similar pattern of up-regulation as
in the Zic3 single knockdown, but was signiﬁcantly
enhanced in this Zic2/Zic3 coknockdown.
Zic3 Maintains ES Cell Pluripotency
Vol. 18, April 2007 1355
embryo: mesoderm, ectoderm, and endoderm (Evans and
Kaufman, 1981; Martin, 1981). In the pluripotent state, ES
cells remain undifferentiated and do not express speciﬁc
lineage markers. We were interested in examining the effect
of Zic3 knockdown on the maintenance of ES pluripotency
using speciﬁc lineage markers as an assessment of differen-
tiation after Zic3 knockdown (Table 1). Here we show that
ablation of Zic3 expression in both mouse and human ES
cells resulted in a signiﬁcant increase in markers of endoder-
mal lineage (Figures 4, 7, and 8). These results suggest that
Zic3 may have an important role in preventing endodermal
speciﬁcation in ES cells.
Many reports support this observation: First, Zic3 knock-
down in ES cells induced expression of Gata4 and Gata6, and
forced expression of Gata4 and Gata 6 in ES cells result in
differentiation toward extraembryonic endoderm (Fujikura et
al., 2002). Further strengthening this association is the fact that
all other endodermal markers assayed (PDGFRA, Sox17, and
FoxA2) are also expressed in extraembryonic endoderm deriv-
atives (Kunath et al., 2005). Second, Zic3 regulates Nodal ex-
pression through direct interaction with its promoter during
gastrulation, and it has been shown that Nodal expression is
essential in proper speciﬁcation of the embryonic visceral
endoderm (Mesnard et al., 2006). This signiﬁcance is under-
scored by studies reporting that the earliest abnormalities ob-
served in Zic3 null mice are defects in proper patterning of the
anterior visceral endoderm (Ware et al., 2006b). Finally, Zic3
clonal knockdown lines exhibit a signiﬁcant decrease in Nanog
gene expression (Figures 7A and 8C), and several groups have
reported that RNAi-mediated depletion of Nanog expression
resulted in an induction of extraembryonic endoderm markers
Gata4 and Gata6 (Mitsui et al., 2003; Hyslop et al., 2005; Hough
et al., 2006).
Here we have shown that Zic3 functions as a gatekeeper
of pluripotency in ES cells by preventing their differentiation
into cells that express endodermal markers. Corroborating
this, we have found that Nanog expression is signiﬁcantly
reduced in the Zic3 clonal lines. This reduction is notewor-
thy as Nanog is a key regulator of pluripotency in ES cells
(Chambers et al., 2003), and it is well established that dis-
ruption of Nanog expression results in development of ex-
traembryonic endoderm character in ES cells (Mitsui et al.,
2003; Hyslop et al., 2005; Hough et al., 2006). Thus, we
demonstrate here an important role for Zic3 in the mainte-
nance of pluripotency in ES cells through prevention of
endodermal lineage speciﬁcation, and we suggest that its
action may in part be mediated through the key pluripo-
tency regulator Nanog (Figure 9).
The role of Zic3 in preventing endodermal speciﬁcation is
further supported by evidence indicating its restricted ex-
pression within the mesoderm and ectoderm lineages dur-
ing gastrulation (Herman and El-Hodiri, 2002). In addition,
Zic3 activity has been speciﬁcally implicated in the meso-
dermal and ectodermal molecular pathways in the early
developing embryo (Nakata et al., 1997; Kitaguchi et al., 2002;
Maeda et al., 2002; Kelly et al., 2006). These data in combi-
nation with our results suggest that although Zic3 is instruc-
tive for mesodermal and ectodermal speciﬁcation in embry-
onic development, it may simultaneously function as a
repressor of ectopic endodermal induction in these tissues.
Figure 7. Zic3 knockdown clonal lines dem-
onstrate endodermal gene marker speciﬁca-
tion. Three Zic3 knockdown clonal lines and
two vector controls were assayed as indicated
in the diagrams. (A) The pluripotency markers
Oct4 and Sox2 were slightly down-regulated
between 20 and 30%, whereas Zic3 and Nanog
decreased signiﬁcantly between 60 and 80%
relative to the vector controls. (B) All endoder-
mal markers assayed in the knockdown lines
were signiﬁcantly up-regulated between 20-
and 120-fold relative to the control lines. (C)
Mesendodermal, mesodermal, ectodermal,
trophectodermal, and Wnt pathway genes did
not change signiﬁcantly in knockdown lines,
demonstrating 2-fold changes relative to the
vector controls. Gene expression levels were
assayed by real-time PCR. The samples were
assayed in triplicate and normalized to endog-
enous -actin. Mean values 
 SE are plotted
as percentages relative to the vector control.
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The transcription factor Zic3 shares ﬁve highly conserved
Zinc ﬁnger domains with family members Zic1, Zic2, Zic4,
and Zic5 (Aruga et al., 1994, 1996a,b, 2004). Their partially
overlapping spatial and temporal patterns of expression
during early development suggests potential functional re-
dundancy between the Zic family members (Nagai et al.,
1997; Elms et al., 2004). We observed that Zic2 gene levels
were up-regulated when Zic3 expression was reduced (Fig-
ure 6A). Because Zic2 is also differentially expressed be-
tween pluripotent and differentiation states of ES cells
(Brandenberger et al., 2004; Wei et al., 2005) and binding of
the key pluripotency transcription factor Nanog has been
mapped to the Zic2 regulatory region (Supplementary Fig-
ure 2), we reasoned that Zic2 may participate in the regula-
tion of ES cell pluripotency along with Zic3. To unveil the
possible effects of functional redundancy between Zic2 and
Zic3, a double knockdown was performed in mouse ES cells.
We report that repression of Zic2 and Zic3 expression sig-
niﬁcantly enhanced endoderm speciﬁcation in ES cells (Fig-
ure 6C). The evidence that Nanog binds to the Zic2 regula-
tory region suggests that it may be involved in similar
pathways as Zic3 in repressing endoderm expression. Thus,
Zic2 and Zic3 may participate in redundant or partially
overlapping networks to silence endoderm specifying gene
expression and contribute to the maintenance of pluripo-
tency in ES cells.
CONCLUSION
In this article, we expand on the signiﬁcance of Zic3 as a
target of the key stem cell regulatory factors in ES cells. Our
results highlight a role for Zic3 in the maintenance of plu-
ripotency downstream of Oct4 and Sox2, and uncovers its
role as a gatekeeper controlling differentiation of ES cells
into endoderm-speciﬁc lineages. In support of this, we
present evidence that a key regulator of pluripotency,
Nanog, which is shown to be important in repressing
endodermal lineage speciﬁcation, may directly or indirectly
be regulated by Zic3 in ES cells. Having now established that
Zic3 plays an important role in maintenance of pluripotency,
Figure 8. Protein expression in Zic3 knockdown clonal lines. (A)
Oct4 protein expression was high in all three Zic3 knockdown lines,
and the expression of speciﬁc endodermal marker proteins Foxa2,
Gata6, and Sox17 was observed in the same cells. (B) The Zic3
knockdown lines expressed stem cell surface protein, SSEA-1, which
is speciﬁc to murine ES cells. (C) The Zic3 clonal knockdown lines
demonstrated a signiﬁcant decrease in Nanog expression.
Figure 9. A model of Zic3 function in embryonic stem cells. Zic3
contributes to the maintenance of pluripotency by operating down-
stream of Oct4, Nanog, and Sox2 to inhibit endoderm lineage spec-
iﬁcation as characterized by endodermal markers Sox17, PDGFRA,
Gata4, Gata6, Foxa2, and Sox7. The presence of Zic3 also maintains
the expression of the homeodomain protein Nanog, a key regulator
of pluripotency in embryonic stem cells.
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it will be valuable to search for Zic3-regulated target genes,
which will extend our understanding of the transcriptional
network that governs lineage speciﬁcation. The elucidation
of molecular signatures of early ES cells in this manner will
contribute to validation and extension of the ES cell tran-
scriptional network beyond Oct4, Nanog, and Sox2. The
critical need to dissect their transcriptional networks is un-
derscored by their potential to yield critical insights into
genetic mechanisms at the earliest stages of embryo devel-
opment and to provide signiﬁcant inroads into the proper-
ties ES cell unlimited growth and differentiation potential
that will render them therapeutically useful.
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Supplementary Figure 1. The Zic3-RNAi targeted
region and Zic3-RNAi R3M modifications (red codons)
encoding mutations that render immunity to RNAi 
targeting, but functional viability due to degeneracy of 
the genetic code.
Supplementary Figure 2 
Supplementary Figure 2. A summary of Chromatin-IP mapping of
Oct4, Nanog and Sox2 binding sites on the Zic2 regulatory region in
Mouse ES cells. Oct4 and Sox2 sites were not present in this region.
Three Nanog binding sites were located upstream of the Zic3
transcription start site (Loh et al., 2006; Sox2). Each unit on the 
scale represents 10 kb.
Supplementary Figure 3. Endodermal marker
staining for E14 cells. The negative staining here 
demonstrates specificity of positive staining for Zic3 
knockdown clonal lines in Figure 8.
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Jmjd1a and Jmjd2c histone H3 Lys 9
demethylases regulate self-renewal in
embryonic stem cells
Yuin-Han Loh,1,2,4 Weiwei Zhang,1,2,4 Xi Chen,1,2 Joshy George,3 and Huck-Hui Ng1,2,5
1Gene Regulation Laboratory, Genome Institute of Singapore, Singapore 138672; 2Department of Biological Sciences,
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Embryonic stem (ES) cells are pluripotent cells with the ability to self-renew indefinitely. These unique
properties are controlled by genetic factors and chromatin structure. The exit from the self-renewing state is
accompanied by changes in epigenetic chromatin modifications such as an induction in the
silencing-associated histone H3 Lys 9 dimethylation and trimethylation (H3K9Me2/Me3) marks. Here, we
show that the H3K9Me2 and H3K9Me3 demethylase genes, Jmjd1a and Jmjd2c, are positively regulated by the
ES cell transcription factor Oct4. Interestingly, Jmjd1a or Jmjd2c depletion leads to ES cell differentiation,
which is accompanied by a reduction in the expression of ES cell-specific genes and an induction of lineage
marker genes. Jmjd1a demethylates H3K9Me2 at the promoter regions of Tcl1, Tcfcp2l1, and Zfp57 and
positively regulates the expression of these pluripotency-associated genes. Jmjd2c acts as a positive regulator
for Nanog, which encodes for a key transcription factor for self-renewal in ES cells. We further demonstrate
that Jmjd2c is required to reverse the H3K9Me3 marks at the Nanog promoter region and consequently
prevents transcriptional repressors HP1 and KAP1 from binding. Our results connect the ES cell transcription
circuitry to chromatin modulation through H3K9 demethylation in pluripotent cells.
[Keywords: Histone demethylase; embryonic stem cell; chromatin immunoprecipitation; self-renewal;
pluripotency; Jumonji]
Supplemental material is available at http://www.genesdev.org.
Received June 28, 2007; revised version accepted August 29, 2007.
Embryonic stem (ES) cells possess the remarkable prop-
erties of self-renewal and pluripotency. They may be cul-
tured in vitro for an indefinite period of time while re-
taining the capacity to give rise to all cell types of the
organism (Smith 2001; Loebel et al. 2003). For this rea-
son, there has been much interest in ES cells as a source
of differentiated cell types in cell replacement therapy
(Donovan and Gearhart 2001). A key feature of the ES
cell plasticity is the maintenance of the uncommitted
“stemness” state, while being poised to enter lineage-
specific differentiation programs.
ES cells exhibit unique chromatin features (Meshorer
and Misteli 2006). In mouse ES cells, there are rapid ex-
changes of architectural chromatin proteins such as HP1
and histones H1, H2B, and H3, which might constitute a
hyperdynamic and open chromatin environment (Me-
shorer et al. 2006). Upon differentiation, the binding dy-
namics of these factors are reduced, and they tend to be
immobilized to the chromatin. In general, methylation
of the Lys 4 residue of histone H3 (H3K4) correlates with
active gene status, while methylation of histone H3K9
and K27 serve as repressive chromatin marks (Lachner
and Jenuwein 2002; Turner 2002; Martin and Zhang
2005; Kouzarides 2007). Recent studies have reported the
finding of “bivalent domains” in mouse ES cells (Azuara
et al. 2006; Bernstein et al. 2006), where nucleosomes
contain both the histone H3K4 trimethylation
(H3K4Me3) mark as well as the histone H3K27 trimeth-
ylation (H3K27Me3) mark. The occurrence of these op-
posing chromatin marks is thought to keep lineage-spe-
cific genes repressed, yet keep them poised for activation
upon differentiation. ES cell chromatin is also enriched
in active marks (methylation of H3K4 and acetylation of
H3 and H4) and deficient in silencing modifications
(methylation of H3K9) (Lee et al. 2004; Meshorer and
Misteli 2006). Differentiation of ES cells is accompanied
by global changes in histone modifications and a transi-
tion to a transcriptionally less-permissive chromatin
state characterized by a decrease in H3K4Me3 and an
elevation of H3K9 methylation. These findings suggest
4These authors contributed equally to this work.
5Corresponding author.
E-MAIL nghh@gis.a-star.edu.sg; FAX 65-6478-9004.
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that the dynamic repression of developmental pathways
as well as the maintenance of transcriptional permissive
chromatin with a low level of H3K9 methylation in ES
cells by epigenetic processes is required for the mainte-
nance of ES cells’ plasticity and pluripotency. However,
the mechanisms and histone-modifying enzymes in-
volved in maintaining this unique ES cell epigenetic
state remain unclear. Hence, in addition to the identifi-
cation of genetic factors that influence the decision be-
tween self-renewal and differentiation (Nichols et al.
1998; Avilion et al. 2003; Chambers et al. 2003; Mitsui et
al. 2003; Elling et al. 2006; Ivanova et al. 2006; Loh et al.
2006; Matoba et al. 2006; Wang et al. 2006; Wu et al.
2006; Zhang et al. 2006; Galan-Caridad et al. 2007; Lim
et al. 2007), the roles of epigenetic regulators are also of
interest.
Jmjd1a, Jmjd2c, and several other JmjC domain-con-
taining proteins have recently been shown to be histone
demethylases (JHDMs) (Cloos et al. 2006; Fodor et al.
2006; Klose et al. 2006; Tsukada et al. 2006; Whetstine et
al. 2006; Yamane et al. 2006). JHDMs catalyze oxidative
demethylation reactions with iron and -ketoglutarate
as cofactors (Trojer and Reinberg 2006; Shi and Whet-
stine 2007). Jmjd1a can demethylate H3K9 mono- and
dimethylation in vitro and functions as a coactivator for
androgen receptor (AR) to demethylate chromatin of
AR target genes (Yamane et al. 2006). Jmjd2c has a dif-
ferent specificity and is shown to convert H3K9 and
H3K36 from trimethylation to dimethylation (Whetstine
et al. 2006). Little is known about the role that these
JHDMs play in modulating the chromatin structure of
ES cells.
Oct4 is a POU domain-containing transcription factor
encoded by Pou5f1. In the preimplantation embryo,Oct4
expression is restricted to the inner cell mass (ICM).
Oct4 is also highly expressed in human and mouse ES
cells (Palmieri et al. 1994). In the absence of Oct4, both
in vivo (ICM) and in vitro (ES cells) pluripotent cells are
induced to differentiate into the trophoblast lineage
(Nichols et al. 1998). Thus Oct4 has an essential role in
controlling cell fate decision and maintaining pluripo-
tency in the early mammalian embryo and the ES cells.
We previously mapped the Oct4-binding sites using
chromatin immunoprecipitation (ChIP) coupled to a
paired end ditag (PET) sequencing approach (Loh et al.
2006).
In this study, we showed that genes encoding for the
histone demethylases Jmjd1a and Jmjd2c are bona fide
targets of Oct4 in mouse ES cells. Using RNA interfer-
ence (RNAi), we found that depletion of these JHDMs in
ES cells resulted in cellular differentiation, providing
evidence for their roles in the maintenance of self-re-
newal in ES cells. Furthermore, we have identified Tcl1
and Nanog to be downstream effectors of Jmjd1a and
Jmjd2c, respectively. Our data support a model in which
Oct4 up-regulates downstream histone demethylases,
which, in turn, maintain permissive histone modi-
fications with a low level of H3K9 methylation at the
promoters of genes critical for the self-renewal of ES
cells.
Results
Oct4 regulates the expression of histone modifiers
Jmjd1a and Jmjd2c
We have previously mapped the in vivo binding sites of
an ES cell transcription factor, Oct4 (Loh et al. 2006). We
postulate that Oct4 controls the chromatin architecture
of ES cells through downstream targets that encode for
histone-modifying enzymes. Our previous ChIP-PET-
binding site mapping study revealed Oct4-binding clus-
ters within Jmjd1a and Jmjd2c genes (Supplementary
Fig. 1A,B). We confirmed that Oct4 binds to Jmjd1a and
Jmjd2c using the ChIP assay (Fig. 1A). Furthermore,
depletion of Oct4 by RNAi led to decreased Jmjd1a and
Jmjd2c expression (Fig. 1B). Depletion of two other tran-
scription factors that have been implicated in ES cell
self-renewal, Esrrb and Nanog, had no or little effect on
Jmjd1a and Jmjd2c levels compared with Oct4 depletion
(Fig. 1B; Supplementary Fig. 1C,D).
A probe was also designed based on the peak of the
Oct4-binding profile at Jmjd1a intron (Supplementary
Fig. 1A). This sequence contained two Oct4-binding sites
and was used to test the interaction with Oct4 (Fig. 1C).
Using the electrophoretic mobility shift assay (EMSA),
we showed that Oct4 in ES cell nuclear extract bound to
this probe (Fig. 1C, lanes 2–4) and that mutations intro-
duced to the two Oct4-binding sites abolished the inter-
action (Fig. 1C, lanes 6,7). We were also able to demon-
strate that ectopically expressed Oct4 in 293T cells
bound to this probe through the Oct4-binding sites (Fig.
1C, lanes 9–11,13,14). A probe derived from the Jmjd2c
intron contained an Oct4-binding site and was also
bound by Oct4 (Fig. 1D).
Next, we cloned the Jmjd1a and Jmjd2c intronic DNA
containing these Oct4-binding sites upstream of or
downstream from a luciferase reporter to test for en-
hancer activity. We observed robust enhancer activity
when these constructs were transfected into ES cells
(Fig. 1E). Importantly, the same mutations that disrupted
the in vitro Oct4/DNA interactions also abolished the
enhancer activities (Fig. 1E). Taken together, these data
show that Oct4 positively regulates the expression of
these histone demethylase genes through the intronic
Oct4 sites. Conversely, reprogramming of fibroblasts to
induced pluripotent stem (iPS) cells is accompanied by
increased expression of Jmjd1a and Jmjd2c (Supplemen-
tary Fig. 1E; Takahashi and Yamanaka 2006). Hence, the
expression of Jmjd1a and Jmjd2c is positively correlated
with the pluripotent state of ES and iPS cells.
Jmjd1a and Jmjd2c are critical regulators of ES cells
To confirm the activity of Jmjd1a and Jmjd2c in ES cells,
we depleted their expression by RNAi. We used two
short-hairpin RNA (shRNA) constructs targeting differ-
ent regions of each transcript to ensure that the effects
are specific. Both constructs were effective in reducing
the RNA and protein levels (Fig. 2A–C). As expected, the
level of H3K9Me2, but not H3K9Me3, of total cell his-
Loh et al.
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tone H3, was increased upon Jmjd1a knockdown, indi-
cating that Jmjd1a is involved in the reversal of
H3K9Me2 of bulk chromatin in ES cells (Fig. 2B). Also as
expected, Jmjd2c depletion increased H3K9Me3, but not
H3K9Me2 (Fig. 2C). The level of H3K36Me3 was, how-
ever, not significantly affected by Jmjd2c depletion. The
lack of change in H3K36 trimethylation could be due to
redundancy of histone demethylases in ES cells or is re-
flective of the in vivo activity of Jmjd2c. These results
indicate that Jmjd1a and Jmjd2c regulate the global lev-
Figure 1. Oct4 regulates the expression of
Jmjd1a and Jmjd2c in pluripotent mouse ES
cells. (A) Oct4 binds to the intronic regions
of Jmjd1a and Jmjd2c. Real-time PCR detec-
tion of enriched fragments from ChIP assays
in ES cells using Oct4 or control antibodies.
Fold enrichment is the relative abundance of
DNA fragments at the amplified region (see
Supplementary Fig. 1) over a control ampli-
fied region. Validation of Oct4 ChIP was car-
ried out using primers specific for known
binding sites at the Oct4 enhancer locus.
GST (glutathione S-transferase) antibody
was used as a mock ChIP control. Data are
presented as the mean ± SEM. (B) Oct4
knockdown down-regulated endogenous
Jmjd1a and Jmjd2c mRNA levels. Oct4 sup-
pression in ES cells by RNAi resulted in con-
comitant reductions in endogenous Jmjd1a
and Jmjd2c. Nanog and Esrrb RNAi-trans-
fected ES cells exhibited little or no reduc-
tion in Jmjd1a and Jmjd2c mRNA. cDNAs
were prepared from the knockdown mouse
ES cells and were analyzed using real-time
PCR. The levels of the transcripts were nor-
malized against control Luc (Luciferase)
shRNA-transfected cells. After 24 h of trans-
fection, the ES cells were selected for 3 d
before harvest. Data are presented as the
mean ± SEM. (C) Oct4 binds to the intronic
sequences of Jmjd1a. EMSA was used to
analyze the interactions between Oct4 and a
27-bp double-stranded DNA probe contain-
ing the oct elements (indicated by arrows).
Both ES cell nuclear extracts and extracts
from 293 cells overexpressing Oct4 (Oct4
OE extracts) were used for EMSAs. (Lanes
3,10) EMSA with the wild-type probe de-
tected specific Oct4/DNA complexes as
confirmed by supershift analysis. (Lanes
6,7,13,14) When mutant probe was used, no
interaction was detected. The bottom panel
shows the sequence of the oct elements and
corresponding mutations (shaded) used in
this study. (D) Oct4 binds to the intronic
sequences of Jmjd2c. EMSA was used to ana-
lyze the interactions between Oct4 and a 27-
bp double-stranded DNA probe containing
the oct element (indicated by arrow). (Lanes
3,10) EMSA with the wild-type probe de-
tected a specific Oct4/DNA complex as confirmed by supershift analysis. (Lanes 6,7,13,14) When mutant probe was used, no inter-
action was detected. The bottom panel shows the sequence of the oct element and corresponding mutations (shaded) used in this
study. (E) The Oct4-bound intronic regions of Jmjd1a (a 655-bp fragment) or Jmjd2c (a 679-bp fragment) was inserted either upstream
of (Enh-Luc) or downstream from (Luc-Enh) a luciferase gene driven by an Oct4 minimal promoter. Reporters were transiently
transfected into ES cells for 3 d before measurement of luciferase activities. Enhancer constructs with mutated Oct4-binding sites
(Jmjd1a/Jmjd2c Enh-Luc Mut or Jmjd1a/Jmjd2c Luc-Enh Mut) were also tested for enhancer activity in ES cells. For each transfection,
we cotransfected a construct expressing Renilla luciferase driven by SV40 promoter to serve as an internal control. Data are presented
as the mean ± SEM.
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els of H3K9Me2 and H3K9Me3, respectively. Strikingly,
the colony morphology of ES cells was changed dramati-
cally, and the cells became flattened and fibroblast-like
upon Jmjd1a or Jmjd2c knockdown (Fig. 2D). The alka-
line phosphatase staining typical of undifferentiated ES
cells was also reduced upon knockdown of both tran-
scripts, indicative of differentiation (Fig. 2D). As target-
ing both transcripts by RNAi led to differentiation, we
performed additional control experiments to establish
the specificity of these shRNA constructs. Knockdown
of Jmjd1a did not appreciably affect Jmjd2c and vice
versa (Supplementary Fig. 2A,B). Therefore, each shRNA
set was specific for targeting the intended transcript. To
further substantiate the specificity of the Jmjd1a knock-
down experiment, we mutated two nucleotide bases in
our Jmjd1a shRNA constructs (Supplementary Fig. 3A).
These mutations abolished their silencing effects, as the
endogenous level of Jmjd1awas not affected (Supplemen-
Figure 2. Jmjd1a and Jmjd2c are required
for the maintenance of self-renewal of ES
cells. (A) Quantitative real-time PCR
analysis of Jmjd1a and Jmjd2c expression
after knockdown using two shRNA con-
structs targeting different regions of the re-
spective transcripts. After 24 h of transfec-
tion, the ES cells were selected for 4 d
before harvest. The levels of the tran-
scripts were normalized against control
Luc shRNA-transfected cells. Data are pre-
sented as the mean ± SEM. (B) Reduction
of Jmjd1a after RNAi-mediated knock-
down led to increased H3K9Me2. Western
blot analyses of Jmjd1a knockdown and
control ES cell lysates were carried out us-
ing anti-Jmjd1a, anti-H3K9Me2, or anti-
H3K9Me3 antibodies. Anti-histone H3
and anti--tubulin antibodies were used as
loading controls. (C) Reduction of Jmjd2c
after RNAi-mediated knockdown led to
increased H3K9Me3. Western blot analy-
ses of Jmjd2c knockdown and control ES
cell lysate were carried out using anti-
Jmjd2c, anti-H3K9Me2, anti-H3K9Me3, or
anti-H3K36Me3 antibodies. Anti-histone
H3 and anti--tubulin antibodies were
used as loading controls. (D) Jmjd1a and
Jmjd2c knockdown led to differentiation.
Flattened fibroblast-like cells were formed
after Jmjd1a or Jmjd2c depletion. For con-
trol Luc or Gfp shRNA-transfected cells,
distinct alkaline phosphatase-positive (red
staining) ES cell colonies were main-
tained. The cells were stained after 4 d of
puromycin selection. (E) Real-time PCR
analysis of ES cell-associated gene expres-
sion (left panel) and lineage-specific
marker gene expression (right panel) in
Jmjd1a knockdown ES cells. The levels of
the transcripts were normalized against
control Luc shRNA-transfected cells. Data
are presented as the mean ± SEM. (F) Real-
time PCR analysis of ES cell-associated
gene expression (left panel) and lineage-
specific marker gene expression (right
panel) in Jmjd2c knockdown ES cells. The
levels of transcripts were normalized against control Luc shRNA-transfected cells. Data are presented as the mean ± SEM. (G) Venn
diagram of overlapping and specifically up-regulated genes between Jmjd1a- and Jmjd2c-depleted ES cells. DNA microarrays were used
to profile the gene expression of these cells. The levels of transcripts were compared with control Luc shRNA-transfected cells. The
P-value for the overlap as computed using Monte Carlo simulation is <1e−08. (H) Venn diagram of overlapping and specifically
down-regulated genes between Jmjd1a- and Jmjd2c-depleted ES cells. DNA microarrays were used to profile the gene expression of
these cells. The levels of transcripts were compared with control Luc shRNA-transfected cells. The P-value for the overlap as
computed using Monte Carlo simulation is <1e−08.
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tary Fig. 3B). Cells transfected with shRNA mutants also
retained proper ES cell morphology and did not show
appreciable changes in the ES cell markers (Supplemen-
tary Fig. 3C–E). As with Jmjd1a, introduction of two
nucleotide mutations in the Jmjd2c shRNA constructs
abolished their silencing effects (Supplementary Fig.
4A,B). The cells transfected with shRNA mutants also
retained proper ES cell morphology, maintained the
same levels of ES cell markers, and showed no induction
of differentiation markers (Supplementary Fig. 4C–E).
The differentiation phenotype is specific to Jmjd1a and
Jmjd2c knockdown ES cells, as we did not observe mor-
phology changes or any reduction in Oct4 expression
when we depleted transcripts coding for other JmjC do-
main-containing proteins—Jarid2, Jarid1a, and Jhdm1
(Supplementary Fig. 5). To further characterize the
Jmjd1a- and Jmjd2c-depleted ES cells, we analyzed their
ability to form colonies in a replating assay. Transfected
cells were dissociated with trypsin and replated to allow
the ES cells to expand into colonies. Jmjd1a and Jmjd2c
knockdown reduced the number of ES cell colony-form-
ing units (CFUs) by fourfold to 19-fold compared with
control knockdown (Supplementary Fig. 6). Taken to-
gether, our results indicate that Jmjd1a and Jmjd2c are
critical for the maintenance of the self-renewal state of
ES cells. Cellular differentiation induced by Jmjd1a or
Jmjd2c knockdown was accompanied by a corresponding
reduction in certain pluripotency markers and induction
of genes associated with differentiation. Oct4, Sox2, and
Nanog were down-regulated in response to the Jmjd1a or
Jmjd2c depletion (Fig. 2E,F). It should be noted, however,
that the reduction is modest compared with the knock-
down of transcription factors such as Oct4. The ex-
pression of Tdgf1 was also not affected by Jmjd1a deple-
tion. Time-course analyses indicated that Oct4, Sox2,
and Nanog levels continued to decrease after an ex-
tended period of selection (Supplementary Fig. 7).
We also examined the expression of lineage markers (Fig.
2E,F). Interestingly, Jmjd1a and Jmjd2c knockdown cells
expressed markers of different lineages. For instance,
Jmjd1a depletion induced the mesodermal marker
Brachyury, while Jmjd2c depletion induced the endo-
dermal markers Gata4 and Gata6. Knockdown of
either transcript induced the expression of Msx1, Fgf5,
and Cdx2 (Fig. 2E,F). Hence, the resulting cells were
likely to be composed of multiple differentiated cell
types. To understand the molecular basis of the JHDMs’
requirements in ES cell maintenance, we used Illumina
gene expression microarrays to identify potential down-
stream target genes. One-hundred-sixty-five and 311
genes were up-regulated in Jmjd1a and Jmjd2c knock-
down cells, respectively, while 45 of these genes were
common between the two (Fig. 2G; Supplementary
Table 1). On the other hand, 155 and 502 genes were
down-regulated in Jmjd1a and Jmjd2c knockdown
cells, respectively. Fifty-five of these genes were com-
monly down-regulated (Fig. 2H). Taken together, these
data show that Jmjd1a and Jmjd2c may have overlapping
but distinct roles in regulating gene expression in ES
cells.
Jmjd1a regulates the expression of Tcl1 through
demethylation of H3K9Me2
We reasoned that Jmjd1a and Jmjd2c could positively
control the expression of candidate target genes
through modulation of H3K9Me2 and H3K9Me3 lev-
els. Because of the differentiation phenotype we ob-
served upon Jmjd1a or Jmjd2c depletion, we also hy-
pothesized that the genes controlled by Jmjd1a and
Jmjd2c could be self-renewal regulators. Among the
down-regulated genes identified by global gene expres-
sion profiling of Jmjd1a knockdown cells (Fig. 3A;
Supplementary Table 1) are Tcl1, Tcfcp2l1, and Zfp57.
These genes are preferentially expressed in pluripo-
tent ES cells (Ivanova et al. 2002; Ramalho-Santos et al.
2002). We validated the down-regulation of these
genes using real-time PCR (Fig. 3B; Supplementary Fig.
8). Tcl1, a gene encoding for a cofactor of the Akt1 ki-
nase, is of particular interest as it has been shown to
regulate self-renewal of ES cells (Ivanova et al. 2006;
Matoba et al. 2006). We depleted Tcl1 using two differ-
ent shRNA constructs (Supplementary Fig. 9). Con-
sistent with a previous report, we found that Tcl1 is
required to maintain the undifferentiated state of ES
cells (Ivanova et al. 2006). Similar to Jmjd1a-depleted
cells, differentiated markers (Fgf5, Mxs1, and Brachyury)
were induced upon Tcl1 knockdown (Supplementary
Fig. 9). To test if Jmjd1a regulates H3K9Me2 of chro-
matin associated with Tcl1, we used a ChIP assay to
measure the level of H3K9Me2 at the promoter region. A
series of primer pairs was used to interrogate this region
(Fig. 3C). Interestingly, we detected an increase of
H3K9Me2 at the Tcl1 promoter upon Jmjd1a deple-
tion (Fig. 3D). Our two shRNA constructs showed the
same effect and did not alter the level of H3K9Me3,
indicating that this is a specific role of Jmjd1a (Fig. 3D).
Knockdown of Jmjd2c did not alter the H3K9Me2
or H3K9Me3 level to the same extent as Jmjd1a
depletion, further demonstrating the predominant
modulation of H3K9Me2 at the Tcl1 promoter by
Jmjd1a (Fig. 3D). As knockdown by RNAi will have in-
direct effects, we sought further evidence to confirm
the action of Jmjd1a. To this end, we performed a ChIP
assay using two independently generated anti-Jmjd1a
antibodies. The result showed that Jmjd1a was bound
to the Tcl1 promoter (Fig. 3E). In contrast, Jmjd2c
showed only a very low or near background level of
binding (Fig. 3F). Furthermore, the depletion of Jmjd1a
using either shRNA construct abolished the Jmjd1a
ChIP signal, indicating that the antibodies specifically
recognized Jmjd1a (Fig. 3G). We and others have
shown that the Tcl1 promoter is bound by Oct4
(Loh et al. 2006; Matoba et al. 2006). Next, we asked if
the increase in H3K9Me2 affects Oct4 occupancy. The
ChIP assay showed that the Oct4 binding at the
Tcl1 promoter but not at the Oct4 enhancer, Tdgf1
and Rif1 loci, was abolished by Jmjd1a depletion
(Fig. 3H,I). The loss of Oct4 binding is a likely
cause for the down-regulation of Tcl1 upon Jmjd1a deple-
tion.
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Tcl1 is a downstream effector of Jmjd1a in regulating
ES cells maintenance
If Tcl1 is a key effector of Jmjd1a, one would predict that
overexpression of Tcl1 will rescue the effects of Jmjd1a
knockdown. To test this hypothesis, we cotransfected a
Tcl1 expression plasmid with control, Jmjd1a, Jmjd2c,
or Oct4 shRNA constructs. ES cells cotransfected with a
vector control plasmid and Jmjd1a, Jmjd2c, or Oct4
shRNA constructs underwent differentiation based on
the morphology changes, loss of ES cell colonies, and
alkaline phosphatase staining (Fig. 4A). However, cells
cotransfected with Tcl1 and Jmjd1a shRNA expression
plasmids were found to retain ES cell morphology and
alkaline phosphatase expression (Fig. 4A). The depletion
of Jmjd1a was equally efficient in the control and Tcl1-
overexpressing ES cells (Fig. 4B). This excludes the pos-
sibility that the phenotypic differences were due to in-
sufficient depletion of Jmjd1a. In contrast, the degree of
rescue by Tcl1 in Jmjd2c-depleted cells was less pro-
nounced. Consistent with the morphology data, we ob-
served a smaller reduction in ES cell markers and less
induction of differentiation markers in Tcl1-rescued
cells (Fig. 4C,D). Jmjd2c-depleted cells showed little res-
toration of Oct4, Sox2, or Nanog expression (Supplemen-
tary Fig. 10A). The expression of Msx1 but not Fgf5 was
Figure 3. Jmjd1a regulates expression of
Tcl1 through demethylation of H3K9Me2.
(A) Microarray heat map depicting expres-
sion changes of selected ES cell-associated
genes (Ivanova et al. 2002; Ramalho-San-
tos et al. 2002; Mitsui et al. 2003) after
Jmjd1a knockdown. The gene expression
levels were mean-centered to show their
relative changes, and the genes were or-
dered according to their mean fold
changes. (B) Jmjd1a positively regulates
the expression of Tcl1. The expression of
Tcl1 was analyzed after depletion of
Jmjd1a using two shRNA constructs. After
24 h of transfection, the ES cells were se-
lected with puromycin for 4 d before har-
vest. The levels of the transcripts were
normalized against control Luc (Lucifer-
ase) shRNA-transfected cells. Data are
presented as the mean ± SEM. (C) Sche-
matic showing the locations of the ampli-
cons (black bars labeled 1–3) used to detect
ChIP-enriched fragments over the Tcl1
promoter. Amplicons are numbered in or-
der relative to their sites along the gene.
The open box represents an exon. (D)
Analysis of H3K9Me2/Me3 modifications
along the Tcl1 promoter by ChIP. ES cells
were transfected with Luc (control)
shRNA, Jmjd1a shRNA 1, Jmjd1a shRNA
2, or Jmjd2c shRNA 1. Fold enrichment is
the relative abundance of DNA fragments
detected by real-time PCR at the amplified
region over a control amplified region and
normalized with control Luc. GST anti-
body was used as a ChIP control. Data are
presented as the mean ± SEM. (E) Jmjd1a
interacts with the Tcl1 promoter region.
ChIP assays were performed with two dif-
ferent anti-Jmjd1a antibodies. A primer
pair targeting amplicon 3 was used. GST
antibody was used as a ChIP control. Data
are presented as the mean ± SEM. (F)
Jmjd2c ChIP and real-time PCR showed no
enrichment over the Tcl1 promoter region.
Data are presented as the mean ± SEM. (G) Knockdown of Jmjd1a abolished the ChIP signal derived from anti-Jmjd1a antibody. ES cells
were transfected with control Luc shRNA, Jmjd1a shRNA 1, or Jmjd1a shRNA 2. Data are presented as the mean ± SEM. (H) ChIP
analysis showed that Oct4 binding to the Tcl1 promoter was diminished upon Jmjd1a depletion. ES cells were transfected with control
Luc shRNA, Jmjd1a shRNA 1, or Jmjd1a shRNA 2. A primer pair targeting amplicon 3 was used. Data are presented as the
mean ± SEM. (I) Oct4 binding at Oct4 enhancer and Tdgf1 and Rif1 loci was not affected in Jmjd1a depletion. Data are presented as
the mean ± SEM.
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reduced, indicating incomplete rescue by Tcl1 (Supple-
mentary Fig. 10B). Taken together, our Tcl1 rescue result
indicates that Tcl1 can compensate for the loss of
Jmjd1a. In addition, we screened the promoter regions of
six other genes for Jmjd1a-dependent modulation of the
H3K9Me2 level (Supplementary Table 2A) and detected
Jmjd1a-dependent H3K9Me2 demethylation at Tcfcp2l1
and Zfp57. We also confirmed that Jmjd1a associates
with these two promoters by ChIP assay (Supplementary
Fig. 8). The data support a role of Jmjd1a in positively
regulating these pluripotency-associated genes by de-
methylation of H3K9Me2 at their promoters. As we did
not detect any changes in the H3K9Me2 level of Oct4
and Nanog promoter regions by ChIP, this indicates that
not all differentially regulated genes are subject to
Jmjd1a-mediated H3K9Me2 demethylation (Fig. 5;
Supplementary Fig. 11). Using the two criteria of Jmjd1a
occupancy and Jmjd1a-dependent change in the
H3K9Me2 level, we conclude that Tcl1, Tcfcp2l1, and
Zfp57 are direct targets of Jmjd1a.
Jmjd2c regulates the expression of Nanog through
demethylation of H3K9Me3
To extend our study to Jmjd2c, we examined the
H3K9Me3 status of Jmjd2c-regulated genes. Our marker
gene analysis and microarray result showed that the ex-
pression of Nanog was reduced upon Jmjd2c depletion
(Fig. 5A; Supplementary Table 1). Nanog is a key tran-
scription factor important for the maintenance of pluri-
potency and self-renewal of ES cells (Chambers et al.
2003; Mitsui et al. 2003). Nanog expression was reduced
to 50% upon Jmjd2c depletion (Fig. 2F), suggesting that
there could be a Jmjd2c-dependent mechanism of regu-
lating Nanog. Using a ChIP assay, we scanned the pro-
moter region of Nanog (Fig. 5B). Upon knockdown using
two shRNA constructs against Jmjd2c, we detected in-
creased levels of H3K9Me3 to >2.5-fold at region 3 (Fig.
5C). This effect is specific to Jmjd2c, because knock-
down of Jmjd1a did not result in an increase in
H3K9Me2 or H3K9Me3 levels (Fig. 5C). The H3K9Me3
status at the promoter regions of nine other genes
(Supplementary Table 2B) was, however, not affected by
Jmjd2c depletion, indicating that Jmjd2c specifically
regulates the chromatin associated with the Nanog pro-
moter. Next, we asked if Jmjd2c is bound to the region
that showed the greatest induction of H3K9Me3 upon
Jmjd2c depletion. With two independently generated
anti-Jmjd2c antibodies, we were able to detect Jmjd2c
binding at the Nanog promoter (Fig. 5D). ChIP using an
anti-Jmjd1a antibody showed no binding (Fig. 5E). The
binding of Jmjd2c was abolished by either of our two
Jmjd2c shRNA constructs, further showing that the
Figure 4. Tcl1 is the key downstream ef-
fector of Jmjd1a responsible for maintain-
ing ES cells’ self-renewal. (A) Enforced
Tcl1 overexpression (OE) could rescue the
differentiation phenotype induced by
Jmjd1a depletion. ES cells were transfected
with a Tcl1-overexpressing vector and
challenged with shRNA directing against
various transcripts (Jmjd1a, Jmjd2c, or
Oct4). The cells were stained for alkaline
phosphatase activity, and the morpholo-
gies were examined by microscopy after 4 d
of puromycin selection. Note the mor-
phological rescue and the maintenance of
alkaline phosphatase-positive colonies in
Jmjd1a shRNA-treated cells. Little or no
morphological rescue was observed when
the cells were challenged with Jmjd2c or
Oct4 shRNA, respectively. (B) Jmjd1a was
similarly depleted both in Tcl1-overex-
pressing and control ES cells. Quantitative
real-time PCR analysis of Jmjd1a expres-
sion after knockdown using two shRNA
constructs cotransfected into ES cells with
either control or Tcl1-overexpressing vec-
tor. The levels of the transcripts were nor-
malized against control plasmid-trans-
fected cells. Data are presented as the
mean ± SEM. (C) Enforced Tcl1 over-
expression reduced the down-regulation of
Sox2 and Nanog upon Jmjd1a depletion.
The levels of the transcripts were nor-
malized against control plasmid trans-
fected cells. Data are presented as the
mean ± SEM. (D) Enforced Tcl1 overexpression compensated for the Jmjd1a loss of function by reducing the induction of differentia-
tion markers Fgf5, Msx1, and Brachyury. Data are presented as the mean ± SEM.
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ChIP signal is specific to Jmjd2c (Fig. 5F). Hence, the
increase in H3K9Me3 level after Jmjd2c knockdown
could be explained by the binding of Jmjd2c. As Nanog is
a direct target gene for Oct4, we examined the Oct4 oc-
cupancy at the proximal promoter of Nanog. The ChIP
assay showed that Oct4 binding at the Nanog promoter
(Fig. 5G) was not affected by Jmjd2c depletion. H3K9Me3
can serve as a binding site for the transcriptional repres-
sor protein HP1 in the silencing of gene expression (Ban-
nister et al. 2001). We used a ChIP assay to test if the
increase in H3K9Me3 levels over the Nanog promoter
after Jmjd2c depletion leads to recruitment of the HP1-
/KAP1 corepressor complex (Ryan et al. 1999). Upon
knockdown using two shRNA constructs against
Jmjd2c, we detected an increase in HP1- binding of up
to twofold (Fig. 5H). Unlike Jmjd2c-depleted cells, we
did not observe increased HP1- after Jmjd1a knock-
down in ES cells (data not shown). The ChIP assay also
showed that the binding of corepressor KAP1 was in-
duced after depletion of Jmjd2c (Fig. 5I). Taken together,
these results suggest that Jmjd2c positively regulates
Nanog by preventing H3K9 trimethylation and the bind-
ing of HP1/KAP1 complex on its promoter.
Nanog is a downstream effector of Jmjd2c
in regulating ES cell maintenance
To determine if Nanog is a downstream effector of
Jmjd2c in the maintenance of ES cells, we treated a
Figure 5. Jmjd2c regulates expression of
Nanog through demethylation of
H3K9Me3. (A) Microarray heat map plot
depicting expression changes of selected ES
cell-associated genes (Ivanova et al. 2002;
Ramalho-Santos et al. 2002; Mitsui et al.
2003) after Jmjd2c knockdown. The gene
expression levels were mean-centered to
show their relative changes, and the genes
were ordered according to their mean fold
changes. (B) Schematic showing the loca-
tion of the amplicons (black bars labeled
1–5) used to detect ChIP-enriched frag-
ments over the Nanog promoter. Ampli-
cons are numbered in order relative to their
sites along the gene. The open box repre-
sents an exon. (C) Analysis of H3K9Me2/
Me3 modifications along the Nanog pro-
moter region by ChIP. ES cells were trans-
fected with Luc (control) shRNA, Jmjd2c
shRNA 1, Jmjd2c shRNA 2, or Jmjd1a
shRNA 1. Fold enrichment is the relative
abundance of DNA fragments detected by
real-time PCR at the amplified region over
a control amplified region and normalized
with control Luc. GST antibody was used
as a ChIP control. Data are presented as the
mean ± SEM. (D) Jmjd2c associates with
the Nanog promoter region. ChIP assays
were performed with two different anti-
Jmjd2c antibodies. A primer pair targeting
amplicon 3 was used. GST antibody was
used as a ChIP control. Data are presented
as the mean ± SEM. (E) ChIP analysis
showed no enrichment of Jmjd1a over the
Nanog promoter region. A primer pair tar-
geting amplicon 3 was used. Data are pre-
sented as the mean ± SEM. (F) Knockdown
of Jmjd2c abolished the ChIP signal derived
from anti-Jmjd2c antibody. ES cells were
transfected with control Luc shRNA,
Jmjd2c shRNA 1, or Jmjd2c shRNA 2. A
primer pair targeting amplicon 3 was used. Data are presented as the mean ± SEM. (G) ChIP analysis showed Oct4 binding to theNanog
promoter remained unchanged upon Jmjd2c depletion. ES cells were transfected with control Luc shRNA, Jmjd2c shRNA 1, or Jmjd2c
shRNA 2. A primer pair targeting amplicon 5 was used. Data are presented as the mean ± SEM. (H) ChIP analysis showed that HP1-
binding to the Nanog promoter was increased upon Jmjd2c depletion. ES cells were transfected with Luc shRNA (control), Jmjd2c
shRNA 1, or Jmjd2c shRNA 2. A primer pair targeting amplicon 3 was used. Data are presented as the mean ± SEM. (I) ChIP analysis
showed that KAP1 binding to the Nanog promoter was increased upon Jmjd2c depletion. ES cells were transfected with Luc shRNA
(control), Jmjd2c shRNA 1, or Jmjd2c shRNA 2. A primer pair targeting amplicon 3 was used. Data are presented as the mean ± SEM.
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Nanog-overexpressing ES cell line (Loh et al. 2006) with
shRNAs against Jmjd2c. Interestingly, the two Jmjd2c
shRNA constructs were unable to induce efficient differ-
entiation as alkaline phosphatase-positive ES cell colo-
nies were readily obtained (Fig. 6A). The depletion of
Jmjd2c was equally efficient in the control and Nanog-
overexpressing ES cells (Fig. 6B); this excludes the pos-
sibility that the phenotypic differences were due to in-
sufficient depletion of Jmjd2c. Depletion of Jmjd1a in
the Nanog-overexpressing ES cells showed more differ-
entiation than Jmjd2c-depleted cells (Fig. 6A), suggesting
that Nanog could not compensate for the loss of Jmjd1a.
The rescued phenotype in Nanog-overexpressing cells
was also supported by marker gene analyses. The levels
of Oct4, Sox2, and Tdgf1 remained relatively unchanged
(Fig. 6C), while the induction of differentiation mark-
ers such as Fgf5 and Msx1 was also reduced in Nanog-
overexpressing ES cells as compared with control ES
cells (Fig. 6D). Consistent with the morphology data,
Jmjd1a knockdown cells showed no restoration of ES
cell markers and little or no reduced expression of dif-
ferentiation markers (Supplementary Figure 12). These
results demonstrate that Nanog is able to rescue the
knockdown effects of Jmjd2c depletion. Altogether, our
finding provides mechanistic explanations for how
Jmjd1a and Jmjd2c maintain the undifferentiated state of
ES cells.
Discussion
Genetic network and epigenetic landscape in ES cells
During the process of ES cell division, the choice be-
tween self-renewal or differentiation is decided by the
complex interplay between signaling pathways, tran-
scription factor networks, and epigenetic processes. Re-
cent studies have begun to define key players in the tran-
scriptional factor networks of mouse ES cells (Nichols et
al. 1998; Avilion et al. 2003; Chambers et al. 2003; Mit-
sui et al. 2003; Elling et al. 2006; Ivanova et al. 2006; Loh
et al. 2006; Matoba et al. 2006; Wang et al. 2006; Wu et
al. 2006; Zhang et al. 2006; Galan-Caridad et al. 2007;
Lim et al. 2007). Alongside genetic factors, epigenetic
mechanisms such as methylation of histones could also
have important roles in maintaining self-renewal and
pluripotency of ES cells.
In this study, we place two genes encoding JHDMs as
downstream targets of Oct4, a critical regulator of pluri-
potency in ES cells. Oct4 binds to the regulatory regions
of Jmjd1a and Jmjd2c as shown by the in vivo ChIP
and in vitro EMSA assays. Significantly, both knock-
down and reporter assays confirm that Oct4 is a positive
regulator of the JHDMs. It is interesting to note that
JMJD1A is also bound by OCT4 in human ES cells (Boyer
et al. 2005); this could indicate evolutionary conserva-
tion of an important regulatory function. Apart from the
Figure 6. Nanog is the key downstream
effector of Jmjd2c responsible for main-
taining ES cells’ self-renewal. (A) Overex-
pression of Nanog can rescue differentia-
tion phenotype induced by Jmjd2c deple-
tion. ES cells with constitutive Nanog
overexpression (Loh et al. 2006) were chal-
lenged with shRNA directing against
various transcripts (Jmjd2c, Jmjd1a, or
Oct4). The cells were stained for alkaline
phosphatase activity, and the morpho-
logies were examined by microscopy.
Note the morphological rescue and the
maintenance of alkaline phosphatase-
positive colonies in Jmjd2c shRNA-
treated cells. Little or no morphological
rescue was observed when the cells were
challenged with Jmjd1a or Oct4 shRNA,
respectively. (B) Jmjd2c was similarly de-
pleted both in Nanog-overexpressing and
control ES cells. Data are presented as
the mean ± SEM. (C) Overexpression of
Nanog reduced the down-regulation of
Oct4, Sox2, and Tdgf1 upon Jmjd2c deple-
tion. The levels of the transcripts were
normalized against control plasmid-trans-
fected cells. Data are presented as the
mean ± SEM. (D) Enforced Nanog overex-
pression compensated for the Jmjd2c loss
of function by reducing the induction of
differentiation markers Fgf5 and Msx1.
Data are presented as the mean ± SEM.
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JHDMs identified from the present study, Oct4 may also
regulate genes encoding chromatin-modifying com-
plexes in both human (e.g., SET, SMARCA, and MYST)
(Boyer et al. 2005) and mouse ES cells (Ehmt1, Smarcad1,
Myst2) (Loh et al. 2006). This suggests that Oct4 may
govern the chromatin state of pluripotent ES cells by
regulating the expression of genes directly involved in
the epigenetic systems.
The repressive histone mark, H3K9 methylation, is
maintained at a low level in ES cells. In contrast, differ-
entiated cell types exhibit elevated levels of H3K9 meth-
ylation (Meshorer et al. 2006), which suggests a role for
histone H3K9 demethylases in maintaining a transcrip-
tionally permissive chromatin state. Removal of the
JHDMs results in an elevation of global histone H3K9Me
level, suggesting that the JHDMs play active roles in
maintaining transcriptionally permissive chromatin in
pluripotent ES cells. The up-regulation of these JHDMs
in ES cells may explain the low level of repressive H3K9
methylation. However, it is not clear if the low global
level of H3K9 methylation is required for the mainte-
nance of the “stemness” state of ES cells.
Roles of Jmjd1a and Jmjd2c in the maintenance
of the ES cell self-renewal
Previous studies have investigated the role of histone
methylases in ES cells or early embryonic development.
Setdb1 and Ezh2 knockout embryos show early embry-
onic lethality (embryonic day 3.5–4.5 [E3.5–E4.5]) and are
defective in outgrowth of the ICM (O’Carroll et al. 2001;
Dodge et al. 2004). It is not clear, however, if Setdb1 or
Ezh2 is required to maintain the self-renewal of ES cells.
G9a-null embryos survive until E9.5, but G9a knockout
ES cells showed compromised differentiation processes
(Tachibana et al. 2002). Similarly, while Suz12−/− ES
cells (Pasini et al. 2007) can be established and expanded
in tissue culture, the ability to give rise to proper differ-
entiation is impaired.
In this study, we showed that ES cells depleted of
Jmjd1a and Jmjd2c lost their distinctive colony mor-
phologies and gave rise to fibroblast-like cells. Moreover,
the knockdown cells were not able to efficiently form
colonies in secondary replating assays. Differentiation
induced by the depletion of these JHDMs led to the loss
of pluripotency and self-renewal. Apart from these
JHDMs, no other histone-modifying enzyme has been
shown to be important in the maintenance of self-re-
newal of ES cells (Niwa 2007). Transcription regulators
promote self-renewal through different mechanisms.
These mechanisms may involve inhibition of differen-
tiation or promoting proliferation (Niwa 2007). We pro-
vided evidence that Jmjd1a and Jmjd2c maintain the
“stemness” state of ES cells through regulating down-
stream genes that encode for self-renewal regulators
(Chambers et al. 2003; Mitsui et al. 2003; Ivanova et al.
2006; Matoba et al. 2006).
Previous work has shown that Jmjd1a demethylates
H3K9Me2 of LamB1 and Stra6 in F9 embryonic carci-
noma cells (Yamane et al. 2006). Knockdown of Jmjd1a
in F9 cells also slightly reduces the expression of Oct4,
Sox2, and Nanog (Yamane et al. 2006). We showed that
Jmjd1a prevents the promoter regions of pluripotency-
associated genes (Tcl1, Tcfcp2l1, and Zfp57) from H3K9
dimethylation (Fig. 7). An increase in H3K9 dimethyl-
ation is correlated with a reduction in the expression of
the target genes, indicating that Jmjd1a positively regu-
lates their expression. Oct4 recruitment to the Tcl1 pro-
moter was reduced in the Jmjd1a knockdown ES cells. It
is likely that the increased H3K9Me2 limited the access
of Oct4 to the oct element of the Tcl1 promoter region.
Thus we have identified a novel mechanism by which
Jmjd1a maintains the pluripotent epigenetic state of a
key regulator of ES cells. Tcl1, a gene encoding for a
cofactor of the Akt1 kinase, is of interest as it has been
shown to regulate self-renewal of ES cells (Ivanova et al.
2006; Matoba et al. 2006). Interestingly, forced expres-
sion of Tcl1 can rescue the differentiated phenotype
brought about by the knockdown of Jmjd1a, but not
Jmjd2c. Moreover, most of the pluripotent and differen-
tiation markers’ levels were restored in the Tcl1 rescue
experiments. This suggests that Tcl1 is the dominant
target of Jmjd1a in regulating self-renewal. However, we
observed that the Tcl1 rescue was only partial, as some
differentiated cells were still observed. Thus it is pos-
sible that other Tcl1-independent mechanisms exist for
Jmjd1a in regulating the self-renewal of ES cells. Further
analysis using genome-wide ChIP will be important to
define other regulatory targets of Jmjd1a that could be
important in ES cell biology.
Overexpression of the Jmjd2 family of JHDMs has
been shown to demethylate H3K9Me3-enriched pericen-
tric heterochromatin and cause delocalization of HP1-
(Cloos et al. 2006; Fodor et al. 2006; Klose et al. 2006).
Here, we show that Jmjd2c is involved in regulating the
euchromatin H3K9Me3 status of a key pluripotency
gene, Nanog. Our result also suggests that the specific
demethylation of H3K9Me3 by Jmjd2c at the Nanog pro-
moter may prevent the binding of transcription corepres-
sors such as HP1 and KAP1. Forced expression of Nanog
Figure 7. Model for the maintenance of self-renewal of ES cells
by Jmjd1a and Jmjd2c. Schematic showing the interplay of Oct4
with Jmjd1a and Jmjd2c in sustaining ES cells’ self-renewal. In
ES cells, Oct4 up-regulates the levels of Jmjd1a and Jmjd2c.
Jmjd1a and Jmjd2c maintain Tcl1 and Nanog by demethylation
of the repressive H3K9Me2 and H3K9Me3 marks, respectively.
Notably, Tcl1 and Nanog are both downstream targets of Oct4.
With differentiation, the down-regulation of Jmjd1a and Jmjd2c
(dashed arrows) results in an elevation of the repressive
H3K9Me2/Me3 modifications and reduced expression of down-
stream genes.
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can rescue the knockdown effects of Jmjd2c. However, as
seen in the Tcl1 rescue, overexpressing Nanog does not
completely rescue the Jmjd2c knockdown effect. This
could indicate the presence of other Nanog-independent
mechanisms downstream from Jmjd2c in the mainte-
nance of self-renewal of ES cells.
A series of recent studies reported that ectopic expres-
sion of four transcription factors alone (Oct4, Sox2,
c-Myc, and Klf4) is able to reprogram somatic cells to the
pluripotent stem cell state (Takahashi and Yamanaka
2006; Maherali et al. 2007; Okita et al. 2007; Wernig et
al. 2007). These remarkable studies demonstrate that the
genetic program and epigenetic landscape of stem cells
can be restored in differentiated cells. We postulate that
some of these reprogramming factors may be able to up-
regulate histone modifiers such as Jmjd1a and Jmjd2c to
assist in the resetting of the epigenetic landscape of so-
matic cells. In the present study, we identified two novel
nodes in the Oct4 transcription regulatory network, ex-
tending from Jmjd1a and Jmjd2c to Tcl1 and Nanog, re-
spectively (Fig. 7). Hence, these state-specific demethyl-
ases appear to directly regulate a distinct set of genes.
This is also the first example of an ES cell transcription
factor regulating a novel pathway that specifies the epi-
genetic status of pluripotency-associated genes.
Materials and methods
Cell culture and transfection
Feeder-free E14 mouse ES cells were cultured at 37°C with 5%
CO2. All cells were maintained on gelatin-coated dishes in Dul-
becco’s modified Eagle’s medium (DMEM; GIBCO), supple-
mented with 15% heat-inactivated fetal bovine serum (FBS;
GIBCO), 0.055 mM -mercaptoethanol (GIBCO), 2 mM L-glu-
tamine, 0.1 mM MEM nonessential amino acid, 5000 U/mL
penicillin/streptomycin, and 1000 U/mL LIF (Chemicon), as de-
scribed previously (Chew et al. 2005). Transfection of shRNA
and overexpression plasmids was performed using Lipofect-
amine 2000 (Invitrogen) according to the manufacturer’s in-
structions. Briefly, 2 µg of plasmids were transfected into ES
cells on 60-mm plates for RNA and protein extraction. For the
ChIP assay, 18 µg of plasmids were transfected into ES cells on
150-mm plates. Puromycin (Sigma) selection was introduced 1 d
after transfection at 1.0 µg/mL, and maintained for 4 d prior to
harvesting. For the replating assay, after 3 d of puromycin se-
lection, shRNA-transfected cells were trypsinized and resus-
pended in medium. Ten-thousand cells were plated onto newly
gelatin-coated 60-mm plates to form secondary ES cell colonies.
After 4 d, emerging colonies were stained for alkaline phospha-
tase activity. For all the data shown (unless indicated other-
wise), the cells were harvested and analyzed after 4 d of puro-
mycin selection. Detection of alkaline phosphatase, which is
indicative of the undifferentiated state of ES cells, was carried
out using a commercial ES Cell Characterization Kit from
Chemicon (catalog no. SCR001).
RNAi assay
shRNA constructs were designed as described previously (Chew
et al. 2005). Two shRNA constructs each for Jmjd1a and Jmjd2c
were designed to target 19-base-pair (bp) gene-specific regions.
The oligonucleotides used for Jmjd1a and Jmjd2c shRNA con-
structs are shown in Supplementary Figures 3A and 4A. These
oligonucleotides were cloned into pSuperpuro (BglII and HindIII
sites; Oligoengine). The pSuperpuro plasmid carries a puromy-
cin gene driven by a PGK promoter. We used pSuperpuro con-
structs expressing shRNA against Luciferase (Firefly) or Green
fluorescent protein (Gfp) as controls. These constructs were ef-
fective in knocking down coexpressed Luciferase or Gfp; there-
fore, they produced effective small interfering RNAs (siRNAs)
in ES cells.
RNA isolation, reverse transcription, and real-time
PCR analysis
Total RNA was extracted using Trizol (Invitrogen) and was pu-
rified with an RNeasy minikit (Qiagen). cDNA synthesis was
performed with 1 µg of total RNA using the SuperScript II kit
(Invitrogen) according to the manufacturer’s instructions. En-
dogenous mRNA levels were measured by real-time PCR analy-
sis based on SYBR Green detection with the ABI Prism 7900HT
machine (Applied Biosystems). Results were normalized with
-actin. The real-time PCR primers are available on request.
Protein extraction and Western blotting
Histones were extracted using the acid extraction method.
Briefly, cells were scraped from culture dishes in chilled PBS,
centrifuged, and washed once with ice-cold PBS. Cell pellets
were then incubated in Triton extraction buffer (PBS, 0.5% Tri-
ton X-100, 2 mM PMSF) for 10 min on ice. Pellets were resus-
pended in 0.2 N HCl overnight for the extraction of histone.
Total protein extracts were prepared by lysing cells in SDS load-
ing buffer. Total protein (40 µg) or histone (5 µg) was separated
by SDS-PAGE and transferred to PVDF membrane. The mem-
brane was probed with either anti-H3K9Me2 (ab7312; Abcam),
anti-H3K9Me3 (ab8898; Abcam), anti-Jmjd1a (amino acids
1–400 of mouse Jmjd1a raised in rabbit), or anti-Jmjd2c (amino
acids 351–551 of mouse Jmjd2c raised in rabbit). Anti-H3
(ab1791; Abcam) or anti--tubulin was used as loading control.
Microarray
mRNAs derived from Jmjd1a shRNA 1-, Jmjd2c shRNA 1-, and
Luc shRNA-treated ES cells were reverse-transcribed, labeled,
and analyzed using the Illumina microarray platform (Sentrix
Mouse-6 Expression BeadChip version 1.0). Arrays were pro-
cessed as per the manufacturer’s instructions. Three biological
repeats of the profiles (each for control and knockdown of the
two genes) were used to generate statistically significant gene
lists. Rank Invariant normalization was used to normalize the
microarrays. Significance analysis of microarrays (SAM) was
used to select differentially expressed genes. The differentially
expressed genes were selected based on the following three cri-
teria: fold change (FC) > 1.5 for up-regulated, FC < 0.6 for down-
regulated; q value < 2%; and detection probability >0.99 in at
least all three samples of any one group (control or treatment).
Microarray data will be uploaded to a public microarray re-
source site. To compute the nominal P-value for the overlapping
gene lists, we performed Monte Carlo simulation as described
previously (Loh et al. 2006)
ChIP assay
ChIP assay was carried out as described previously (Loh et al.
2006). Briefly, cells were cross-linked with 1% (w/v) formalde-
hyde for 10 min at room temperature, and formaldehyde was
then inactivated by the addition of 125 mM glycine. Chromatin
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extracts containing DNA fragments with an average size of 500
bp were immunoprecipitated using anti-Oct4 (sc-8628; Santa
Cruz Biotechnology), anti-Sox2 (sc-17320; Santa Cruz Biotech-
nology), anti-H3K9Me2 (ab7312; Abcam), anti-H3K9Me3
(ab8898; Abcam), anti-Jmjd1a Ab1 (amino acids 1–300 of mouse
Jmjd1a raised in rabbit), anti-Jmjd1a Ab2 (amino acids 1–400 of
mouse Jmjd1a raised in rabbit), anti-Jmjd2c Ab1 (amino acids
523–702 of mouse Jmjd2c raised in rabbit), anti-Jmjd2c Ab2
(amino acids 351–551 of mouse Jmjd2c raised in rabbit), anti-
HP1- (MAB3448; Chemicon), or anti-KAP1 (ab22553; Abcam)
antibodies. Anti-GST (sc-459; Santa Cruz Biotechnology) or
anti-GFP (sc-9996; Santa Cruz Biotechnology) antibodies were
used as mock ChIP controls. Quantitative PCR analyses were
performed in real time using the ABI PRISM 7900 sequence
detection system and SYBR green master mix. Threshold cycles
(Ct) were determined for both immunoprecipitated DNA and
known amount of DNA from input sample for different primer
pairs. Relative occupancy values (also known as fold enrich-
ments) were calculated by determining the immunoprecipita-
tion efficiency (ratios of the amount of immunoprecipitated
DNA to that of the input sample) and were normalized to the
level observed at a control region, which was defined as 1.0. The
coordinates for the control region, which is downstream from
the Nanog gene, is chr6:123352993–123353158 (mm5 genome
build). For all the primers used, each gave a single product of the
right size, as confirmed by agarose gel electrophoresis and dis-
sociation curve analysis. The real-time PCR primers are avail-
able on request.
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Nanog shRNA Esrrb shRNA






























































































































































































































































































































































Jmjd1a shRNA 1 :          GAGUAUGUGUAGAUUGCUA
Jmjd1a shRNA A
Jmjd1a shRNA 2 :          GUAGACCUAGUCAAUUGUA
Jmjd1a shRNA 1
Jmjd1a shRNA 2
Jmjd1a shRNA 1 mut




















































































































































































































































































 1 mut :   GAGUAUGUAUCGAUUGCU








Jmjd2c shRNA 1 mut :
Jmjd2c shRNA 1 :          GGACUGUUCACGCAAUACA
Jmjd2c shRNA 2 mut :


































































































































































































































































































































































































Jmjd1a shRNA 1 Jmjd2c shRNA 1 mut
Jmjd2c shRNA 2
j 2c sh  1














































































































Jarid 2 shRNA 1
Jarid 2 shRNA 2
Jarid 1a shRNA 1










































































































Luc shRNA Jmjd1a shRNA 1 Jmjd1a shRNA 2












































































































































































































































































































































































































































































































































































































































Luc shRNA Tcl1 shRNA1 Tcl1 shRNA2
Tcl1 shRNA 1  :          GAAGCACGUGUACUUGGAU
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Luc shRNA Jmjd1a shRNA 1
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